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Summary 
 
The most severe form of malaria, caused by Plasmodium falciparum, is an enormous 
burden for the endemic countries without any commercial vaccine available 
currently. P. falciparum possesses a complex life cycle, changing from different hosts 
and environmental conditions, and hence requires intensive and essential 
mechanisms for regulation of gene expression to survive and take advantage from 
external environments. In recent years, epigenetic control of gene expression 
emerged as an important mechanism to regulate expression of genes involved in 
virulence and sexual differentiation. Among epigenetic histone marks, histone 3 lysine 
9 trimethylation (H3K9me3), which is considered the hallmark of heterochromatin 
formation, is recognized by an evolutionary conserved silencing factor called 
heterochromatin protein 1 (HP1). HP1 is a small protein consisting of three domains: 
two conserved domains at the N and C-terminus, namely the chromo domain (CD) 
and chromoshadow domain (CSD), respectively, and a variable hinge or linker 
domain in between them. The CD recognizes and binds to H3K9me3 to establish 
heterochromatin while the CSD interacts with a large number of effector proteins. HP1 
possesses a number of posttranslational modifications, among which phosphorylation 
is highly important in regulating its functions. P. falciparum encodes only one HP1 
isoform in contrast to most other eukaryotes that contain two to five HP1 paralogs. 
Although HP1 has been well studied in model eukaryotes, the detailed functions of 
each PfHP1 domain as well as PfHP1 phosphorylation in P. falciparum are poorly 
understood. My PhD project aimed to investigate PfHP1 function in detail using 
CRISPR/Cas9-based gene editing combined with the DiCre/loxP system for conditional 
mutagenesis. The two specific objectives were (1) to uncover the roles of the individual 
PfHP1 domains in PfHP1 function and (2) to understand if and how phosphorylation of 
PfHP1 regulates its function. Both objectives focused on the three known PfHP1-
dependent cellular processes: (1) the maintenance of heritable silencing and mutually 
exclusive expression of var genes, (2) mitotic progression of asexual blood stage 
parasites, and (3) sexual commitment. 
In the first project, I aimed to analyse the functional contribution and conservation of 
the CD, Hinge and CSD domains of PfHP1 using the approach mentioned above to 
generate PfHP1 truncation and hybrid mutant lines. I found that nuclear localization 
ability of PfHP1 is underlined in the N-terminal 29 amino acids (1-29) and the C-terminal 
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76 amino acids (191-266). The former polypeptide is supposed to have weak ability of 
nuclear delivery while the later one is necessary for fully targeting PfHP1 to nucleus. I 
also showed that an intact PfHP1 containing all three structural domains is required for 
heterochromatin localization and the normal asexual growth pathway of blood stage 
malaria parasites. Third, I successfully generated a PfHP1 knock out cell line with more 
pronounced phenotype that allowed massive production of more than 82% of sexual 
commitment rate once induced and suggested a PfHP1-independent regulatory 
pathway of var gene silencing during gametocytogenesis. Finally, I showed that the 
HP1 Hinge and CSD domains are functionally conserved between human – and 
rodent malaria parasites. 
In the second project, I aimed to address (1) the kinases phosphorylating PfHP1 and 
their target residues and (2) the role of selected phosphorylated residues in regulating 
PfHP1 function using similar approach mentioned above to generate conditional 
PfHP1 phosphomutant cell lines. Liquid chromatography tandem mass spectrometry 
(LC-MS/MS) analysis of immunoprecipitated native PfHP1 showed that PfHP1 is 
phosphorylated mostly in the CD and hinge domains. In vitro kinase assays revealed 
that PfHP1 is a substrate of P. falciparum CK2 (PfCK2). LC-MS/MS analysis showed that 
PfCK2 targets three clustered serine residues within the PfHP1 hinge region in vitro. By 
generating conditional PfHP1 phosphomutant cell lines using CRISPR/Cas9-mediated 
genome editing and the DiCre/LoxP system, I found that PfCK2-dependent 
phosphorylation of PfHP1, and phosphorylation of the PfHP1 hinge domain in general, 
is dispensable for proper PfHP1 localization, gene silencing, parasite growth and sexual 
conversion. 
In summary, for the first time, in-depth function and functional conservation of 
PfHP1domains as well as phosphorylation of PfHP1 have been studied in detail in the 
three main PfHP1-dependent processes (var gene silencing, mitotic proliferation, 
sexual commitment). The experimental pipeline established in this study provides an 
elegant approach to interrogate function of other essential proteins. In addition, the 
study also provides a tool for robust production of gametocytes used in further studies 
on gametocyte biology or high-throughput anti-malaria gametocyte drug screen. This 
study is highly relevant to study pathogenesis and transmission as well as underlying 
epigenetic mechanisms in some other unicellular pathogenic eukaryotes since they 
also share common features such as changing living environments and mutually 
exclusive expression of surface antigens. 
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Chapter 1. Introduction  
1.1 Malaria and Plasmodium falciparum 
Malaria is a complex parasitic disease transmitted by female Anopheles mosquitoes 
through blood feeding. In 2017, 219 million cases of malaria occurred worldwide, 2 
million cases more compared with 2016 (World Health Organization – World malaria 
report 2018 at https://www.who.int/malaria/publications/world-malaria-report-
2018/report/en/).  
Five species of the Plasmodium genus infect humans, namely P. vivax, P. ovale, P. 
malaria, P. knowlesi  and P. falciparum (Cox-Singh et al., 2008). Among them, P. 
falciparum causes the most lethal and severe malaria, especially among children 
under five years old (Elliott and Beeson, 2008). The massive proliferation of intra-
erythrocytic parasites during blood stage infection is responsible for all malaria-related 
symptoms. A number of surface antigens on the infected red blood cell (RBC) 
membrane, in particular P. falciparum erythrocyte membrane protein 1 (PfEMP1), 
interact with receptors on blood endothelial cells such as ICAM-1, CD-36 and with 
uninfected RBCs (rosetting), resulting in cellular adherence and sequestration of 
infected RBC (iRBC)  (Newbold et al., 1997; Rowe et al., 2009). Hence, iRBC clearance 
from the blood stream is reduced as the parasite escapes passage through the spleen 
(Yazdani et al., 2006). Furthermore, sequestration causes severe malaria outcomes 
such as cerebral or placental malaria by blocking blood flow, damaging tissues and 
triggering inflammatory responses (Miller et al., 2013). Antigenic variation and diversity 
of PfEMP1 and many other antigens contribute significantly to immune evasion and 
hence to the establishment of chronic infection (Reeder and Brown, 1996). Although 
acquired immune responses develop gradually after repeated exposure (Marsh and 
Kinyanjui, 2006), sterile immunity is not acquired even after life-long exposure to 
malaria parasites (Ferreira et al., 2004).   
1.2 Plasmodium falciparum life cycle 
P. falciparum has a complex life cycle in two different hosts and various environments: 
the sexual reproduction in mosquitoes and several cycles of asexual proliferation and 
development in the mosquitoes and the human host (Figure 1.1). During their blood 
meal, the female Anopheles injects sporozoites which travel to the liver where they 
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first infect hepatocytes (Scherf et al., 2008). The parasites then undergo asexual 
division to produce merozoites and are released into the blood stream to invade RBCs 
(Scherf et al., 2008). Within RBCs, parasites reside in a parasitophosphorous vacuole 
and develop into the ring stage, starting to synthesise stage-specific proteins that are 
actively exported into the host cell to refurnish the erythrocyte cytosol and membrane 
(Maier et al., 2009).  Among these proteins, PfEMP1, encoded by var gene family, is 
considered the major parasite virulence factor. var gene expression is controlled 
tightly in a mutually exclusive manner that only one var gene is transcribed by a single 
parasite (Deitsch and Dzikowski, 2017; Dzikowski and Deitsch, 2009; Kyes et al., 2007; 
Scherf et al., 1998; Voss et al., 2014; 2006) in order to avoid exhausting the surface 
antigen repertoire. Once PfEMP1s is exported to the RBC membrane, the protein is 
assembled in so-called knob structures (Maier et al., 2009). The N-terminal (binding) 
region of PfEMP1 is directed on the external surface of iRBCs while the acidic C-
terminal sequence (ATS) faces the erythrocyte cytosol (Baruch et al., 1995; J. D. Smith 
et al., 1995). The extracellular part of PfEMP1 is responsible for causing cellular 
adherence and antigenic variation which is the driving force of chronic infection 
(Bannister and Mitchell, 2003). When intra-erythrocytic parasites enter the schizont 
stage, the parasite nucleus divides multiple times and finally cytokinesis generates 16-
32 merozoites that are released into the blood circulation to reinvade RBCs and start 
another 48-hour intraerythrocytic cycle. Importantly, during each round of intra-
erythrocytic development, a small subpopulation of asexual parasites exits the cell 
cycle and undergoes sexual differentiation to form gametocytes (Ngotho et al., 2019). 
After 10-12 days of maturation, male and female stage V gametocytes are able to 
infect mosquitoes (Bruce et al., 1990; Inselburg, 1983; Silvestrini et al., 2000; T. G. Smith 
et al., 2000). Further in the mosquito, gamete egress, fertilization and sporogonic 
development occur to ultimately produce infective sporozoites ready for transmission 
to the next human.  
During progression through the life cycle, P. falciparum expresses distinct global 
transcriptomes and proteomes (Horrocks et al., 2009). For instance, inside the 
mosquito, a noticeable proportion (46%) of proteins appear to be unique for the 
ookinete stage (Patra et al., 2008). Similarly, 49% of proteins found in sporozoites are 
specific for this stage and in merozoites, trophozoites and gametocytes 20-33% of all 
detected proteins are likely specific for the corresponding stage (Florens et al., 2002). 
Only a small number (6%) of proteins have been detected in all life cycle stages 
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(Florens et al., 2002). Even during the intraerythrocytic developmental cycle (IDC), 
transcription profiles during rings, trophozoites and schizonts are also stage-specific, 
showing that gene expression regulation during the IDC is tightly regulated in P. 
falciparum (Bozdech et al., 2003).  
 
 
Figure 1.1. Life cycle of P. falciparum (Rowe et al., 2009) 
 
It has therefore been suggested that P. falciparum transcribes many genes in a “just-
in-time” manner where genes are only expressed when their protein products are 
needed (Bozdech et al., 2003). For example, genes important for the merozoite 
invasion process including ama1, eba175, msp1, msp4 or msp5 are transcribed in 
middle and late schizonts, whereas var genes and many genes required for host cell 
remodelling are expressed in ring stages, early after invasion (Bozdech et al., 2003). 
1.3 Gene regulation in Plasmodium falciparum  
As mentioned above, P. falciparum lives an extraordinarily complex life cycle during 
which morphology, function, metabolism and antigens are stage-specific. Hence, 
intensive and essential mechanisms for a tight regulation of gene expression are 
required for the parasite in order to survive and progress through vastly different 
environments (Horrocks et al., 2009; Voss et al., 2014). It is not surprising that P. 
falciparum controls gene expression at multiple levels (Horrocks et al., 2009) and 
interconnects different layers of regulation, including transcriptional regulation and 
epigenetic mechanisms to govern many important cellular processes, for example, 
the clonally variant expression of var genes to evade host immunity and sexual 
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conversion pathways in order to transform/switch from the asexual blood stage form 
to gametocytes, the transmissible form of the parasites. 
1.3.1 Transcriptional regulation and specific transcription factors 
One central mechanism of gene-specific transcriptional control in model eukaryotes 
is the fine-tuned interplay between trans-acting factors, for example transcription 
factors, and cis-regulatory elements in a sequence-specific manner at promoter 
regions (Horrocks et al., 2009).  Compared to other eukaryotes, P. falciparum possesses 
a unique small set of specific transcription factors (TFs) (Coulson et al., 2004).  
There have been few P. falciparum transcription factors (TFs) characterized so far 
including Myb1 protein (Gissot et al., 2005; Komaki-Yasuda et al., 2013) and several 
Apicomplexa apetala2 (ApiAP2) family factors (Balaji et al., 2005; Jeninga et al., 2019; 
Modrzynska et al., 2017; Painter et al., 2011).  
While the mechanisms that P. falciparum uses to tightly control transcription are not 
well understood, several lines of evidences imply an important role of ApiAP2 factors 
in this type of regulation. ApiAP2 is a phylum-specific family of sequence-specific DNA-
binding proteins in Apicomplexa phylum (De Silva et al., 2008). The proteins are varied 
in size but the AP2-intergrase DNA binding like domain containing 60 amino acids is 
highly conserved between ApiAP2 members (Balaji et al., 2005). Each of ApiAP2- 
family members has one to four AP2 domains (Balaji et al., 2005). Using protein binding 
microarrays (PBMs), a large number of these AP2 domains were shown to bind to 
specific DNA motifs that are also found in the promoter regions of subsets of parasite 
genes (Campbell et al., 2010; De Silva et al., 2008). As AP2 domains from particular 
ApiAp2 proteins are able to bind several DNA sequence motifs, this feature highly likely 
increases the number of genes regulated by one transcription factor (Campbell et al., 
2010).  
Most of P. falciparum apiap2 genes (22/27 genes) are expressed in a stage-specific 
manner during the 48-hour IDC (Balaji et al., 2005). As presumed master regulators of 
parasite development, ApiAP2 factors have been shown to take part in 
developmental transition processes such as ookinete formation (Yuda et al., 2009), 
sporozoite formation (Yuda et al., 2010), liver stage development (Iwanaga et al., 
2012) and gametocyte commitment within the human blood stream (Kafsack et al., 
2014; Sinha et al., 2014). Up to date, there have been a number of ApiAP2 proteins 
characterized in detail. There are some ApiAP2 proteins functioning as transcription 
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factors that mediate gene expression, including five that have been characterized in 
the rodent malaria parasite, P. berghei and three have been characterized in P. 
falciparum. They are PbAP2-O (ortholog of PF3D7_1143100) (Yuda et al., 2009), PbAP2-
L (ortholog of PF3D7_0730300) (Iwanaga et al., 2012), PbAP2-G2 (no otholog in P. 
falciparum) (Modrzynska et al., 2017; Yuda et al., 2015), PbAp2-SP (otholog of 
PF3D7_1466400 or PfAP2-exp) (Modrzynska et al., 2017; Yuda et al., 2010), PbAP2-G 
(ortholog of PfAP2-G) (Sinha et al., 2014),  PfAP2-exp (Martins et al., 2017),  PfAp2-I 
(Santos et al., 2017) and the PfAP2-G (Kafsack et al., 2014).  
In the rodent malaria parasite P. berghei, PbAP2-L has a wide range of expression 
including salivary gland sporozoites, erythrocytic trophozoites and liver stages 
(Iwanaga et al., 2012). Depletion of PbAP2-L resulted in the arrest of parasites at mid-
schizont development (36 hpi) in hepatocytes, thus decreasing the ability of liver 
infection (Iwanaga et al., 2012). Meanwhile, PbAP2-O and PbAP2-SP transcription 
factors were described to be exclusively expressed in mosquito stages (Yuda et al., 
2010; 2009). PbAP2-O is highly expressed in ookinetes, the mosquito midgut-invading 
stage and plays an essential role for the normal morphogenesis of oocyst 
development (Yuda et al., 2009). The PbAP2-SP is expressed in oocyst and salivary 
gland sporozoites and disruption of pbap2-sp caused loss of sporozoite formation in 
oocyst (Yuda et al., 2010). Orthologs of PbAP2-L, PbAP2-O and PbAP2-SP in P. 
falciparum, in contrast,  are all expressed during IDC (Balaji et al., 2005; Bozdech et 
al., 2003; Iwanaga et al., 2012; Le Roch et al., 2003; Otto et al., 2010; Yuda et al., 2009), 
suggesting that they might have IDC-related functions. To be specific, the disruption 
of pfap2-exp (ortholog of pbap2-sp) resulted in the alteration of the knob-morphology 
(rougher and larger) and an upregulation of some clonally variant gene families at 
sub-telomeric regions such as rif, stevor and Pfmc-2TM (Martins et al., 2017). Recently, 
PfAP2-I has been found to associate with the promoters of genes involved in wide 
range of functions in P. falciparum such as invasion genes (msp, rap, and rhopH gene 
families), nucleosome and chromatin-related genes, cell division/cell-cycle-related 
genes and genes related to vesicle formation and host cell remodelling (Santos et al., 
2017). 
In 2014, whole genome sequencing of gametocyte non-producer lines in both P. 
falciparum and P. berghei has discovered mutations in ap2-g, a conserved member 
of the ApiAp2 family among all species in Apicomplexa phylum (Sinha et al., 2014), 
connected to this phenotype (Kafsack et al., 2014; Sinha et al., 2014). Knock out of 
Chapter 1|   Introduction 
 6 
ap2-g in the two parasites resulted in the complete loss of gametocyte producibility 
(Kafsack et al., 2014; Sinha et al., 2014). The correction of AP2-G mutations or 
complementation of an ap2-g deletion mutant in P. berghei restores gametocyte 
reducibility to that of wildtype parasites (Sinha et al., 2014). A number of gametocyte-
specific genes have been found to be deregulated in the gametocyte non-producer 
ap2-g mutant lines by qRT-PCR and microarray (Kafsack et al., 2014; Sinha et al., 2014). 
Both of PfAP2-G and PbAP2-G DNA binding domain binds to a 6-mer palindrome 
motifs (GxGTAC and GTACxC) which occur frequently within promoters of genes 
upregulated in gametocytes (Kafsack et al., 2014; Sinha et al., 2014). These binding 
motifs are also found in the upstream region of the pfap2-g and pbap2-g genes, 
suggesting that the expression of AP2-G might follow an auto feedback regulatory 
mechanism (Kafsack et al., 2014; Sinha et al., 2014). In addition, pfap2-g locus was 
found associated with histone silencing marker (H3K9me3) (Kafsack et al., 2014; Lopez-
Rubio et al., 2009) and is the only PfHP1-regulated member of the apiap2 family 
(Brancucci et al., 2014; Flueck et al., 2009), implying that pfap2-g expression is also 
controlled by epigenetic mechanisms.  
PbAP2-G2 (PBANKA_103430, no ortholog in P. falciparum) was first addressed as a 
transcription factor that is significantly associated with sexual commitment but acts 
downstream of this irreversible commitment point to rather modulate gametocyte 
maturation (Kafsack et al., 2014). PbAP2-G2 was later shown to bind to 5-mer motifs in 
the promoters of a series of genes that are required for asexual proliferation (Yuda et 
al., 2015). Many of these genes were found to be upregulated in PbAP2-G2 depleted 
cell line (Yuda et al., 2015), suggesting that PbAP2-G2 plays as a suppressor of genes 
important for asexual stages in gametocytes. Further, in a pure asexual population 
due to pbap2-g depletion, an upregulation in gene transcription and protein 
translation of gametocyte-specific and ookinete-specific genes was found upon 
pbap2-g2 depletion (double knockout) (Modrzynska et al., 2017). The later study 
suggested that PbAP2-G2 plays as a suppressor of transmission genes in asexual 
parasites (Modrzynska et al., 2017). Together, these studies revealed PbAP2-G2 as a 
transcriptional repressor in both asexual and sexual blood stages in the rodent malaria 
parasites (Modrzynska et al., 2017; Yuda et al., 2015).  
In addition to the transcription factors above, there are also ApiAp2 members that 
play other general functions, of which two have been characterized in P. falciparum, 
PfSIP2 (Flueck et al., 2010) and PfAP2-Tel (Sierra-Miranda et al., 2017). PfSIP2 
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(Plasmodium falciparum SPE2-interacting protein) was shown to interact preferentially 
with SPE2 motifs located in telomere-associated repetitive elements (TAREs) 2/3 
regions and directly upstream of upsB-type var genes (Flueck et al., 2010; Voss et al., 
2003). While orthologs of PfSIP2 were found in other sequenced Plasmodium species, 
sub-telomeric SPE2 elements were exclusively found in P. falciparum (Flueck et al., 
2010; Voss et al., 2003). The protein was proposed to play multiple functional roles 
including var gene silencing, heterochromatin formation and organization, genome 
integrity, chromosome replication and segregation (Flueck et al., 2010) but the exact 
function of PfSIP2 remains unknown. Recently, in 2017, Sierra-Miranda M. and 
colleagues have reported PfAP2-Tel as a component of a telomere-binding complex 
in P. falciparum (Sierra-Miranda et al., 2017). The protein was identified with one 
canonical DNA-binding domain and conserved among all Plasmodium spp. (Sierra-
Miranda et al., 2017). PfAP2-Tel localizes to telomeric clusters throughout all parasite 
stages in the IDC (Sierra-Miranda et al., 2017). Genome-wide profiling using ChIP-Seq 
revealed its predominant distribution at 14 telomere ends and protein binding assays 
revealed its direct binding to the GGGTT(T/C)A conserved telomeric tandem repeat 
(Mancio-Silva et al., 2008; Sierra-Miranda et al., 2017). It is interesting that this telomere 
repeat-binding factor (TRF) does not contain a sequence-specific MYB-type DNA-
binding domain as all known TRFs have in other model eukaryotes (Giraud-Panis et al., 
2010), but uses AP2 binding domain instead, thus opening a new insight into telomere 
biology in P. falciparum as well as set a novel function of ApiAP2 members. 
Up to date, only two transcription factors outside the ApiAp2 family have been 
characterized in detail, namely PfMyb1 (Gissot et al., 2005) and PfPREBP (Kornberg, 
2007). The PfMyb1 protein contains three Myb domains with DNA binding ability at the 
C-terminal region (Boschet et al., 2004). PfMyb1 protein was shown to be an essential 
transcription factor for the erythrocytic cycle of P. falciparum and for regulating key 
genes, such as pfpk5 and PFL1285c, a homologue of proliferating cell nuclear antigen 
(PCNA) which is involved in cell cycle regulation and progression (Gissot et al., 2005). 
In addition, the transcription factor PREBP in P. falciparum was discovered as a novel 
and unique transcription factor by possessing four K-homology (KH) domains that are 
usually found in RNA- and single-stranded DNA-binding proteins (Valverde et al., 
2008). The binding of PREBP to a 102 bp-cis enhancer region of the pf1-cys-prx gene 
regulates the expression timing of this antioxidant protein exclusively in trophozoites 
and schizont stages (Komaki-Yasuda et al., 2013).  
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1.3.2 Epigenetic regulation 
Another alternative primary mode of transcriptional regulation is epigenetic control, 
which P. falciparum utilizes to govern nutrient uptake, clonally variant gene expression 
of virulence genes in blood stage parasites and sexual differentiation (Voss et al., 
2014). Epigenetics is a biological term referring to the heritable, reversible change in 
phenotype occurring through changes in chromatin structure without changes in the 
underlying DNA sequence (Berger et al., 2009). The two major states of chromatin are 
known as euchromatin and heterochromatin. Euchromatin is rather loosely packed 
chromatin, allowing transcriptional activation of genes located in these regions. In 
contrast, heterochromatin consists of a more condensed chromatin structure related 
to gene inactivation/heritable silencing (Woodcock and Ghosh, 2010). In eukaryotes, 
DNA methylation, non-coding RNA and chromatin modifications are favourable 
processes involved in epigenetic regulation of gene expression (A. D. Goldberg et al., 
2007; Handy et al., 2011).  
In Plasmodium falciparum, DNA methylation is still an enigma. It has been reported 
that only a small proportion of the cytosines was asymmetrically methylated and non-
CG methylations also occurs in the P. falciparum genome during its IDC (Ponts et al., 
2013). While a potentially putative C5 DNA methytransferase gene (PF3D7_0727300, 
encoding for PfTRDMT1) was detected computationally (Ponts et al., 2013), the DNA 
methyltransferase activity of this protein was still controversial as a recent study has 
shown that PfTRDMT1 only methylated endogenous aspartic acid tRNA at cytosine 
position 38 but not DNA (Govindaraju et al., 2017). These results, together with an 
extreme A+T richness (80.6%) in the genome (Gardner et al., 2002)  suggest that the 
parasite has lost its DNA methylation machinery during evolution, just like the other 
apicomplexan parasites Toxoplasma gondii and Cryptosporidium parvum (Gissot et 
al., 2008).  
Another epigenetic mode to control gene expression in P. falciparum is the non-
coding RNA machinery. As its name suggests, such RNAs are transcribed but not 
translated into proteins. Although P. falciparum lacks functional small RNA-
interference machinery (RNAi) (Baum et al., 2009), long non-coding (lncRNAs) and 
antisense long non-coding RNAs (aslncRNAs) are observed in the parasite during its 
IDC (Gunasekera et al., 2004; López-Barragán et al., 2011; Patankar et al., 2001; Siegel 
et al., 2014; Vembar et al., 2014; Wei et al., 2014). lncRNAs have been controversially 
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shown to associate with either inactive or active var genes (Epp et al., 2009; Jiang et 
al., 2013; Ralph et al., 2005). To date, there have been more and more evidences 
revealing the association of aslncRNAs with the active var gene in a sequence-
specific and dose-dependent manner (Amit-Avraham et al., 2015; Jing et al., 2018). 
Interestingly, while Voss and colleagues revealed an exogenous var promoter is 
sufficient to repress endogenous var gene transcription, thus controlling the singular 
choice of var gene expression (Voss et al., 2006), Q Jing and colleagues in contrast 
showed the co-transcription of both dominant endogenous and the newly induced 
var genes by an exogenous aslncRNA in one single parasite, thus breaking var gene 
mutually exclusive expression in short-term culture of parasites (Jing et al., 2018). 
Therefore, the var gene activation by aslncRNA is considered as a relative 
independent intermediary step of the regulation of singular var gene expression (Jing 
et al., 2018). Currently, antisense RNA transcript has been indicated as negative 
regulator for the expression of the gametocyte development 1 gene (Pfgdv1) which 
plays an important role in regulating sexual commitment (Filarsky et al., 2018). Deletion 
of pfgdv1 aslncRNAs resulted in the expression of GDV1 and consequently the 
upregulation of pfap2-g, which in turns triggers sexual commitment and 
gametocytogenesis (Filarsky et al., 2018). The AP2-G, encoded by pfap2-g, is a 
conserved member of the ApiAp2 family and was previously discovered as a master 
regulator of gametocytogenesis in both P. falciparum and P. berghei (Kafsack et al., 
2014; Sinha et al., 2014). The activation of ap2-g resulted in subsequent expression of 
genes encoding earliest known gametocyte markers, for example Pfs16, Pfg27/25, 
Pfg14.744 (Kafsack et al., 2014) and genes required for early gametocyte 
development such as several members of the PHIST family (Eksi et al., 2005). 
Furthermore, chromatin modification is a well-known mode of chromatin-based 
epigenetic mechanisms mediating gene expression in a wide range of organisms from 
yeast to human. Because of the lack of apparent DNA methylation and a functional 
RNAi pathway, the malaria parasite seems to largely exploit the pool of histone 
posttranslational modifications (PTMs) and histone variants to modulate chromatin 
accessibility. Beside the four canonical histone components (H2A, H2B, H3.1 and H4) 
making up nucleosomes as in other eukaryotes, four histone variants have been 
identified so far in P. falciparum (H3.3, centromere-specific H3 (cenH3), H2A.Z, H2B.Z 
(H2B.v)) (Miao et al., 2006). While H2A.Z was found at promoters and transcription 
starting sites (TSSs) of euchromatic genes in other eukaryotic models (Raisner et al., 
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2005; Schones et al., 2008), PfH2A.Z was constantly found at 5’and 3’ flanking regions, 
marking its presence at the intergenic regions throughout the IDC, especially with the 
colocalization of some particular histone PTMs such as H3K4me3 and H3K9ac (Bartfai 
et al., 2010). The double variant PfH2A.Z/H2B.Z was found at the same nucleosomes 
with H3K4me3 that occupied most 5’ flanking regions (Petter et al., 2013). The 
enrichment of the double variant Pf H2A.Z/Pf H2B.Z at A-T rich intergenic and promoter 
regions of the actively transcribed var gene (Hoeijmakers et al., 2013; Petter et al., 
2013) was shown to be correlated with var gene transcription and developmentally 
regulated (Petter et al., 2013). As the euchromatic intergenic region is especially rich 
in AT content (~90%) (Gardner et al., 2002), which is considered relative rigid and not 
easy to wrap around histone core, it seems the parasite has taken advantage of 
histone variants H2A.Z and H2B.Z to bind AT-rich DNA more effectively (Batugedara et 
al., 2017). Meanwhile, the PfH3.3 was discovered as a GC-content dependent histone 
variant that associates with euchromatic coding regions and sub-telomeric regions 
where the GC content is higher (Fraschka et al., 2016). Interestingly, PfH3.3 occupies 
promoter and coding regions of activated and poised var genes, raising a possibility 
of its epigenetic role in the memory of var gene expression (Fraschka et al., 2016). 
At least 106 individual histone PTMs have been identified so far in P. falciparum 
(Coetzee et al., 2017; Gupta et al., 2013; Saraf et al., 2016) and many of those have 
been found in other eukaryote models. Among those modifications, histone 
acetylation and histone methylation are the most abundant and widely studied.  
At least four histone acetyl transferases (HATs) and three classes of histone 
deacetylases (HDACs) have been identified in P. falciparum (Liwang Cui and Miao, 
2010). Acetylated lysines on histone tails such as lysine 9 at histone 3 (H3K9ac) and its 
associated HAT, PfGCN5 - a yeast GCN5 homologue involved in chromatin 
remodelling (Fan et al., 2004) were found at putative transcriptional starting sites (TSSs) 
and associated with gene activation (Long Cui et al., 2007). In contrast, PfSIR2, a P. 
falciparum HDAC homolog of yeast SIR2 protein (silent information regulator 2), which 
is responsible for the deacetylation of acetylated lysines on histone 3 and 4 (Merrick 
and Duraisingh, 2007), was found at promoters of the silenced var2csa gene and has 
been shown to mediate the mutually exclusive expression of sub-telomeric virulent 
genes including var and rifin (Duraisingh et al., 2005).  
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While histone acetylation is involved in gene activation, histone methylation could be 
involved in both gene activation and silencing. To be specific, H3K4me3 is associated 
with actively transcribed genes in P. falciparum (Salcedo-Amaya et al., 2009), PfSET2-
dependent H3K36me3 is enriched at the TSSs and associated with transcriptional 
repression, specifically with var gene silencing, controlling the singular choice of var 
gene expression (Jiang et al., 2013). Hence, by incorporating these modifications, 
histones can dictate higher order structure of chromatin, regulating transcriptional 
accessibility through recruitment of non-histone proteins (Kouzarides, 2007). To fulfil this 
function, histone PTM patterns (so-called histone codes) need to be recognized or 
read by histone code “reader” proteins containing specific domains binding to 
histone PTMs.  
In P. falciparum, there have been several histone code readers discovered including 
the phosphorylated histone reader - Pf14-3-3I (Dastidar et al., 2013), the acetylated 
histone reader - PfBDP1 (Josling et al., 2015) and the methylated histone reader - PfHP1 
(Brancucci et al., 2014; Flueck et al., 2009; Pérez-Toledo et al., 2009). Among those, 
PfBDP1 and PfHP1 have been functionally characterized in vivo.  
The PfBDP1 or bromodomain protein encoded by PF3D7_1033700 contains one 
bromodomain at the C-terminus and binds preferentially to H3K9ac and H3K14ac 
(Josling et al., 2015). PfBDP1 was found to interact with another bromodomain-
containing protein namely PfBDP2 (Josling et al., 2015). PfBDP1 was enriched near the 
transcriptional starting sites at the promoter regions of a number of genes important 
for invasion (Josling et al., 2015). Moreover, PfBDP1 depletion resulted in the 
downregulation of genes involved in invasion ligands and motility during invasion in 
schizont stage (Josling et al., 2015). Thus, these findings imply a role of PfBDP1 in 
invasion gene recognition and regulation (Josling et al., 2015).  
Plasmodium falciparum heterochromatin protein 1 (PfHP1), a reader of H3K9me3 is a 
conserved protein from fission yeast to human (Voss et al., 2014). The protein has stood 
out for its functions in epigenetically regulatory mechanisms in various cellular 
processes including antigenic variation, life cycle progression and sexual 
differentiation (Brancucci et al., 2014). As its name suggests, HP1 is an essential 
component of heterochromatin (Kwon and Workman, 2011). P. falciparum 
heterochromatin protein 1 (PfHP1) specifically recognizes the H3K9me3 mark and 
plays a central role in gene silencing (Voss et al., 2014). The vast majority of parasite 
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genes located within heterochromatin are clonally variant genes such as var, rifin, 
stevor (Rovira-Graells et al., 2012). Recently, Brancucci and colleagues have revealed 
a central role of PfHP1 in controlling the mutually exclusive expression of the var gene 
family (Brancucci et al., 2014). In addition, this study also showed that PfHP1 is required 
for the parasite to enter S phase and mitotic proliferation during the IDC (Brancucci 
et al., 2014). Interestingly, PfHP1 also orchestrates at the ap2-g locus, which encodes 
for the transcription factor AP2-G that is essential for sexual commitment in P. 
falciparum (Brancucci et al., 2014; Kafsack et al., 2014). Because of the important 
functions of PfHP1 in these crucial processes, PfHP1 should be studied in more detail 
on the functional level in order to acquire a deeper insight into antigenic variation, 
parasite proliferation and sexual commitment.  
1.4 Heterochromatin protein 1 in eukaryotes 
HP1 was originally identified in Drosophila melanogaster as a non-histone 
chromosomal protein associated with heterochromatin (Eissenberg et al., 1990; James 
and Elgin, 1986). It is well conserved in eukaryotes and has been studied extensively in 
fission yeast (Schizosaccharomyces pombe), D. melanogaster and mammals 
(Lomberk et al., 2006b). 
HP1 is a main component of heterochromatin structure. Heterochromatin is generally 
enriched at centromeric and telomeric regions and localises at the nuclear periphery 
(Lomberk et al., 2006b). Other studies also revealed the association of HP1 with some 
euchromatic regions and this somehow depends on specific isoforms of HP1 (Hiragami 
and Festenstein, 2005).  
The major and well-known function of HP1 lies in heterochromatin formation and gene 
silencing. HP1 recognizes and binds to H3K9me3 (Lomberk et al., 2006b). In turn, HP1 
forms a homodimer, which recruits a H3K9me-specific histone methyltransferase 
(HKMT) (Lomberk et al., 2006b). As a consequence, heterochromatin and gene 
silencing can spread in cis along the chromatin fibre. Other functions of HP1 include 
the silencing of euchromatic genes, enhancing DNA repair by relaxing the 
heterochromatin structure in response to DNA damage, targeting and protecting 
telomeres, up-regulating genes located at heterochromatin regions or stabilizing 
transcript processing and elongation (Kwon and Workman, 2011).   
In mammals, there are three HP1 variants encoded by a class of genes called 
chromobox (cbx) genes. They are cbx5/HP1α, cbx1/HP1β and cbx3/HP1γ, which are 
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highly similar in the amino acid sequence (Hayakawa et al., 2003). While HP1α and 
HP1β localize at centromeric and telomeric heterochromatin (Dialynas et al., 2007; 
Zeng et al., 2010), HP1γ associates with both heterochromatic and euchromatic 
regions (Minc et al., 2000).  
In S. pombe, Switching 6 (Swi6) and Chromo domain-containing protein 2 (Chp2) are 
two important homologs of HP1 protein involved in gene silencing and 
heterochromatin formation (Zeng et al., 2010). Both Chp2 and Swi6 contribute to the 
localization of histone deacetylase (HDAC) repressor complexes such as Clr3/Clr6-
HDAC to heterochromatin loci (Fischer et al., 2009; Sugiyama et al., 2007; Yamada et 
al., 2005). Not only does histone deacetylation by these HP1-associated complexes 
prevent the transcriptional machinery from accessing heterochromatin but this also 
provides proper nucleosome orders required for higher chromatin structure (Sugiyama 
et al., 2007; Yamada et al., 2005). The double deletion of Swi6 and Chp2 caused an 
increase in Pol II enzyme occupancy at centromeric heterochromatin, indicating an 
essential role of Swi6 and Chp2 in heterochromatin silencing effects (Fischer et al., 
2009).  
1.4.1 HP1 structure and domain function 
HP1 is a small protein containing three regions: two conserved domains at the N- and 
C-terminus, namely the chromo domain (CD) and the chromoshadow domain (CSD), 
respectively, and a variable linker or hinge domain between them (Aasland and 
Stewart, 1995; Kwon and Workman, 2008; Lomberk et al., 2006a).  
Chromodomain – a recognizer of a specific histone mark  
The chromatin organization modifier domain or chromo domain (CD) is located at the 
N-terminus of HP1 and this domain is highly conserved among animals, fungi and 
plants (Lomberk et al., 2006b). Conserved amino acid residues form the backbone of 
a relatively open hydrophobic groove on the beta sheet of the CD (Singh and 
Georgatos, 2002). The total negative charge distribution of the CD suggests that the 
domain is more likely to interact with proteins rather than with DNA (Eissenberg and 
Elgin, 2000). The CD interacts directly with H3K9me2/3 via its hydrophobic pocket, 
altering the chromatin structure to form heterochromatin (Lomberk et al., 2006b). 
Mutations at highly conserved amino acids such as Tyr24, Va26, Trp45 and Tyr48 in the 
CD of Drosophila HP1 can incapacitate the binding to H3K9me3, resulting in functional 
defects of HP1 (Lomberk et al., 2006b). Consistently, the substitution of some aromatic 
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hydrophobic amino residues in the CD of Swi6 caused Swi6 loss-of-function 
phenotypes, for example the abolishment in mating-type switching to the opposite 
allele and reducing the number of cells that can form normal zygotic asci (Wang et 
al., 2000).  
Chromo Shadow Domain – a domain directs protein-protein interactions  
The chromo shadow domain (CSD) is a unique motif of the HP1 family (Lomberk et al., 
2006b). It locates at the C-terminus of HP1. Regardless of the high similarity in sequence 
and structure with the CD, the CSD plays different roles in self-dimerization and 
interaction with various non-histone proteins (Lomberk et al., 2006b). A consensus 
pentapeptide sequence motif (PxVxL) in this domain is required for homodimerization 
and is also found in proteins interacting with HP1 (Brasher et al., 2000; Cowieson et al., 
2000; Lechner et al., 2000; Smothers and Henikoff, 2000). Mutations in this motif interfere 
with HP1 homo-dimer formation, causing defects in H3K9m3e binding and 
heterochromatin establishment (Brasher et al., 2000; Schultz et al., 2002). 
Hinge region - more than a linker  
The linker or hinge region separating the CD and CSD domains is less conserved and 
has a flexible structure. The domain was assumed to be exposed on the surface of 
HP1 (Singh and Georgatos, 2002). In a study in S. pombe, the length of the hinge 
domain was shown to be essential for the full function of Swi6 (Wang et al., 2000). 
When the Swi6 hinge domain was shortened by 80 amino acids down to the size of 
the hinge domain of mouse HP1β (M31), Swi6 was still fully functional and localized to 
nucleus (Wang et al., 2000). However, with a larger deletion in the hinge domain by 
112 amino acids, the truncated Swi6 only retained 25% of wild type activity and was 
not strictly localized within the nucleus (Wang et al., 2000).  
1.4.2 HP1 post-translational modifications – functional decorations 
In general, HP1 possesses a number of posttranslational modifications (PTMs) that 
include mainly phosphorylation but also acetylation, methylation, formylation, 
uquibitination and sumoylation (Kwon and Workman, 2011; LeRoy et al., 2009; 
Lomberk et al., 2006a). The dynamics in the PTMs of HP1 is highly important in 
regulating its functions. In humans, HP1α was shown to be a substrate of the nuclear 
Dbf2-related (NDR) kinase (Chakraborty et al., 2014). In an NDR mutant, the 
unphosphorylated HP1α, prominently at serine 95 (S95) in the hinge domain, caused 
a significant increase in the proportion of cells at prometaphase while a decrease in 
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cells at metaphase was observed (Chakraborty et al., 2014). In the NDR-depleted 
cells, chromosome alignment was defective and mitotic progression was delayed, 
suggesting an important role of the phosphorylated S95 in mitosis (Chakraborty et al., 
2014). In another study, hyperphosphorylation at the N-terminus of murine HP1α 
demonstrated a significant influence on the localization of HP1 to heterochromatin as 
well as on chromosomal stability (Hiragami-Hamada et al., 2011). When a 
phosphorylated residue (S14) was replaced with an unphosphorylatable alanine (A), 
the mutated HP1 showed weak binding to H3K9me3 and diffused heterochromatic 
localization(Hiragami-Hamada et al., 2011). A mutant containing multiple 
phosphomutations (S11A-S14A) showed multiple abnormal chromosomes such as 
diplochromosomes, circular chromosomes and long fused chromosomes (Hiragami-
Hamada et al., 2011). The phosphomutant also showed little or no affinity to casein 
kinase 2 (CKII) compared to wild type HP1α which also bound strongly to H3K9me3 
after being phosphorylated by CKII (Hiragami-Hamada et al., 2011). In S. pombe, Swi6 
phosphorylation contributes to heterochromatic silencing at centromeres and 
phosphorylated Swi6 catalysed by CKII is required for its interaction with other effectors 
(Shimada et al., 2009).  
1.5 Heterochromatin protein 1 in Plasmodium falciparum 
1.5.1 Plasmodium falciparum heterochromatin protein 1 at a glance 
Unlike most other eukaryotes, P. falciparum encodes only a single HP1 protein 
denoted as PfHP1 (Flueck et al., 2009; Pérez-Toledo et al., 2009). In general, PfHP1 also 
retains a common HP1 structure: a CD domain at the N-terminus, a hinge domain and 
a CSD domain at the C-terminus. Genome-wide profiling showed that PfHP1 mainly 
localizes to telomeric/subtelomeric regions and some chromosome-internal islands, 
but not in peri-centromeric regions (Flueck et al., 2009) where H3K9me3 is also absent 
(Lopez-Rubio et al., 2009; Salcedo-Amaya et al., 2009). This indicates that PfHP1 might 
not contribute to maintenance of centromere structure and function as in other 
eukaryotes (Flueck et al., 2009; Pérez-Toledo et al., 2009). The PfHP1-demarcated 
heterochromatic domains contain a large number of protein-coding genes (approx. 
425) of which most belong to gene families encoding exported virulence proteins that 
are specific for P. falciparum (Flueck et al., 2009). The association of PfHP1 and 
H3K9me3 at these loci highlights an underlying role of PfHP1 in regulating the 
phenotypic/antigenic variation of virulence factors, with the best-known example 
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being the mutually exclusive expression of var/PfEMP1 (Brancucci et al., 2014; Flueck 
et al., 2009). Another regulatory role of PfHP1/H3K9me3 was implied in regulating 
invasion pathway switching involved in facultative interchanging between 
transcriptionally permissive and silent states of Pfrh4 (invasion gene) and a 
neighbouring pseudogene, pfeba-165 (Coleman et al., 2012). Silent state of pfrh4 was 
found associated with H3K9me3-marked heterochromatin regions near TSS and ORF 
(Coleman et al., 2012; Jiang et al., 2010) and preferably recruited to a  transcriptionally 
repressive heterochromatic zone at nuclear periphery (Coleman et al., 2012). Further, 
during gametocytogenesis, genes encoding for key components of gametocyte 
determinant like pfap2-g (Kafsack et al., 2014) and earliest gametocyte markers, for 
example pfs16, pfg27, pfg 14-744/748 (Eksi et al., 2005; 2012) were reduced in 
PfHP1/H3K9me3 occupation (Brancucci et al., 2014; Flueck et al., 2009; Fraschka et 
al., 2018). In contrast, genes involving in host cell remodelling like mesa, pfemp3, hsp40 
and kahrp were found associated with PfHP1/H3K9me3 during gametocytogenesis 
(Fraschka et al., 2018). Interestingly, studies on genome-wide distribution of 
heterochromatin have shown the association of PfHP1/H3K9me3 with variance gene 
families and pfap2-g in intracellular blood stage as well as in salivary gland sporozoites 
with a similar enrichment (Brancucci et al., 2014; Flueck et al., 2009; Lopez-Rubio et al., 
2009; Zanghì et al., 2018). Notably, mutually exclusive expression of PfEMP1 was also 
implied in sporozoites similarly to blood stage parasites (Brancucci et al., 2014; Voss et 
al., 2006) and possibly involved in sporozoite migration and hepatocyte infectivity 
(Zanghì et al., 2018). Thus, these understandings strengthen a role of PfHP1/H3K9me3 
in stage-specific epigenetic regulation during the parasite life cycle using 
heterochromatin restructuring. 
1.5.2 PfHP1 functions during intracellular development cycle 
Recently, Brancucci and Bertschi et al. have studied the function of PfHP1 through a 
PfHP1 knockdown clone by targeting PfHP1 with the FKPB destabilization domain (DD) 
(Armstrong and D. E. Goldberg, 2007; Brancucci et al., 2014) (Figure 1.2). The DD allows 
the targeted degradation of DD fusion proteins when cells are cultured in absence of 
the stabilizing ligand Shield-1 (Armstrong and Goldberg, 2007). After Shield-1 removal 
at 4-12 hpi, 3D7/PfHP1-GFP-DDOFF parasites can still complete the current cycle 
(generation 1) but showed very pronounced phenotypes after reinvasion in 
generation 2 (Figure 1.2). These phenotypes are summarised in the following 
paragraphs. 
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Figure 1.2. The pipeline of Shield-1 removal (at 4-12 hpi in generation 1) and light 
microscopic observation of Giemsa smears for 3D7/PfHP1-GPF-DDON/OFF through 
generation 1 and 2. 3D7/ PfHP1-GFP-DDOFF showed a very pronounced morphological 
phenotype compared to the control after reinvasion in generation 2 (Brancucci et al., 
2014).  
First, in the OFF Shield-1 condition, a high proportion of subtelomeric PfHP1-associated 
genes were up-regulated such as rifin, pfmc-2tm and especially the var gene 
family(Brancucci et al., 2014).  To be specific, when Shield-1 was withdrawn at 4-12hpi 
in generation 1, var gene transcription was comparable between 3D7/PfHP1-GPF-
DDOFF and 3D7/PfHP1-GPF-DDON during the current cycle (Brancucci et al., 2014). 
However, at 16-24 hpi in generation 2, there was a massive de-repression of most var 
genes such that 52 out of 60 genes of this family were highly upregulated (Brancucci 
et al., 2014). In brief, these results identified a central role for PfHP1 in silencing 
heterochromatic genes and controlling mutually exclusive expression of var genes.  
 
Figure1.3. Hyper-induction of gametocytogenesis and normal gametocyte 
maturation observed in approximately 52% of 3D7/PfHP1-GFP-DDOFF parasites in 
generation 2 (upper panel) (Brancucci et al., 2014). The remaining subset of PfHP1-
depleted parasites did not commit to sexual development but was unable to enter S-
phase and arrested prior to schizogony (lower panel). 
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Second, a high percentage of early stage I gametocytes was observed in the 
3D7/PfHP1-GFP-DDOFF population in generation 2 (Brancucci et al., 2014). This striking 
phenotype occurred as a result of the activation of the pfap2-g gene in generation 1 
trophozoites or schizonts (Brancucci et al., 2014). In asexual parasites, pfap2 locus is 
silencing by PfHP1/H3K9me3-marked heterochromatin (Brancucci et al., 2014; Flueck 
et al., 2009; Josling and Llinás, 2015; Kafsack et al., 2014). Interestingly, Brancucci and 
colleagues found that in PfHP1-depleted parasites, PfHP1 and H3K9me3 occupancy 
were substantially reduced at the pfap2-g locus in schizonts of the same cycle of 
induction (generation 1) and in the ring progeny (generation 2) (Brancucci et al., 
2014). The removal of H3K9me3-bound PfHP1 is mediated by the upstream regulator 
of sexual commitment, PfGDV1 (Gametocyte gene development 1), which results in 
the derepression of pfap2-g, thus triggering sexual commitment (Filarsky et al., 2018). 
The depletion of PfHP1 initiates de-repression of pfap2-g in committed schizonts which 
then release sexually committed merozoites that re-invade and undergo full 
gametocyte maturation over the next 8-10 days (Figure 1.3, upper and middle panel) 
(Brancucci et al., 2014). Approximately 52% of the 3D7/PfHP1-GFP-DDOFF population 
committed to gametocytes in comparison to ~2% in the control (Brancucci et al., 
2014). The sexual commitment process driven by this PfHP1-dependent pathway is 
considered as a canonical next cycle conversion (NCC) route in which an additional 
round of replication occurs after sexual commitment (Bancells et al., 2019).   
Third, a role for PfHP1 in mitotic proliferation was revealed through PfHP1 depletion. 
After 24 hpi in generation 2, the approx. 45% of 3D7/PfHP1-GFP-DDOFF parasites that 
did not undergo sexual commitment arrested at the trophozoite stage and were 
unable to enter schizogony because of a failure in DNA replication (Figure 1.3, lower 
panel, Brancucci et al., 2014). Interestingly, these arrested trophozoites remained in a 
dormant state (Figure 1.3, lower panel) and were able to re-accumulate PfHP1 and 
re-enter replication cycles when Shield-1 was added back to the culture medium 
(Brancucci et al., 2014). Indeed, delayed replication timing and cell cycle progression 
at the S and G2/M phase have been observed in other eukaryote models like S. 
pombe and D. melanogaster when HP1 was depleted (De Lucia et al., 2005; Hayashi 
et al., 2009; Schwaiger et al., 2010). 
Taken together, the study of Brancucci and colleagues has identified essential 
functions of PfHP1 in (1) the maintenance of heritable silencing and mutually exclusive 
expression of var genes, (2) in mitotic progression of asexual blood stage parasites, 
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and (3) in the sexual differentiation switch (Brancucci et al., 2014). This study hence 
provides a fundamental basis for further investigation on detailed functions of PfHP1 
in these processes.  
1.5.3 PfHP1 phosphorylation 
Large-scale phosphoproteomics studies in P. falciparum so far identified several 
phosphorylated residues in PfHP1. They include T2, S4, S33, S57, S89, S92, S108, T110, 
S122, S125, S174  (Collins et al., 2014; Filarsky et al., 2018; Lasonder et al., 2012; 2015; 
Pease et al., 2013; Solyakov et al., 2011; Treeck et al., 2011), and the Y32 and S136 
residues that have been identified as additional phosphosites in a recent study 
investigating native PfHP1 complexes (Filarsky et al., 2018). Unsurprisingly, PfHP1 is 
mainly phosphorylated in the hinge domain as observed in HP1s from other eukaryotes 
(Lomberk et al., 2006b). As mentioned above, mutations in the hinge region have 
been shown to hamper the location and functions of HP1. Therefore, we considered 
it worthy to study in detail whether phosphorylation controls some of the known 
functions of PfHP1. Moreover, the kinases that phosphorylate PfHP1 and their target 
phosphosites on PfHP1 are still elusive.  
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1.6 Main aims and objectives 
My research pursued in this PhD project aimed to investigate PfHP1 function in detail 
using CRISPR/Cas9-based gene editing combined with the DiCre/loxP system for 
conditional mutagenesis. The two specific objectives were: 
Objective 1: To uncover the roles of the individual PfHP1 domains in PfHP1 function. 
Objective 2: To understand if and how phosphorylation of PfHP1 regulates its function. 
Both objectives focused on the three known PfHP1-dependent cellular processes: (1) 
the maintenance of heritable silencing and mutually exclusive expression of var 
genes, (2) mitotic progression of asexual blood stage parasites, and (3) sexual 
commitment (Brancucci et al., 2014). The first study analysed the functional 
contribution and conservation of the CD, hinge and CSD domains of PfHP1. The main 
results from this project were presented in Chapter 3 (manuscript in preparation). 
Some preliminary results related to this project were presented in Chapter 4.  Some 
initial results obtained during this study using functional complementation assays were 
presented in Chapter 5. The second project addressed (1) the kinases phosphorylating 
PfHP1 and their target residues (in collaboration with Prof. C. Doerig, Monash 
University, Melbourne, Australia and Prof. Isabel Lucet, Walter and Eliza Hall Institute of 
Medical Research, Melbourne, Australia); and (2) the role of selected phosphorylated 
residues in regulating PfHP1 function. The main results from this study were presented 
in Chapter 2 (Bui et al., manuscript submitted).  
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2.1 Abstract  
Previous studies in model eukaryotes have demonstrated that phosphorylation of 
heterochromatin protein 1 (HP1) is important for dynamically regulating its various 
functions. However, in the malaria parasite Plasmodium falciparum both the function 
of HP1 phosphorylation and the identity of the protein kinases targeting HP1 are still 
elusive. In order to functionally analyze phosphorylation of P. falciparum HP1 (PfHP1), 
we first mapped PfHP1 phosphorylation sites by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) analysis of native PfHP1, which identified motifs from which 
potential kinases could be predicted; in particular, several phosphorylated residues 
were embedded in motifs rich in acidic residues, reminiscent of targets for P. 
falciparum casein kinase 2 (PfCK2). Secondly, we tested recombinant PfCK2 and a 
number of additional protein kinases for their ability to phosphorylate PfHP1 in in vitro 
kinase assays. These experiments validated our prediction that PfHP1 acts as a 
substrate for PfCK2. Furthermore, LC-MS/MS analysis showed that PfCK2 
phosphorylates three clustered serine residues in an acidic motif within the central 
hinge region of PfHP1. To study the role of PfHP1 phosphorylation in live parasites we 
used CRISPR/Cas9-mediated genome editing to generate a number of conditional 
PfHP1 phosphomutants based on the DiCre/LoxP system. Our studies revealed that 
neither PfCK2-dependent phosphorylation of PfHP1, nor phosphorylation of the hinge 
domain in general, affect PfHP1’s ability to localize to heterochromatin, and that PfHP1 
phosphorylation in this region is dispensable for the proliferation and sexual 
differentiation of P. falciparum blood stage parasites. 
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2.2 Introduction 
Euchromatin and heterochromatin are the two main structures of chromatin in 
eukaryotes. While euchromatin is associated with active gene transcription, 
heterochromatin is associated with heritable gene silencing. Heterochromatin is 
characterized by the enrichment of heterochromatin protein 1 (HP1) bound to 
trimethylated histone 3 lysine 9 (H3K9me3) (Bannister et al., 2001; Lachner et al., 2001; 
Lomberk et al., 2006). HP1 recruits chromatin modifiers such as H3K9me-specific histone 
methyltransferases, which in turn methylate H3K9 in neighbouring nucleosomes, thus 
facilitating the binding of further HP1 proteins and consequently the regional 
spreading of heterochromatin in a sequence-independent manner (Grewal and 
Moazed, 2003; Lomberk et al., 2006). In addition to promoting gene silencing and 
heterochromatin maintenance HP1 also plays roles in centromere function in fission 
yeast and humans and in DNA replication and repair (Kwon and Workman, 2008; Zeng 
et al., 2010).  
HP1 is widely conserved among eukaryotes and consists of three functional domains, 
namely the N-terminal chromo domain (CD) that binds H3K9me3 (Jacobs et al., 2001; 
Lachner et al., 2001; Platero et al., 1995), the C-terminal chromoshadow domain (CSD) 
that mediates HP1 homodimerisation and specific interactions with other regulatory 
proteins (Brasher et al., 2000; Cowieson et al., 2000; Schotta et al., 2002), and a variable 
hinge region located between the CD and CSD domains that has been shown to 
interact with DNA and/or RNA (Meehan et al., 2003; Muchardt et al., 2002; Sugimoto 
et al., 1996). Some eukaryotes have several HP1 paralogs; for instance, 
Schizosaccharomyces pombe encodes two HP1 variants (Swi6 and Chp2) and 
mammals possess three HP1 variants (HP1α, HP1β and HP1γ) (Kwon and Workman, 
2008; Lomberk et al., 2006). 
The parasitic protist Plasmodium falciparum, the causative agent of the most severe 
form of malaria in humans, possesses a single HP1 ortholog (PfHP1). PfHP1 binds to and 
co-localizes with H3K9me3 to heterochromatic domains in the subtelomeric regions of 
all 14 chromosomes and to internal heterochromatic islands on some chromosomes 
(Flueck et al., 2009; Fraschka et al., 2018; Lopez-Rubio et al., 2009; Perez-Toledo et al., 
2009; Salcedo-Amaya et al., 2010). There is no evidence for the presence of either 
PfHP1 or H3K9me3 in peri-centromeric regions, suggesting that PfHP1 does not 
contribute to the maintenance of centromere structure and function in this organism 
(Flueck et al., 2009; Fraschka et al., 2018; Hoeijmakers et al., 2012; Lopez-Rubio et al., 
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2009; Salcedo-Amaya et al., 2010). The subtelomeric and chromosome-internal 
heterochromatic domains collectively cover over 400 protein-coding genes, most of 
which belong to P. falciparum-specific gene families that encode virulence factors 
exported to the host erythrocyte (Flueck et al., 2009; Fraschka et al., 2018; Lopez-Rubio 
et al., 2009; Salcedo-Amaya et al., 2010). In addition, PfHP1 also binds to a small 
number of euchromatic loci, including the gene encoding the master transcription 
factor of sexual differentiation PfAP2-G (Flueck et al., 2009; Fraschka et al., 2018). 
Consistent with a role for PfHP1 in heritable gene silencing, almost all PfHP1-associated 
genes are expressed in a clonally variant manner (Rovira-Graells et al., 2012). The best-
studied example is provided by the var gene family that consists of approximately 60 
members, each encoding a variant of the erythrocyte membrane protein 1 (PfEMP1) 
antigen that is exposed on the surface of infected red blood cells (iRBCs) (Baruch et 
al., 1995; Gardner et al., 2002; Smith et al., 1995; Su et al., 1995). The PfEMP1-dependent 
binding of iRBCs to endothelial cells and uninfected RBCs leads to parasite 
sequestration in the microvasculature, which strongly contributes to severe disease 
(Hviid and Jensen, 2015; Scherf et al., 2008). Importantly, expression of the var gene 
family is controlled in a mutually exclusive manner (aka singular gene choice), such 
that at any given time only a single var gene is transcribed while all other family 
members are epigenetically silenced in a PfHP1-dependent manner (Brancucci et al., 
2014; Deitsch and Dzikowski, 2017; Guizetti and Scherf, 2013; Scherf et al., 1998). 
Switches in var gene transcription then lead to clonal antigenic variation of PfEMP1, 
allowing the parasite to evade adaptive immune responses and establish chronic 
infection (Scherf et al., 2008; Smith et al., 1995). 
Using an inducible PfHP1 loss-of-function parasite line, where PfHP1 expression levels 
can be modulated via the FKBP/DD-Shield-1 conditional expression system (Armstrong 
and Goldberg, 2007; Banaszynski et al., 2006), we recently identified three important 
roles for PfHP1 in the biology of blood stage parasites (Brancucci et al., 2014). First, we 
found that PfHP1 is essential for the heritable silencing of heterochromatic gene 
families as PfHP1 depletion resulted in the de-repression of almost all var genes and 
many other subtelomeric gene families in the progeny. Second, we demonstrated that 
PfHP1 depletion leads to a 25-fold increase in sexual conversion rates, with over 50% 
of parasites in the progeny differentiating into gametocytes (which are required for 
malaria transmission via the mosquito vector). This striking phenotype was linked to de-
repression of the ap2-g locus in absence of PfHP1. Third, we showed that the remaining 
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asexual parasites in the PfHP1-depleted progeny failed to enter S-phase, revealing a 
crucial role for PfHP1 in the control of proliferation (Brancucci et al., 2014). 
Studies in model eukaryotes have shown that HP1 is post-translationally modified, 
particularly by phosphorylation. Phosphorylation of HP1 regulates various functions in 
a number of cellular processes in fission yeast and mammals, including 
heterochromatic gene silencing, mitosis and DNA repair (Kwon and Workman, 2011; 
Shimada and Murakami, 2010). For instance, casein kinase 2 (CK2)-dependent 
phosphorylation of serine residues in the N-terminal part of Swi6 is important for 
transcriptional silencing and the recruitment of the histone deacetylase complex 
SHREC in S. pombe (Shimada et al., 2009). Similarly, in mice the N-terminal 
phosphorylation of HP1α by CK2 is important for targeting HP1 to heterochromatin as 
well as for chromosomal stability. While a single substitution of serine 14 with alanine 
(S14A) impaired the binding of HP1 α to H3K9me3 and caused diffuse heterochromatic 
localization, multiple substitutions of clustered serines (S11A to S14A) hampered 
chromosomal integrity (Hiragami-Hamada et al., 2011). In humans, HP1 
phosphorylation has been shown to play a role in progression through mitosis. Human 
HP1α is a substrate of the nuclear Dbf2-related (NDR) kinase; in an NDR-depleted cell 
line, the lack of HP1α phosphorylation at serine 95 in the hinge domain resulted in 
chromosome alignment defects, aberrant spindle morphology and a delay in 
metaphase progression (Chakraborty and Prasanth, 2014). Furthermore, HP1 
phosphorylation has also been shown to play a role the DNA damage response in 
humans. CK2-dependent phosphorylation of HP1β at threonine 51 was shown to 
modulate the dispersion of HP1 from chromatin, which in turns facilitates histone H2AX 
phosphorylation and recruitment of downstream regulators involved in repairing 
chromosomal DNA breaks (Ayoub et al., 2008). 
In contrast to model eukaryotes, the functional role of HP1 phosphorylation in P. 
falciparum and the kinases involved are still unknown. Hence, to begin understanding 
how PfHP1 function is regulated in P. falciparum, we studied PfHP1 phosphorylation 
using in vitro and in vivo assays. Liquid chromatography tandem mass spectrometry 
(LC-MS/MS) analysis of immunoprecipitated native PfHP1 showed that PfHP1 is 
phosphorylated in its CD and hinge domains. In vitro kinase assays revealed that PfHP1 
is a substrate of P. falciparum CK2 (PfCK2). LC-MS/MS analysis showed that PfCK2 
targets three clustered serine residues within the PfHP1 hinge region in vitro. By 
generating conditional PfHP1 phosphomutant cell lines using CRISPR/Cas9-mediated 
genome editing combined with the DiCre/LoxP system (Collins et al., 2013; Jones et 
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al., 2016), we found that PfCK2-dependent phosphorylation of PfHP1, and 
phosphorylation of the PfHP1 hinge domain in general, is dispensable for proper PfHP1 
localisation, gene silencing, parasite growth and sexual conversion.  
2.3 Results 
Identification of phosphorylated PfHP1 residues and parasite kinases phosphorylating 
PfHP1  
Several large-scale phosphoproteomics studies in P. falciparum collectively detected 
13 phosphorylated residues in PfHP1 (T2, S4, S33, T38, S57, S89, S92, S108, T110, S122, 
S125, S129, S174) (Collins et al., 2014; Lasonder et al., 2012; Lasonder et al., 2015; Pease 
et al., 2013; Solyakov et al., 2011; Treeck et al., 2011). The Y32 and S136 residues have 
been identified as additional phosphosites in a recent study investigating native PfHP1 
complexes (Filarsky et al., 2018). To confirm and possibly expand these results, we used 
LC-MS/MS experiments to map phosphorylated residues in native PfHP1. To this end, 
we purified PfHP1-GFP by immunoprecipitation (IP) from nuclear extracts prepared 
from 3D7/HP1-GFP parasites (Brancucci et al., 2014) in four independent biological 
replicate experiments (Figure 1A). LC-MS/MS analysis of the eluted protein samples 
identified a total of eleven phosphosites in PfHP1 (Figure 1B and Table S1). One of these 
phosphosites (S206) has not been identified in any of the earlier studies, and five 
previously mapped phosphosites (T38, S57, S92, S108 and T110) have not been 
identified here (Figure 1B). Two of the sites identified in our study are located in the first 
few residues preceding the CD domain (T2, S4), two are located within the CD domain 
in a predicted flexible loop (Y32, S33), six are located in the hinge region (S89, S122, 
S125, S129, S136, S174) and one is located in a predicted loop in the CSD domain (S206) 
(Figure 1B). 
Several of the identified phosphosites conform to CK2 target sites in view of their 
richness in acidic residues (e.g. S129; SDEE), while others appear as potential targets of 
proline-directed kinases such as CDK, GSK3 or MAPK (e.g. S174; ESP), or of basic 
residues-directed kinases such as AGC kinases (e.g. S89; SIK) (Table S1) [see Amanchy 
and colleagues for a comprehensive list of phosphorylation motifs (Amanchy et al., 
2007)]. To identify candidate kinases possibly phosphorylating PfHP1, we screened a 
set of six recombinant functional parasite kinases, namely PfCK2 (Holland et al., 2009), 
PfGSK3 (Droucheau et al., 2004), PfMAP2 (Dorin et al., 1999), PfNEK2 (Reininger et al., 
2009), PfNEK4 (Reininger et al., 2005) and PfPK6 (Bracchi-Ricard et al., 2000), for their 
ability to phosphorylate recombinant PfHP1 in vitro, which includes the potential 
Chapter 2|                           Mapping and functional analysis of PfHP1 phosphorylation 
 37 
candidates PfCK2, PfGSK3 and PfMAP2 predicted by the phosphorylation site motifs 
outlined above. For this purpose, we expressed recombinant full-length PfHP1 and a 
truncated PfHP1 polypeptide encompassing the CD domain and hinge region 
(PfCD.H) in Escherichia coli and purified them by fast protein liquid chromatography 
(Figure 2A). To perform the kinase reactions, we used an in vitro assay based on 
luminescence signal detection (ADP-GloTM, Promega). The enzymatic reaction starts 
when a kinase is added into a mixture containing the substrate and ATP. Upon 
completion of the reaction, the ADP-GloTM assay quantifies the levels of ADP released 
from consumed ATP as a measure of kinase activity. Among the recombinant parasite 
kinases screened, PfMAP2, PfPK6, PfNEK2 and PfNEK4 showed little or no activity on 
PfHP1 (Figure S1). PfGSK3 showed some positive enzymatic activity on PfHP1 but this 
result was inconclusive due to the high level of autophosphorylation exerted by this 
kinase both in the ADP-Glo assay as well as in a radioactive kinase activity assay 
employing γ-P32-ATP (Figure S2). Importantly, however, PfCK2 displayed remarkable 
activity in phosphorylating PfHP1 in vitro. In the ADP-Glo assay, PfCK2 showed 
autophosphorylation activity and was able to phosphorylate the control substrate β-
casein. In absence of PfCK2, PfHP1 and PfCD.H exhibited no signals of phosphorylation 
activity as expected. In contrast, when PfCK2 was added to the PfHP1 and PfCD.H 
substrates, ADP conversion increased substantially compared to PfCK2 alone or PfCK2 
with β-casein (Figure 2B). Consistent results were obtained for PfCK2 using the in vitro 
γ-P32-ATP kinase assay. PfCK2 again showed auto-phosphorylation activity but was 
clearly capable of phosphorylating β-casein as a positive control and, at substantially 
higher levels, the PfHP1 and PfCD.H substrates (Figure 2C). To further probe the 
specificity of the CK2-dependent kinase reaction towards PfHP1 and PfCD.H, 4,5,6,7-
tetrabromobenzimidazole (TBB), a selective ATP-competitive inhibitor of CK2 across 
species (Sarno et al., 2001), was added to the kinase reactions. The treatment with 20 
µM TBB resulted in a significant drop of phosphorylation signal intensity in the reactions 
containing the substrates (Figure 2C). Finally, to identify the residues in PfHP1 targeted 
by PfCK2 in vitro, we performed LC-MS/MS analysis of the ADP-GloTM kinase assay 
reactions. The results revealed that PfCK2 phosphorylated a cluster of three serine 
residues in the hinge domain (S122, S125 and S129). Three additional predicted CK2 
target residues in the PfHP1 N-terminus (T2, S4, S33; see Table S1), however, where not 
detected in their phosphorylated form. As expected, no phosphorylated sites were 
detected in recombinant PfHP1 prior to the phosphorylation assay (Table S2). We also 
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failed to detect any phosphorylated residues in PfHP1 after incubation with PfGSK3 
(Table S2). 
Overall, using three independent approaches, we demonstrate that PfHP1 is 
phosphorylated at least at eleven residues during intra-erythrocytic development, that 
most of these residues are located either at the N-terminus, in predicted loop regions 
in the CD and CSD domains or in the hinge domain, and that three residues in the 
hinge region (S122, S125 and S129) are phosphorylated by PfCK2 in in vitro. 
Generation of conditional PfHP1 phosphomutant parasite lines 
To address the in vivo functional significance of PfHP1 phosphorylation, we used two 
subsequent CRISPR-Cas9-based gene editing steps to engineer parasites that allow for 
the conditional expression of PfHP1 phosphomutants based on the DiCre-loxP system 
(Collins et al., 2013) (Figures 3A, S3 and S4). In the first step, a sera2 intron:loxP element 
(Jones et al., 2016) was inserted into the 5’ end of the endogenous pfhp1 gene to 
obtain the 3D7/N31DC mother line. PCRs on gDNA and cDNA and Sanger sequencing 
confirmed the correct editing of the pfhp1 locus and the correct splicing of the sera2 
intron:loxP element (Figure S4). In the second step, a second sera2 intron:loxP element 
followed by a recodonised pfhp1 gene fused to gfp was placed directly downstream 
of the pfhp1 STOP codon (Figures 3A and S3). In these parasites, activation of the DiCre 
recombinase by rapamycin is expected to excise the floxed endogenous pfhp1 gene 
and to place a recodonised version encoding a PfHP1-GFP phosphomutant under 
control of the endogenous promoter (Figure 3A). We generated two such conditional 
PfHP1 phosphomutant lines called 3D7/HP1-3M and 3D7/HP1-HIM, where either the 
three serine residues targeted by PfCK2 in vitro (S122/125/129A) or the cluster of seven 
phosphorylated serine residues in the hinge region (S89/92/122/125/129/136/174A), 
respectively, have been substituted by non-phoshorylatable alanines. We also 
generated a control cell line where rapamycin treatment results in the replacement 
of the endogenous pfhp1 with a recodonized wild type pfhp1-gfp sequence 
(3D7/HP1-Control) (Figure 3A).  
PCR on parasite genomic DNA (gDNA) was used to confirm (1) the correct integration 
of the recodonised pfhp1-gfp gene directly downstream of the endogenous pfhp1 
locus; and (2) the successful DiCre-mediated excision of the floxed endogenous pfhp1 
gene in schizont stages (24-36 hrs after rapamycin treatment) in all three cell lines 
(Figure 3B). To confirm correct splicing of the sera2 intron:loxP element after rapamycin 
treatment and presence of the mutated codons encoding serine-to-alanine 
Chapter 2|                           Mapping and functional analysis of PfHP1 phosphorylation 
 39 
substitutions, RT-PCR and Sanger sequencing was performed (Figure S4). Live cell 
fluorescence imaging in late schizonts at 40-48 hpi (40 hrs after rapamycin treatment) 
showed that in each of the three parasite lines, excision of the endogenous pfhp1 
gene was highly efficient and expression of the recodonised PfHP1-GFP variants was 
observed in close to 100% of parasites in the populations (Figure 3C). In contrast, 
parasites in the DMSO-treated control populations did not express GFP-tagged PfHP1 
variants as expected. Consistent with the live fluorescence imaging results, analysis of 
whole parasite protein lysates by Western Blot showed that the rapamycin-treated 
parasites exclusively expressed the recodonised PfHP1-GFP fusions, while DMSO-
treated control parasites exclusively expressed wild-type untagged PfHP1 (Figure 3D).  
PfHP1 phosphomutants still localize to perinuclear heterochromatin  
In Drosophila melanogaster and mice, CK2-dependent phosphorylation of HP1 is 
required for the correct localization of HP1 to heterochromatin (Hiragami-Hamada et 
al., 2011; Zhao and Eissenberg, 1999). We therefore tested if the PfHP1 phosphomutants 
PfHP1-3M and PfHP1-HIM still localize to subtelomeric heterochromatin. Live cell 
fluorescence imaging in late schizonts at 40-48 hpi and in the late ring stage progeny 
at 16-24 hpi in generation 2 showed that the GFP-tagged PfHP1-3M, PfHP1-HIM and 
control PfHP1-GFP were not expressed in DMSO-treated parasites as expected. 
However, in the rapamycin-treated populations the GFP-tagged PfHP1-3M and PfHP1-
HIM phosphomutants were expressed and showed a punctate pattern at the nuclear 
periphery indistinguishable from that observed for the PfHP1-GFP control protein 
(Figure 4). These results demonstrate that the phosphorylation of serine residues in the 
PfHP1 hinge domain is not required for the correct targeting and localization of PfHP1 
to heterochromatin.  
Phosphorylation of serine residues in the PfHP1 hinge domain is not required for parasite 
multiplication and plays no obvious role in regulating sexual commitment and var 
gene silencing 
In a recent study, we showed that PfHP1 is required for (1) progression through 
schizogony and thus parasite multiplication; (2) var gene silencing and mutually 
exclusive var gene expression; and (3) silencing of the pfap2-g locus and thus inhibition 
of sexual commitment (Brancucci et al., 2014). Here, we asked if phosphorylation of 
serine residues in the PfHP1 hinge domain is required for any of these processes. 
We first monitored the proliferation rates of the PfHP1 phosphomutants and the control 
line over three consecutive generations after rapamycin treatment. As shown in Figure 
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5A, in each parasite line the multiplication of DMSO- and rapamycin-treated parasites 
was highly comparable. This result indicates that phosphorylation of the PfHP1 hinge 
domain is not required for the proliferation of asexual blood stage parasites. 
To identify a possible role for PfHP1 hinge domain phosphorylation in controlling pfap2-
g silencing, we compared the sexual conversion rates between DMSO- and 
rapamycin-treated parasites for all three transgenic parasite lines. Parasite populations 
were split at 0-8 hpi and treated either with DMSO or rapamycin. After re-invasion, ring 
stage progeny (16-24 hpi in generation 2; day 1 of gametocytogenesis) were cultured 
in medium containing 50 mM N-acetyl-glucosamine (GlcNAc) for six consecutive days 
to eliminate asexual parasites (Fivelman et al., 2007; Ponnudurai et al., 1986). 
Gametocytaemia was determined on day six by inspection of Giemsa-stained blood 
smears and sexual conversion rates were calculated as the fraction of 
gametocytaemia on day 6 in relation to the total parasitaemia observed on day 1. As 
shown in Figure 5B, the rapamycin-treated 3D7/HP1-3M and 3D7/HP1-HIM populations 
showed significantly higher sexual conversion rates compared to the DMSO-treated 
populations (p<0.01, unpaired two-tailed Student’s t-test). Unexpectedly, however, 
rapamycin-treated 3D7/HP1-Control parasites, which express a recodonised wild-type 
pfhp1 gene, also displayed significantly increased sexual conversion compared to the 
matched DMSO-treated population. In contrast, the 3D7/1G5DiCre mother line, which 
expresses the DiCre recombinase in absence of a floxed pfhp1 locus, as well as 3D7 
wild type parasites did not show increased sexual conversion rates upon rapamycin 
treatment, showing that rapamycin-induced expression of the DiCre recombinase per 
se or the exposure to rapamycin per se has no effect on sexual conversion rates. 
Hence, the increased sexual conversion rates observed for rapamycin-treated 
3D7/HP1-3M, 3D7/HP1-HIM and the 3D7/HP1-Control parasites rather seem to be linked 
to the DiCre-dependent recombination events at the floxed pfhp1 locus. Whatever 
the mechanisms underlying this puzzling observation, our data clearly suggest that 
phosphorylation of the hinge domain plays no important role in regulating pfap2-g 
silencing. Furthermore, gametocytes expressing either of the two PfHP1 
phosphomutant proteins also developed into stage V gametocytes without any 
apparent morphological differences compared to control gametocytes (data not 
shown), suggesting that hinge domain phosphorylation is also dispensable for 
gametocytogenesis. 
Finally, to test if the PfHP1 phosphomutations investigated affect var/PfEMP1 
expression, we compared the expression of PfEMP1 in the late ring stage progeny of 
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DMSO- and rapamycin-treated 3D7/HP1-3M, 3D7/HP1-HIM and 3D7/HP1-Control 
parasites (16-24 hpi in generation 2) by IFA. We observed comparable fluorescence 
intensity signals for PfEMP1 and percentage of PfEMP1-positive iRBCs in the DMSO- and 
rapamycin-treated parasites of all three lines (Figure 5C), indicating that 
phosphorylation of the PfHP1 hinge domain plays no major role in regulating var gene 
expression. 
2.4 Discussion 
Heterochromatin-dependent gene silencing is an important mechanism employed by 
P. falciparum for clonally variant gene expression. PfHP1 is one of the critical factors in 
this process. In addition, PfHP1 is essential for proliferation of blood stage parasites. 
Phosphorylation of HP1 has been reported to dynamically regulate the function of this 
chromatin reader protein in a variety of eukaryotic organisms. Our study described 
here analysed phosphorylation of PfHP1 and its potential functional role in the biology 
of P. falciparum blood stage parasites.  
Using immunoprecipitation of native PfHP1-GFP followed by LC-MS/MS analysis we 
identified eleven phosphorylated residues in PfHP1 purified from asexual blood stage 
parasites. All except one of these sites (S206) have either been identified on multiple 
tryptic peptides and/or in at least two of the independent IP samples analysed here, 
or they have been detected in previous studies by high-throughput 
phosphoproteomics approaches (Collins et al., 2014; Lasonder et al., 2012; Lasonder 
et al., 2015; Pease et al., 2013; Solyakov et al., 2011; Treeck et al., 2011) and/or the 
mass spectrometry-based analysis of PfHP1 complexes (Filarsky et al., 2018). Hence, 
we assume these residues are truly phosphorylated in intra-erythrocytic parasites. By 
screening a number of recombinant P. falciparum kinases using two independent 
kinase activity assays, we found that PfCK2 and PfGSK3 are able to phosphorylate 
PfHP1 in vitro. However, for PfGSK3 the phosphorylation signals obtained with the 
control and PfHP1 substrates were not noticeably higher compared to those obtained 
from auto-phosphorylation. GSK3 is a serine/threonine protein kinase preferring to 
catalyse substrates upon prior phosphorylation of a residue nearby the consensus 
sequence (S*/T*-X-X-X-S/T) (Doble and Woodgett, 2003; Fiol et al., 1990). Therefore, it is 
likely that GSK3 is only able to efficiently phosphorylate substrates if they have been 
primed by phosphorylation through another kinase, which was not applied in our in 
vitro kinase assays. Moreover, although PfGSK3 phosphorylated PfHP1 in the ADP-Glo 
assay and to some extent also in the radioactive kinase assays, no PfGSK3-dependent 
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phosphosites were detected on the in vitro-reacted PfHP1 substrates by LC-MS/MS 
analysis. Hence, additional experiments with higher sensitivity will be required to 
confirm if PfHP1 is indeed phosphorylated by PfGSK3. 
Importantly, however, we obtained convincing results showing that PfCK2 
phosphorylates PfHP1 at a cluster of three serine residues located in the hinge region 
(LSLS122*DNS125*LKKS129*DEE), at least in vitro. Serine 122 and S129 are embedded in 
a typical CK2 phosphorylation consensus target motif rich in acidic residues (S*/T*-D/E-
X-D/E) (Pinna, 2002; Rusin et al., 2017; St-Denis et al., 2015), whereas S125 lacks the 
favoured acidic residue at position +1 or +3 as the most crucial specificity determinant 
of the phosphoacceptor site (Meggio et al., 1994). However, similar atypical CK2 
recognition sites containing only one acidic residue between -1 to +5 have indeed 
been reported (Bian et al., 2013). In our efforts to analyse the role of PfCK2-dependent 
PfHP1 phosphorylation in vivo, however, we found that substituting the three target 
residues in the hinge domain with non-phosphorylatable alanines (S122/125/129A; 
PfHP1-3M) had no observable effect on PfHP1 function; parasites expressing the PfHP1-
3M triple phosphomutant displayed no marked defects in PfHP1 localisation, ap2-
g/var gene silencing or mitotic progression. Strikingly, we even failed to observe any 
silencing- or growth-related phenotypes in parasites expressing the PfHP1-HIM 
phosphomutant, where seven serine residues in the hinge region have been replaced 
with alanines (S89/92/122/125/129/136/174A). 
In line with these results, it has been reported that phosphorylation of S93 within the 
mouse HP1α hinge region or S89/91 within the human HP1β hinge domain does not 
affect HP1’s localization to chromatin (Ayoub et al., 2008; Hiragami-Hamada et al., 
2011). In addition, co-immunoprecipitation of human HP1β with histone 3 revealed 
only a minor role for S89 phosphorylation in the ability of HP1β to bind H3K9me3, in spite 
of local conformational changes induced upon phosphorylation (Munari et al., 2014). 
In another study on Swi6, the HP1 ortholog in S. pombe, mutations of CK2-dependent 
phosphosites in the hinge and CSD domains (S192/212/220/268/274A) did also not 
affect heterochromatic gene silencing (Shimada et al., 2009). In other systems, 
however, essential roles of phosphorylation within the HP1 hinge region have still been 
reported. In humans, the Aurora A- and NDR1-dependent phosphorylation of serine 
residues in the hinge region of HP1γ and HP1α, respectively, both play crucial roles in 
mitotic progression during the G2/M phase (Chakraborty et al., 2014; Grzenda et al., 
2013). Further, protein kinase A (PKA)-dependent phosphorylation of the hinge domain 
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of a D. melanogaster HP1 variant plays important roles in HP1 dimerisation, protein-
protein interaction and binding to H3K9me3 (Badugu et al., 2005). 
In conclusion, our study confirms that PfHP1 is phosphorylated during intra-erythrocytic 
development at multiple residues particularly in the CD and hinge domains. We also 
show that PfCK2 phosphorylates three clustered serine residues in the PfHP1 hinge 
region in vitro, but the phosphorylation of these sites is not required for proper PfHP1 
function in blood stage parasites. If S122, S125, and S129 are indeed phosphorylated 
by PfCK2 in vivo and if PfCK2 phosphorylates additional target residues in PfHP1 could 
be tested in future experiments employing conditional PfCK2 knock-down cell lines 
(Tham et al., 2015). Surprisingly, we also demonstrate that the simultaneous mutation 
of seven phosphorylation target residues in the hinge has no observable effect on 
parasite viability. We therefore anticipate that phosphorylation of the PfHP1 hinge 
region may play an important role elsewhere in the parasite life cycle, for instance 
during meiosis in the mosquito vector and/or in the replicative phases during male 
gametogenesis, sporogony or exo-erythrocytic schizogony. While our study does not 
provide functional insight into the functional role of PfHP1 hinge domain 
phosphorylation, the experimental pipeline established in this study provides an 
elegant approach to interrogate protein function and the role of post-translational 
protein modifications in the biology of P. falciparum blood stage parasites.  
2.5 Materials and Methods 
Parasite culture and transfection 
3D7/HP1-GFP  parasites (Brancucci et al., 2014) were cultured at 5% hematocrit in 
RPMI-1640 medium supplemented with 25 mM HEPES, 100 mM hypoxanthine, 24 mM 
sodium bicarbonate and 0.5% Albumax II. The transgenic lines generated in this study 
were cultured in the same medium supplemented with 2 mM choline to reduce 
background sexual conversion rates as demonstrated recently (Brancucci et al., 
2017). Parasite cultures were synchronized using 5% sorbitol as described (Lambros and 
Vanderberg, 1979). Co-transfection of CRISPR/Cas9 and donor plasmids into the 
DiCre-expressing line 3D7/1G5DiCre (Collins et al., 2013) and selection of transfected 
populations was performed as described recently (Filarsky et al., 2018). 
Immunoprecipitation of native PfHP1-GFP 
Parasite nuclei were isolated from 30 ml culture of 3D7/HP1-GFP parasites (5% 
hematocrit) as described previously (Filarsky et al., 2018). Nuclear proteins were 
extracted using extraction buffer (2 M L-arginine, 1.925 M HCl, 50 mM H3PO4, and 10 
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mM TCEP) for 20 min on ice. The extract was cleared by centrifugation for 20 min at 
20’000 g and 4°C. The supernatant was diluted 1:5 with wash buffer 1 (WB1) (PBS 
containing additional 324 mM NaCl, 1 M L-proline, 1% octyl β-D-glucopyranoside and 
2 mM TCEP) and spun again using the same conditions. Extraction buffer, WB1 and 
buffers used for nuclear isolation were supplemented with 1x protease inhibitor 
cocktail (Roche), 5 mM ε-aminocaproic acid (protease inhibitor), 3 mM sodium 
butyrate (histone deacetylase inhibitor) and 2 mM NaF, 2 mM β-glycerophosphate, 4 
mM sodium tartrate, 1 mM sodium pyrophosphate and 1 mM activated NaVO3 
(phosphatase inhibitors). GFP-Trap®_A beads (Chromotek) were equilibrated in WB1, 
added to the supernatant and rotated for 1h at room temperature (RT). The beads 
were washed three times with WB1 and twice using WB2 (PBS containing additional 
824 mM NaCl and 0.2 mM TCEP). Proteins were eluted using arginine elution buffer (2 
M L-arginine, 50 mM acetic acid and HCl to pH 4). The eluate was neutralized by 
addition of 0.1 volumes of 1 M tris base. Next, the samples were processed and 
analyzed using LC-MS/MS as detailed below. 
Capillary liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
For the PfHP1 IP experiments, the neutralised elutions were reduced with 10 mM DTT at 
37°C for 1 hr and alkylated with 50 mM iodo-acetamide for 15 min at room 
temperature. Proteins were digested with 250 ng endoproteinase LysC (Wako, Neuss, 
Germany) for two hours at 37°C followed by 500 ng trypsin (Worthington, Lakewood, 
NJ, USA) overnight. The digest was stopped with TFA to 1% final concentration and 
desalted on a microspin column (The Nest Group, Southborough, MA, USA) according 
to the manufacturer’s recommendations. 
For the ADP-GloTM in vitro kinase assay samples, 20 µl of the technical duplicate 
reactions were pooled, precipitated with 20% trichloroacetic acid (TCA) on ice for 
30min, followed by washing the precipitate with 17% TCA and two acetone (ice-cold) 
washes before air-drying the pellets. The protein pellets were dissolved in 30 µl 100 mM 
Tris-HCl (pH 8.0)/6 M Urea, reduced and alkylated as above and digested with 250 ng 
endoproteinase LysC for two hours at 37oC. The urea concentration was diluted to 2 
M with 100 mM Tris-HCl (pH 8.0) and the sample was further digested with 500 ng trypsin 
overnight at 37°C. The digest was acidified with 1% TFA and the sample was desalted 
on a MicroSpin cartridge according to the manufacturer’s recommendations.  
The eluted peptides were dried in a SpeedVac and dissolved in 40 µl 0.1% formic acid 
and analysed by capillary LC-MS/M) using a home-packed separating column (0.075 
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mm x 25 cm) packed with Reprosil C18 reverse-phase material (2.4 µm particle size, Dr. 
Maisch, Ammerbuch-Entringen, Germany). The column was connected on line to an 
Orbitrap Elite FT hybrid instrument (Thermo Scientific, Reinach, Switzerland). The 
solvents used for peptide separation were 0.1% formic acid in water (solvent A) and 
0.1% formic acid and 80% acetonitrile in water (solvent B). 2 µl of peptide digest were 
injected with a Proxeon nLC capillary pump (Thermo Scientific) set to 0.3 µl/min. A 
linear gradient from 0 to 40% solvent B in solvent A in 95 min was delivered with the 
nano pump at a flow rate of 300 nl/min. After 95 min the percentage of solvent B was 
increased to 75% in ten minutes. The eluting peptides were ionized at 2.5 kV. The mass 
spectrometer was operated in data-dependent mode. The precursor scan was done 
in the Orbitrap set to 60,000 resolution, while the fragment ions were mass analyzed in 
the LTQ instrument. A top twenty method was run so that the twenty most intense 
precursors were selected for fragmentation. The MS/MS spectra of the four PfHP1-GFP 
IP samples were searched against a combined P. falciparum (www.plasmoDB.org; 
release 9.3)/human annotated protein database using Proteome Discoverer 2.2 
(Thermo Scientific, Reinach, Switzerland) using the two search engines Mascot and 
SequestHT (Table S1). The PfHP1-GFP IP replicate samples 1 and 2 were additionally 
searched against the PfHP1-GFP sequence (Table S1). The PfCK2 and PfGSK3 ADP-
GloTM in vitro kinase assay samples were searched against the respective PfHP1 and 
PfCD.H recombinant protein sequences (Table S2). For the search, oxidized 
methionine, N-terminal protein acetylation and phosphorylation on serine, threonine 
and tyrosine were used as variable modifications. The identifications were filtered for 
a false discovery rate of 1%. 
Generation of E. coli expression vectors 
In order to increase the solubility strength of the SUMO tag, sequences encoding 
additional solubility tags were inserted upstream of the sequence encoding an N-
terminal 6xHis-SUMO tag as suggested elsewhere (Malakhov et al., 2004). For this 
purpose, the His-SUMO-encoding sequence was PCR amplified from pETA-HS 
(Fraschka et al., 2018) using the primers Bsa_His_f and T7term. The BsaI/XhoI-digested 
product was then cloned into BamHI/XhoI-cut pGB1 (a kind gift of S. Hiller) and pETA-
MBP (Bertschi et al., 2017), yielding the GB1-His-SUMO (pETA-GHS) and MBP-His-SUMO 
(pETA-MHS) expression vectors, respectively. Two gene fragments were amplified from 
3D7 genomic DNA; full-length pfhp1 (using primers HP1_F and HP1_Xho_R) and a 
truncated version encoding the CD and hinge domains only (PfCD.H: M1-T181 (using 
primers HP1_F and CDH_Xho_R). XhoI-digested PCR products were ligated into 
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SfoI/XhoI-cut expression vectors; full-length pfhp1 was cloned into pETA-MHS and 
pfcd.h into pETA-GHS. All primer sequences are listed in Table S3. 
Expression and purification of recombinant PfHP1 
Both recombinant proteins were expressed in E. coli Rosetta2 (DE3) cells (Novagen) 
using auto-induction at 22°C in ZYM-5052 medium (Studier, 2005). Expression cultures 
were spun down at 4°C and the pellets were kept at -20°C. Both recombinant proteins 
were purified using nickel affinity (A), followed by dextrin affinity (MHS-HP1 only) (B) 
and tag removal (C). PfCD.H was further purified using hydrophobic interaction 
chromatography (HIC) (D). Both proteins were polished using gel filtration (E). All 
affinity columns used were produced by GE Healthcare. (A) Nickel affinity. E. coli 
pellets were resuspended in buffer N-A (50 mM H3PO4, 20 mM imidazole, 500 mM NaCl, 
5 mM EACA and NaOH to pH 7.4) and lysed by sonication. The lysates were loaded 
on 1 ml HisTrap columns, washed with 20 column volumes (CV) of the same buffer and 
eluted using N-B (50 mM H3PO4, 225 mM imidazole, 500 mM NaCl, 5 mM EACA). For full 
length HP1, 2 M urea was included in the lysis buffer. The nickel eluate containing 
PfCD.H was buffer exchanged to subtraction buffer (0.75x concentrated N-A 
complemented with 10% glycerol, 1 mM TCEP and additional 125 mM NaCl) using 
three 5 ml HiTrap desalting columns. (B) Dextrin affinity (MHS-HP1 only). The protein was 
eluted from the nickel column directly on a 5 ml MBPTrap HP column placed below 
the HisTrap column. After elution, the nickel column was removed and the MBPTrap 
column was washed with 5 CV of N-A and eluted with N-A containing 2 M urea, 10 
mM maltose and 1 mM TCEP. (C) Tag removal. The GHS and MHS tags were cleaved 
off using recombinantly expressed SUMO protease (L403-K621 of S. cerevisiae ULP1; 
expressed as GB1-ULP1-6xHis fusion and purified by nickel affinity and gel filtration) in 
a ratio of 1:200 and incubated for 1.5 hours at 16°C. In order to subtract the tag, the 
protease and other contaminants, the digest was passed through a HisTrap column. 
In the case of full-length HP1, guanine-HCl was added to a final concentration of 1 M 
for this step. (D) HIC (PfCD.H only). Ammonium sulfate from a 4 M stock (pH adjusted 
to 7 using NH4OH) was added to the protein sample to 1.5 M and this mixture was 
loaded on a 1 ml Phenyl HP column equilibrated in buffer HIC (1.5 M ammonium 
sulfate, 5 mM EACA, 0.5 mM EDTA, 20 mM H3PO4-KOH, pH 6.8, and 10% Glycerol). The 
column was washed with 20 CV of the same buffer and the protein eluted using a 25 
CV long linear gradient, from 1.5 M to 0 M ammonium sulfate. (E) Gel filtration. PfCD.H 
was polished using 10 mM MOPS-KOH, pH 7, 100 mM NaCl, 10% glycerol buffer and a 
Superdex75 10/300 GL column. For full-length HP1, a HiLoad 26/60 Superdex 200 
Chapter 2|                           Mapping and functional analysis of PfHP1 phosphorylation 
 47 
column was prepared in three steps: first, it was equilibrated in storage buffer (20 mM 
MOPS-KOH, pH 7, 0.5 M NaCl, 10 % glycerol). Then, a gradient (1/10th CV) from storage 
buffer to refolding buffer (20 mM MOPS-KOH, pH 7, 800 mM arginine, 267 mM citric 
acid) was loaded to the column, and finally a second gradient (1/8th CV), from 
refolding buffer to buffer N-A containing 2 M urea and 1 M guanine-HCl was loaded. 
As a result, the protein passed first through refolding and later through storage buffer. 
Both proteins were concentrated using Amicon spin filter (Millipore) with a 10K cut-off 
and stored at -80°C. Their purity and concentration were determined by SDS-PAGE 
and NanoDrop™ 2000/2000c spectrophotometer with UV extinction coefficients 
calculated by protparam (https://web.expasy.org/protparam/). 
In vitro kinase assays 
Purified recombinant P. falciparum kinases were prepared as described for PfCK2 
(Holland et al., 2009), PfGSK3 (Droucheau et al., 2004) and PfMAP2, PfNEK2, PfNEK4, 
PfPK6 (Van Voorhis et al., 2016). The ADP-GloTM in vitro kinase assay was performed in 
duplicates according to the manufacturer`s instructions (Promega, USA). The exact 
amount of recombinant kinase (0.6-7 µg) and PfHP1 or PfCD.H (1.8-5.8 µg) substrates 
used in each reaction is indicated in the corresponding figures. 10 µg of either histone 
from calf thymus, bovine myelin basic protein (MBP) or β-casein from bovine milk 
(Sigma-Aldrich) were used as positive controls. 5 µl out of 25 µl of the kinase reactions 
were used for the final ATP depletion and detection steps. The remaining reaction 
volume was used for LC-MS/MS analysis to identify phosphosites (see above).  
The γ-P32-ATP in vitro kinase assays were performed in a standard 25 µl reaction in 
kinase buffer (20 mM Tris HCl pH 7.5, 20 mM MgCl2, 2 mM MnCl2, 10 mM 
glycerolphosphate and 10 mM NaF) containing 10 µM ATP, 5 µCi γ-P32-ATP (3000 
Ci/mmol, Amersham Biosciences), substrates (5.4 µg PfHP1, 5.8 µg PfCD.H, 10 µg β-
casein, 10 µg calf thymus histone, or 5 µg MBP) and recombinant kinases (0.5 µg PfCK2 
or 0.6 µg PfGSK3). In the assay using PfCK2, 20 µM of 4,5,6,7-tetrabromobenzimidazole 
(TBB) in DMSO was use as a specific CK2 inhibitor (Holland et al., 2009; Sarno et al., 
2001). The reactions were carried out for 30 min at 30 °C and stopped by the addition 
of Laemmli buffer. The samples were analyzed by SDS-polyacrylamide gel 
electrophoresis followed by autoradiography. 
Transfection constructs 
We applied CRISPR/Cas9-mediated genome editing and the DiCre/LoxP system 
(Collins et al., 2013; Jones et al., 2016) to generate parasite lines for the conditional 
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expression of PfHP1-GFP phosphomutants. We engineered (1) 3D7/N31DC_PfHP1-3M 
(3D7/HP1-3M) for expression of the S122/125/129A PfHP1 mutant; (2) 
3D7/N31DC_PfHP1-HIM (3D7/HP1-HIM) for expression of the 
S89/92/122/125/129/136/174A PfHP1 mutant; and (3) 3D7/N31DC_PfHP1-Control 
(3D7/HP1-Control) for expression of wild type PfHP1-GFP. To obtain these cell lines we 
performed two subsequent transfection steps.  
In the primary transfection, we generated the mother cell line 3D7-1G5DC/5’-loxPint-
g31 (3D7/N31DC), which carries a sera2 intron:loxP element (Jones et al., 2016) 
inserted into the 5’ end of the pfhp1 coding sequence. To achieve this, we 
constructed the pHF-gC-guide31 plasmid by inserting two annealed complementary 
oligonucleotides (F-g31 and R-g31) encoding the sgRNA target sequence and 
containing appropriate single-stranded overhangs into the BsaI-digested pHF-gC 
SpCas9 plasmid (Filarsky et al., 2018) using T4 DNA ligase. The sgRNA target sequence 
(5’-ATTTATTTAGTAAAATGGAA-3’) is positioned at bps +70 to +89 within the pfhp1 
coding sequence and was identified using the CHOPCHOP web tool 
(http://chopchop.cbu.uib.no) (Labun et al., 2016; Montague et al., 2014). The donor 
plasmid pFdon-N31 was generated by Gibson assembly joining four PCR fragments 
encoding (1) the pFdon plasmid backbone (Filarsky et al., 2018) digested with SalI and 
EcoRI; (2) the 103 bp fragment encoding the sera2 intron:loxP fragment amplified from 
pD_SIP2xGFP plasmid (I. Niederwieser, unpublished) using primers F139 and R143; (3) a 
5’ homology region (5’ HR) spanning bps -490 upstream of the start codon to +87 in 
the pfhp1 coding sequence amplified from 3D7 gDNA using primers F147 and R145; 
and (4) a 3’ HR spanning bps +88 to +756 of the pfhp1 coding sequence amplified 
from 3D7 gDNA using primers F146 and R144 (the pfhp1 coding sequence is 798 bps 
long). For transfection, 50 µg of each plasmid (pHF-gC-guide31 and pFdon-N31) were 
mixed and co-electroporated into DiCre-expressing 3D7/1G5DC parasites (Collins et 
al., 2013). Transfected parasites were selected with 4 nM WR99210 for six days and then 
cultured in absence of drug selection until transgenic populations were established.  
In the second step, 3D7/N31DC parasites were transfected again to generate parasite 
lines 3D7/HP1-3M, 3D7/HP1-HIM and 3D7/HP1-Control that carry a second sera2 
intron:loxP sequence directly downstream of the endogenous pfhp1 STOP codon, 
followed by a recodonised mutated (HP1-3M and HP1-HIM) or wild type (HP1-Control) 
pfhp1-gfp sequence using the following cloning steps. First, we constructed the pBF-
gC-guide250 plasmid by inserting two annealed complementary oligonucleotides (F-
g250 and R-g250) encoding the sgRNA target sequence at the 3’ end of the pfhp1 
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coding sequence and appropriate single-stranded overhangs into the BsaI-digested 
pBF-gC SpCas9 plasmid (Filarsky et al., 2018) using T4 DNA ligase. The sgRNA target 
sequence (5’-AAAAAATTTAAGAGTTCCTG-3’) is positioned at bps +751 to +770 within 
the pfhp1 coding sequence (negative strand) and was identified using CHOPCHOP 
(http://chopchop.cbu.uib.no). Second, we constructed the three donor plasmids. The 
pD-HP1-Control plasmid was constructed by Gibson assembly joining two PCR 
fragments. The first fragment was amplified from the plasmid pD-PfHP1-KO (see 
Supplementary Methods) using primers F162 and R143 and contains, in the following 
order, the gpf coding sequence ending with a STOP codon, a 3’ HR spanning the 824 
bps directly downstream of the pfhp1 STOP codon, the pD plasmid backbone 
(Brancucci et al., 2017), a 5’ HR spanning bps +88 to +798 of the pfhp1 coding 
sequence carrying eight synonymous mutations between bps +757 to +798 (see 
Supplementary Methods) and ending with a STOP codon followed by the 103 bp sera2 
intron:loxP element. The second PCR fragment was amplified from a plasmid 
containing a synthetic recodonized pfhp1 sequence (pUC57-re-pfhp1) (GenScript™) 
(see Figure S3 and Supplementary Methods) using primers F164 and R165 and spans 
bps +88 to +798 of the pfhp1 coding sequence omitting the STOP codon. 
The pD-HP1-3M plasmid was constructed by Gibson assembly joining four PCR 
fragments encoding (1) the 5’ HR spanning bps +88 to +798 of the pfhp1 coding 
sequence ending with a STOP codon followed by the 103 bp sera2 intron:loxP element 
and bps +88 to +384 of the recodonised pfhp1 sequence amplified from the pD-PfHP1-
Control plasmid using primers F158 and R168, the latter of which introduces the 
S122/125A mutations into PfHP1; (2) a fragment spanning bps +367 to +798 of the 
recodonised pfhp1 sequence amplified from pUC57-re-pfhp1 (GenScript™) using 
primers F91 and R165, the former of which introduces the S125/129A mutations into 
PfHP1; (3) the gfp coding sequence ending with a STOP codon followed by the 3’ HR 
amplified from the pFdon-C-loxP-g250 vector (see Supplementary Methods) using 
primers F162 and R163; and (4) the pD plasmid backbone amplified from pUC19 using 
primers PCRA_F and PCRA_R (Brancucci et al., 2017).  
Finally, the pD-HP1-HIM plasmid was constructed in a two-step process. First, a 
fragment containing, in the following order, bps +88 to +798 of the recodonised pfhp1 
sequence encoding the S89/92/122/125/129/136/174A mutations followed by the gfp 
sequence ending with a stop codon and the 3’ HR was generated by Gibson assembly 
joining four fragments encoding (1) bps +88 to +280 of recodonised pfhp1 amplified 
from pD-PfHP1-Control using primers F164 and R172, the latter of which introduces the 
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S89/92A mutations; (2) bps +261 to +409 of the recodonised pfhp1 sequence amplified 
from pD-PfHP1-3M (containing the S122/125/129A mutations) using primers F171 and 
R174, the former of which introduces the S89/92A mutations and the latter of which 
introduces the S136A mutation; (3) bps +390 to +535 of the recodonised pfhp1 
sequence amplified from pD-PfHP1-Control using primers F173 and R176, the former of 
which introduces the S136A mutation and the latter of which introduces the S174A 
mutation; and (4) a fragment containing, in the following order, bps +520 to +798 of 
the recodonised pfhp1 sequence, the gfp coding sequence ending with a STOP 
codon and 3’ HR amplified from pD-PfHP1-Control using primers F175 and R163, the 
former of which introduces the S174A mutation. Second, the resulting fragment from 
the first step was used as template for a second round of PCR amplification using 
primers F164 and R163 and subjected to a second Gibson assembly joining with two 
other PCR fragments, namely the pD plasmid backbone amplified from pUC19 using 
primers PCRA_F and PCRA_R (Brancucci et al., 2017), and a fragment containing the 
5’ HR followed by the sera2 intron:lox P amplified from the pD-PfHP1-Control using 
primers F158 and R143.  
For each of the three transfections, 50 µg of the pBF-gC-guide250 plasmid was mixed 
with 50 µg of either pD-PfHP1-Control, pD-PfHP1-3M or pD-PfHP1-HIM and transfected 
by electroporation into the 3D7/N31DC parasite line as described above. Transfected 
parasites were selected with 5 µg/ml BSD-S-HCl for 10 days and then cultured in 
absence of drug pressure until transgenic populations were established. All 
oligonucleotide sequences used for the cloning of the CRISPR/Cas9 and donor 
plasmids are provided in Table S3. The nucleotide sequence of recodonized pfhp1 is 
provided in Figure S3. 
Nucleic acid isolation and diagnostic PCRs and reverse transcription PCRs 
To confirm correct editing of the pfhp1 locus we performed PCRs using the KAPA HiFi 
HotStart enzyme (Roche Sequencing Store) on gDNA isolated from the transgenic cell 
lines. To evaluate the excision efficiency after rapamycin treatment, diagnostic PCRs 
were performed on gDNA isolated 24-36 hours post rapamycin treatment (Knuepfer et 
al., 2017). To evaluate the splicing efficiency of the sera 2 intron:loxP from the pfhp1 
open reading frame, total RNA from the 3D7/N31DC mother cell line and the 
rapamycin-treated phosphomutant cell lines were isolated using Ribozol (Amresco) 
according to the manufacturer’s instruction. cDNA was then synthesized using 
oligo(dT) primers (RetroScript, Invitrogen) and PCRs on cDNA were performed using 
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primers F106 and R107 that amplify the entire coding sequence. All transfection 
plasmids generated in this study have been validated by Sanger sequencing. All 
transfection plasmids have been designed and Sanger sequencing results analysed 
using the SnapGene software (from GSL Biotech; available at snapgene.com). All 
primer sequences used for PCR are listed in Table S3. 
Induction of DiCre recombinase-mediated DNA excision by rapamycin treatment 
Parasites were synchronized twice 16 hours apart to obtain an eight-hour growth 
window (16-24 hpi). After re-invasion parasites were synchronized again at 0-8 hpi 
(generation 1) and split into two equal populations, one of which was treated with 
0.02% v/v of DMSO (negative control) and the other half was treated with 100 nM 
rapamycin for 1 hour (Knuepfer et al., 2017). The cultures were then spun down, 
washed with an equal volume of culture medium, resuspended in culture medium and 
returned to culture. 
SDS-PAGE and immunoblotting 
After DMSO or rapamycin treatment in generation 1, parasites were allowed to 
complete schizogony and re-invasion. At 16-24 hpi in generation 2, parasites were 
released from infected RBCs (iRBCs) by 0.15% saponin/PBS complemented with 1X 
protease inhibitor (Roche Diagnostics). After washing 2-3 times in ice-cold PBS, parasite 
pellets were lysed in 70°C pre-heated Urea/SDS buffer (8 M Urea, 5% SDS, 50 mM Bis-
Tris, 2 mM EDTA, 25 mM HCl at pH 6.5 supplemented with 2 mM DTT and 1X protease 
inhibitor). Whole parasite protein lysates were separated on NuPage 4-12% Bis-Tris gels 
(Novex) and analyzed by Western blot using mouse mAb α-GFP (Roche Diagnostics 
#11814460001), 1:1000; rabbit α-PfHP1 (Brancucci et al., 2014), 1:5’000; rabbit α-Histone 
4 (Abcam ab10158), 1:10’000. 
Live cell imaging and indirect immunofluorescence assay (IFA) 
To quantify the efficiency of pfhp1 excision after rapamycin treatment, live cell 
fluorescence microscopy was performed as described before (Witmer et al., 2012) 
with minor modifications using Hoechst (Merck) at a final concentration of 5 µg/ml to 
stain the nuclei. Excision efficiency was determined as the percentage of GFP-positive 
schizonts at 40-48 hpi in generation 1 (>100 schizonts counted per experiment). IFAs 
were performed on methanol-fixed cells using mouse IgG1 mAb α-ATS (Duffy et al., 
2002), 1:150; and Alexa Fluor 488-conjugated α-mouse IgG (Molecular Probes), 1:250. 
Images were taken at 63-fold magnification on a Leica DM 5000B microscope with a 
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Leica DFC 300 FX camera, acquired via the Leica IM 1000 software, processed using 
ImageJ software (https://imagej.nih.gov/ij). For each experiment, images were 
acquired and processed with identical settings.   
Parasite multiplication assay  
Parasites were tightly synchronized twice 16 hours apart, split into two equal 
populations after re-invasion at 0-8 hpi (generation 1), of which one half was treated 
with DMSO (negative control) and the other half was induced for DiCre recombinase-
mediated DNA excision by rapamycin treatment as described above. Giemsa smears 
were prepared to determine the parasitaemia at 16-24 hpi (generation 1). Giemsa-
stained smears were prepared every second day onwards for three generations. 
Parasitaemia was counted by visual inspection of Giemsa-stained blood smears 
(>3’000 RBCs counted per experiment). Multiplication rates were determined as the 
parasitaemia observed in the following generation divided by the parasitaemia 
observed in the previous generation. The extrapolative growth curve was generated 
using a starting parasiteamia at 0.1%. 
Gametocyte conversion assay 
Parasites were tightly synchronized twice 16 hours apart and split into two equal 
populations after re-invasion at 0-8 hpi (generation 1), of which one half was treated 
with DMSO (negative control) and the other half was induced for DiCre recombinase-
mediated DNA excision by rapamycin treatment as described above. At 16-24 hpi in 
the subsequent generation (day 1 of gametocytogenesis), cultures were treated with 
50 mM N-acetyl-D-glucosamine (GlcNAc) for six days to eliminate asexual parasites  
(Fivelman et al., 2007; Ponnudurai et al., 1986) and then cultured with normal culture 
medium for another 4-6 days to observe gametocyte maturation. Gametocytaemia 
was determined on day 6 by visual inspection of Giemsa-stained blood smears. Sexual 
conversion rates were determined as the gametocytaemia observed on day 6 as a 
proportion of the total parasitaemia observed on day 1. 
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Figure 1. Identification of phosphorylated residues in PfHP1. (A) Upper panel: silver-
stained SDS-PAGE gel of protein samples from a PfHP1-GFP immunoprecipitation (IP) 
experiment using nuclear extracts from 3D7/HP1-GFP parasites and GFP-Trap®_A 
beads. Lower panel: Western blot analysis of the IP samples using α-PfHP1 antibodies 
showing the presence of PfHP1-GFP in the input and elution samples. FT, flow through; 
W1-W5, wash 1-5; E1/E2, eluates 1 and 2. (B) Overview of all phosphosites (yellow 
circles) identified in PfHP1, either in this study by LC-MS/MS of immunopurified native 
PfHP1-GFP or in other proteomics studies (Collins et al., 2014; Filarsky et al., 2018; 
Lasonder et al., 2012; Lasonder et al., 2015; Pease et al., 2013; Solyakov et al., 2011; 
Treeck et al., 2011). Phosphosites identified here and in at least one previous study are 
highlighted in red letters, those identified only in previous studies are highlighted in 
black letters, and the phosphosite exclusively identified here (S206) is highlighted by a 
green letter. Helices and ß-sheets predicted by the secondary structure prediction tool 
JPred4 (http://www.compbio.dundee.ac.uk/jpred4/index.html) (Drozdetskiy et al., 
2015) are indicated by orange and green boxes, respectively. The approximate 
boundaries of the CD (brown), hinge domain (grey) and CSD (pink) are indicated 
(Flueck et al., 2009). Numbers refer to amino acid positions in the PfHP1 sequence. 
 
Figure 2. PfCK2 phosphorylates PfHP1 and in vitro. (A) Coomassie-stained SDS-PAGE 
gel showing the purified recombinant PfHP1 and PfCD.H proteins. (B) In vitro ADP-GloTM 
assay results reveal that PfCK2 phosphorylates PfHP1 and PfCD.H in vitro. The 
percentage of ADP converted back into ATP (y-axis) is a surrogate measure for kinase 
activity (i.e. the relative amount of ATP consumed in the kinase reaction). β-casein was 
included as a positive control substrate for PfCK2. Recombinant PfHP1 and PfCD.H in 
absence of PfCK2 were used as negative controls. Values represent the average of 
two replicate reactions. Error bars represent SD. (C) Coomassie-stained SDS-PAGE gel 
(top) and corresponding autoradiogram (bottom) of the in vitro γ-P32-ATP PfCK2 kinase 
assay performed with recombinant PfHP1 and PfCD.H substrates. β-casein was used 
as a positive control substrate. 20 µM TBB was used as a specific inhibitor of PfCK2 
(Holland et al., 2009; Sarno et al., 2001). 
 
Figure 3. Generation of DiCre-inducible PfHP1 phosphomutants. (A) Schematics of the 
CRISPR/Cas9-edited pfhp1 loci (left panel) and corresponding PfHP1 protein products 
(right panel) expressed in the 3D7/N31DC mother line (top) and the 3D7/HP1-3M, 
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3D7/HP1-HIM and 3D7/HP1-Control parasites (bottom) before (DMSO) and after (RAP) 
rapamycin-induced DiCre-dependent excision of the wild type pfhp1 locus. HR, 
homology regions used for homology-directed repair of Cas9-induced DNA double-
strand breaks. Blue arrowheads indicate the position of sera2 intron:loxP elements 
(Jones et al., 2016). Red asterisks indicate STOP codons. Blue asterisks indicate the 
relative position of serine-to-alanine substitutions in the PfHP1 hinge region in the 
3D7/HP1-3M and 3D7/HP1-HIM phosphomutants. Orange and blue boxes represent 
the wild type and recodonised pfhp1/PfHP1 sequences, respectively. Numbers in the 
gene and protein schematics refer to nucleotide and amino acid positions, 
respectively. The black arrowheads indicate the binding sites of the F119 and R157 
primers used to confirm correct editing of the pfhp1 locus and efficient DiCre-
mediated excision upon rapamycin treatment by PCR on gDNA (see Figure 3B below). 
(B) PCR on gDNA confirms the correctly edited pfhp1 loci and efficient excision of the 
endogenous pfhp1 gene after rapamycin treatment in 3D7/HP1-3M, 3D7/HP1-HIM and 
3D7/HP1-Control parasites. Using primers F119 and R157 (see Figure 3A) the correctly 
edited pfhp1 locus delivers a PCR product of 3781 bps in the 3D7/HP1-3M (left panel), 
3D7/HP1-HIM (middle panel) and 3D7/HP1-Control line (right panel). In the 3D7/N31DC 
mother line (i.e. prior to the insertion of a recodonised pfhp1-gfp fusion gene) this PCR 
reaction delivers a 2250 bps fragment (right panel). Correct excision of the 
endogenous pfhp1 gene in rapamycin-treated 3D7/HP1-3M, 3D7/HP1-HIM and 
3D7/HP1-Control parasites results in a decrease of the size of the PCR fragment from 
3781 bps to 2964 bps. Primers targeting the cg6 control locus (PF3D7_0709200) have 
been used as control. RAP, rapamycin. (C) The efficiency of DiCre-mediated excision 
of the endogenous pfhp1 gene and resulting expression of the recodonised PfHP1-GFP 
fusion proteins has been quantified by counting the number of GFP-positive parasites 
in paired control (DMSO) and rapamycin-treated (RAP) populations in late schizont 
stages (40-48 hpi) (40 hrs after rapamycin treatment). Values represent the mean of 
three (3D7/HP1-HIM) and four (3D7/HP1-3M and 3D7/HP1-Control) independent 
biological replicate experiments (>100 iRBCs scored for each population). Error bars 
indicate SD. (D) Western blot showing the expression of endogenous untagged PfHP1 
and recodonised PfHP1-GFP in the progeny of DMSO- and rapamycin-treated 
3D7/HP1-3M, 3D7/HP1-HIM and 3D7/HP1-Control parasites (16-24 hpi, generation 2) (64 
hrs after rapamycin treatment). α-histone 4 (H4) antibodies were used as loading 
control. RAP, rapamycin. 
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Figure 4. Sub-nuclear localization of PfHP1 phosphomutants. (A) Representative live 
cell fluorescence images showing the localization of the GFP-tagged PfHP1-3M and 
PfHP1-HIM phosphomutants and the PfHP1-Control protein in late schizonts (LS, 40-48 
hpi, generation 1; 40 hrs after rapamycin treatment) and after re-invasion in the 
progeny at late ring stage (LR, 16-24 hpi, generation 2; 64 hrs after rapamycin 
treatment). Nuclei were stained with Hoechst. DIC, differential interference contrast. 
Scale bar, 5 µm. 
 
Figure 5. Phenotypes of PfHP1 phosphomutants. (A) Growth curves of the control 
(DMSO) and rapamycin-treated (RAP) PfHP1-GFP phosphomutants and control line 
over three generations of intra-erythrocytic replication. Values are the mean of four 
(3D7/HP1-3M and 3D7/HP1-Control) and six (3D7/HP1-HIM) independent replicate 
experiments. Error bars represent SD. (B) Sexual conversion rates of DMSO- and 
rapamycin-treated (RAP) PfHP1-GFP phosphomutants, the PfHP1-Control line, the 
3D7/1G5DiCre mother line and 3D7 wild type parasites. Values represent the mean of 
four (3D7/HP1-3M and 3D7/HP1-Control), six (3D7/HP1-HIM) and three (3D7/1G5DiCre 
and 3D7 wild type) independent replicate experiments. Error bars represent SD. 
Asterisks indicate significant differences in sexual conversion rates between RAP-
treated and DMSO-treated parasites (p<0.01; unpaired two-tailed Student`s t-test). (C) 
Representative images showing PfEMP1 expression in control (DMSO) and rapamycin-
treated (RAP) PfHP1-GFP phosphomutants and control line in the late ring stage 
progeny (LR, 16-24 hpi, generation 2; 64 hrs after rapamycin treatment) as determined 
by IFA using α-ATS antibodies recognizing the conserved ATS domain of PfEMP1 (Duffy 
et al., 2002). The percentage of PfEMP1-positive iRBCs are indicated for each 
population. Values represent the mean of two independent experiments (+/- SD) 
(3D7/HP1-3M and 3D7/HP1-Control) and a single experiment (3D7/HP1-HIM). Nuclei 
were stained with DAPI. DIC, differential interference contrast. Scale bar, 5 µm. 
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Figure 3 
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Figure 4 
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Figure 5 
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2.7 Supplementary Information 
 
 
This Supplementary Information includes: 
Supplementary Methods 
Figures S1 to S4 
Tables S1 to S3 
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Supplementary Methods 
 
Generation of the pFdon-C-loxP-g250 donor plasmid 
The pFdon-C-loxP-g250 plasmid was constructed by Gibson assembly joining five DNA 
fragments. The first fragment represents the pFDon plasmid (Filarsky et al., 2018) 
digested with SalI and EcorI. The second fragment represents a pfhp1 5’ HR spanning 
bps +88 to +798  omitting the stop codon and carrying eight synonymous mutations 
between bps +757 to +798 [ 
(CàT)T(CàA)TTAAATTT(TàC)TTATTATCAAGA(CàT)TAAGATA(CàT)(CàA)G(TàA)AC
AGC(TàG)], followed by 28 bps of the sera2 intron:loxP element. This 5’ HR was 
generated in a four-step PCR process. First, a PCR fragment containing six synonymous 
mutations within the region spanning bps +757 to + 790 of the pfhp1 sequence (of 
which three are located within the sgRNA target sequence) was amplified from 3D7 
gDNA using primers F133 and R138. This sequence was then used as template for a 
second round of amplification adding two more mutations within bps +792 to +798 of 
the pfhp1 sequence followed by six bps of the sera2 intron:loxP sequence (primers F133 
and R138.1). The second sequence was then used as template for a third round of 
amplification adding nine more bps of the sera2 intron:loxP sequence (primers F133 
and R138.2). The third sequence was used as template for the final round of 
amplification to add in total 28 bps of the sera2 intron:loxP sequence to serve as 
overhang for subsequent Gibson assembly (primers F133 and R138.3). The third 
fragment represents the sera2 intron:loxP sequence followed by bps +1 to +356 of the 
gpf coding sequence amplified from the pD_SIP2xGFP plasmid (Igor Niederwieser, 
unpublished) using primers F139 and R148. The fourth fragment spans bps +336 to +714 
of the gfp coding sequence ending with a stop codon and a Gibson assembly 
overhang amplified from the pD_SIP2xGFP plasmid (Igor Niederwieser, unpublished) 
using primers F149 and R136. The fifth and final fragment for Gibson assembly 
represents a pfhp1 3’ HR spanning the 824 bps directly downstream of the stop codon 
amplified from 3D7 gDNA using primers F71 and R134. All oligonucleotide sequences 
used for the cloning of the pFdon-C-loxP-g250 plasmid are provided in Table S3. 
 
Generation of the pD-PfHP1_KO donor plasmid 
The pD-PfHP1-KO donor plasmid was constructed by Gibson assembly joining three 
PCR fragments encoding (1) the plasmid backbone pD amplified from pUC19 using 
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primers PCRA_F and PCRA_R (Brancucci et al., 2017), (2) a 5’ HR spanning bps +88 to 
+798 of the pfhp1 coding sequence ending with a stop codon carrying eight 
synonymous mutations within the region spanning bps +757 to +798 amplified from the 
pFdon-C-loxP-g250 plasmid (see above) using primers F158 and R159; and (3) a PCR 
product amplified from the pFdon-C-loxP-g250 plasmid using primers F139 and R163 
and representing, in the following order, the 103 bp sera2 intron:loxP element, the gfp 
coding sequence ending with a stop codon and a 3’ HR sequence spanning 824 bps 
directly downstream of the pfhp1 stop codon. All oligonucleotide sequences used for 
the cloning of the pD-PfHP1-KO plasmid are provided in Table S3. 
 
Supplementary Figures 
Figure S1. ADP Glo in vitro kinase assay results. Based on ADP-GloTM kinase assays 
PfMAP2, PfPK6, PfNEK2 and PfNEK4 do not specifically phosphorylate PfHP1 and 
PfCD.H in vitro. The percentage of ADP converted back into ATP (y-axis) is a surrogate 
measure for kinase activity (i.e. the relative amount of ATP consumed in the kinase 
reaction). MBP was included as a positive control substrate for PfMAP2, PfPK6 and 
PfNEK2, β-casein was included as a positive control substrate for PfNEK4. Recombinant 
PfHP1 and PfCD.H in absence of recombinant kinases were used as negative controls. 
All kinases except PfNEK4 show substantial autophosphorylation activity. Values 
represent the results of a single experiment each.  
 
Figure S2. PfGSK3 phosphorylates PfHP1 and PfCD.H in vitro. (A) ADP-GloTM kinase 
assay. The percentage of ADP converted back into ATP (y-axis) is a surrogate measure 
for kinase activity (i.e. the relative amount of ATP consumed in the kinase reaction). 
Recombinant PfGSK3 showed strong autophosphorylation activity (column 1). 
Histones from calf thymus were used as positive control substrates (column 2). The 
addition of PfHP1 and PfCD.H increased the ATP consumption compared to 
addition of the control substrate (columns 3 to 6). Recombinant PfHP1 and PfCD.H in 
absence of PfGSK3 were used as negative controls (columns 7 and 8). The amount of 
PfGSK3 and substrates used in the assay is indicated. Values represent the results from 
two replicate reactions. Error bars represent SD. (B) γ-P32-ATP kinase assay. Coomassie-
stained gel (top) and corresponding autoradiogram (bottom) of the in vitro γ-P32-ATP 
PfGSK3 kinase assay performed with recombinant PfHP1 and PfCD.H substrates. 
Recombinant PfGSK3 showed strong autophosphorylation activity (lanes 3-6). 
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Histones from calf thymus were used as positive control substrates (lane 4). PfGSK3 
phosphorylated the control and the PfHP1 and PfCD.H test substrates (lanes 4-6). 
Recombinant PfHP1 and PfCD.H in absence of PfGSK3 were used as negative controls 
(lanes 1 and 2). 0.6 µg of PfGSK3 was used in each reaction. 
 
Figure S3. Two-step CRISPR/Cas9-based gene editing strategy to generate DiCre-
inducible PfHP1 phosphomutant cell lines. (A) First gene editing step: Schematic maps 
of the pfhp1 locus (PF3D7_1220900) in 3D7/1G5DiCre parasites (Collins et al., 2013) 
(top), the co-transfected pFDon-N31 donor plasmid and pHF_gC-guide31 
CRISPR/Cas9 transfection vector (center), and the modified pfhp1 locus after 
CRISPR/Cas9-based gene editing in 3D7/N31DC parasites (bottom). The nucleotide 
positions of the sgt_pfhp1-5’ sgRNA target sequence is indicated (chromosome 12 
coordinates). The pFDon-N31 donor plasmid contains a 103 bp sera2 intron:loxP 
element (light blue triangle) (Jones et al., 2016) flanked by two homology regions (HR) 
(orange, black) for homology-directed repair. The pHF_gC-guide31 plasmid contains 
expression cassettes for SpCas9 (dark grey), the sgRNA (purple) and the hdhfr-yfcu 
fusion selection marker (light grey-brown). Second gene editing step: Schematic maps 
of the pfhp1 locus in 3D7/N31DC parasites (top), the co-transfected pD_HP1 donor 
plasmid (pD_HP1-Control is shown as an example) and pBF_gC-guide250 CRISPR/Cas9 
transfection vector (center), and the modified pfhp1 locus after CRISPR/Cas9-based 
gene editing in 3D7/HP1-3M, 3D7/HP1-HIM and 3D7/HP1-Control parasites (3D7/HP1-
Control is shown as an example) (bottom). The nucleotide positions of the sgt_pfhp1-
3’ sgRNA target sequence is indicated (chromosome 12 coordinates). The pD_HP1 
donor plasmids contain an assembly of the 103 bp sera2 intron:loxP element (light blue 
triangle) (Jones et al., 2016) and the recodonised pfhp1 sequence (dark blue) fused 
to gfp (green) flanked by two homology regions (HR) (orange, black) for homology-
directed repair. The pBF_gC-guide250 plasmid contains expression cassettes for 
SpCas9 (dark grey), the sgRNA (purple) and the bsd-yfcu fusion selection marker (light 
grey-brown). Red stars represent STOP codons. Numbers refer to the nucleotide 
position within the pfhp1 coding sequence. (B) Nucleotide sequences of the wild type 
(pfhp1) and recodonised (pfhp1 re) pfhp1 genes and amino acid sequence of PfHP1. 
Bases altered in the pfhp1 re are highlighted in red letters. Numbers refer to the 
nucleotide position within the pfhp1 coding sequence. 
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Figure S4. Confirmation of successful gene editing by PCR and Sanger sequencing. (A) 
Top: Schematic of the CRISPR/Cas9-edited pfhp1 locus in the 3D7/N31DC mother line 
carrying a 103 bp sera2 intron:loxP element (Jones et al., 2016) inserted into the 5’ end 
of the gene. The homology regions (HR) used for homology-directed repair of the 
Cas9-induced DNA double-strand break are indicated. The blue arrowhead indicates 
the position of sera2 intron:loxP element. The red asterisk indicates the STOP codon. 
Numbers refer to nucleotide positions within the pfhp1 coding sequence. The black 
arrowheads indicate the binding sites of the primers used to confirm correct gene 
editing of the pfhp1 locus by PCR on gDNA. Bottom: PCR on gDNA isolated from 
3D7/N31DC parasites and 3D7/1G5DiCre control parasites (Collins et al., 2013) 
confirms the correctly edited pfhp1 locus in the 3D7/N31DC mother line. Primer pairs 
F156/R143 and F139/R265 deliver PCR products only from the 3D7/N31DC but not from 
the parental 3D7/1G5DiCre line (note that F139 and R143 bind specifically to the sera2 
intron:loxP element). Using primers F156 and R265, the correctly edited pfhp1 locus 
delivers a PCR product of 1893 bps in the 3D7/N31DC line and of 1790 bps in the 
parental 3D7/1G5DiCre line (i.e. prior to the insertion of the sera 2 intron:loxP element). 
Primers targeting the cg6 control locus (PF3D7_0709200) have been used as control. 
(B) Top: Schematic maps of the CRISPR/Cas9-edited pfhp1 gene locus in the 
3D7/N31DC mother line carrying a 103 bp sera2 intron:loxP element (left) and the 
corresponding mRNA/cDNA sequence after splicing of the sera2 intron:loxP element 
(right). The blue arrowhead indicates the position of sera2 intron:loxP element. The red 
asterisk indicates the STOP codon. The black arrowheads indicate the binding sites of 
the F106 and R107 primers used to confirm splicing of the sera2 intron:loxP element. 
Bottom left: PCR on gDNA and cDNA from 3D7/N31DC parasites confirms the correct 
splicing of the sera2 intron:loxP element. The F106 and R107 primers bind up- and 
downstream of the pfhp1 open reading frame and amplify a 1020 bp and 917 bp 
fragment from gDNA and cDNA, respectively. Bottom right: Sanger sequencing of PCR 
products amplified from gDNA and cDNA confirms the correct insertion of the sera2 
intron:loxP element into the pfhp1 gene in 3D7/N31DC parasites and correct splicing 
of the sera2 intron:loxP element, respectively. (C) Top: schematics of the CRISPR/Cas9-
edited pfhp1 locus in 3D7/HP1-3M parasites after rapamycin-induced DiCre-
dependent replacement of endogenous wild type pfhp1 with a recodonised mutated 
pfhp1-3m-gfp fusion gene and the corresponding mRNA/cDNA sequence after 
splicing of the sera 2 intron:loxP element. The blue arrowhead indicates the position of 
sera2 intron:loxP element. The red asterisk indicates the STOP codon. The blue asterisks 
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indicate the relative position of mutations encoding serine-to-alanine substitutions in 
the 3D7/HP1-3M phosphomutant. Orange and blue boxes represent the wild type and 
recodonised pfhp1 sequences, respectively. The black arrowheads indicate the 
binding sites of the F106 and R107 primers used to confirm splicing of the sera2 
intron:loxP element. Bottom left: PCR on gDNA and cDNA from rapamycin-treated 
3D7/HP1-3M parasites confirms the correct splicing of the sera2 intron:loxP element. 
The F106 and R107 primers bind up- and downstream of the pfhp1-gfp open reading 
frame and amplify a 1734 bp and 1631 bp fragment from gDNA and cDNA, 
respectively. Bottom right: Sanger sequencing of the RT-PCR product amplified from 
cDNA from rapamycin-treated 3D7/HP1-3M parasites confirms the successful 
introduction of the mutations encoding the S122A/S125A/S129A substitutions in the 
3D7/HP1-3M phosphomutant.  
  
Chapter 2|                           Mapping and functional analysis of PfHP1 phosphorylation 
 73 
Figure S1 
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Figure S2 
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Figure S3 
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B pfhp1     ATGACAGGGTCAGATGAAGAATTTGAAATTGGTGATATACTTGAAATAAAAAAAAAGAAGAATGGTTTTATTTATTTAGTAAAATGGAAAGGAT   94  
          M  T  G  S  D  E  E  F  E  I  G  D  I  L  E  I  K  K  K  K  N  G  F  I  Y  L  V  K  W  K  G     
pfhp1  re ATGACAGGTAGT GATGAAGAATTTGAAATTGG AGATATA TT AGAAATTAAAAAGAAGAAAAATGGTTTTAT CTACTTAGTAAAATGGAAAGGAT   94  
pfhp1     ATTCAGATGATGAGAATACTTGGGAACCCGAAAGTAATTTAATACATTTGACAACATTTAAGAAAAAGATGGAAAGCTTAAAAACGAATTTTTT  188  
         Y  S  D  D  E  N  T  W  E  P  E  S  N  L  I  H  L  T  T  F  K  K  K   M  E  S  L  K  T  N  F  L  
pfhp1  re ATAGTGATGATGAAAATACATGGGAACCAGAATCA AATTT GATTCATTTGACAAC TTTTAA AAAGAAAATGGAATCA TTAAAAAC AAATTT CTT  188  
pfhp1     ATCGAAAGCTAATGAGACAAATGGTGATGGGAAAATTTTGAAAAATCATATATTAGCACCAACACAAGAAGACGATAGTATTAAATCAAAAGGT  282  
           S   K  A  N  E  T  N  G  D  G  K  I  L  K  N  H  I   L   A  P  T   Q  E   D  D  S   I   K  S   K  G 
pfhp1  re ATC TAAAGCAAATGAAACAAATGGAGATGGTAAAATATT AAAGAATCATAT T TTAGC TCCAACACAAGAAGATGATAGTAT AAAATCAAAAGGT 282  
pfhp1     AGAAGTTCCTTAGCACCCCGACGAAAAATGAGTAGAAAAAGTTTAACGAACAAACTAGAAAATAAAAAGAACTTATCTTTATCAGACAATTCTT  376  
          R  S   S   L   A  P  R  R  K  M  S   R  K  S   L   T   N  K  L   E   N  K  K  N  L   S   L   S   D  N  S   
pfhp1  re AGAAGTTCATTAGCACC TAGAAGAAAAATGTC TAGAAAAAGTTTAAC AAATAAGTTAGAAAATAAGAAAAATTT GTC ATTATC T GATAATTC AT 376  
pfhp1     TAAAAAAAAGTGATGAAGAAGATAATGAATCTGTAAAACATGAGAATCACGTTAATGATGGAAATTTATTAAATGTTGAAGATGTATATAGCGT  470  
         I  K  K  S  D  E  E  D  N  E  S  V  K  H  E  N  H  V  N  D  G  N  L  L   N  V  E  D  V  Y  S  V   
pfhp1  re TAAAGAAAAGTGATGAAGAAGATAATGAATCTGT TAAACATGAAAATCATGTAAATGATGGAAATTT GTTAAATGT AGAAGATGTTTATAG TGT 470  
pfhp1     TCGTATTAAAAATAAGAAATTGGAGTTTTTGGCTAGCTTGAAAAATGAATCTCCACAATGGGTAGAAGAAACAAATATTAGAAGAACTGGACAT  564  
           R  I  K  N  K  K  L  E  F  L  A  S  L  K  N  E  S  P  Q  W  V  E  E  T  N  I  R  R  T  G  H      
pfhp1  re AAGAATTAAAAATAAGAAATT AGAATTTTT AGCTTCT TT AAAGAATGAAAGTCCACAATGGGT TGAAGAAACAAATATTAGAAGAACAGGT CAT  564  
pfhp1     TTAAATATTAAAGTCAATGATTTTAAAAGATATGTAAGAAGAAAAAAAAGTTCTAGGGGTAATAGAATAGTTATCAAAAATCTACACAACGTTG  658  
          L  N  I  K  V  N  D  F  K  R  Y  V  R  R  K  K  S  S  R  G  N  R  I  V  I  K  N  L  H  N  V   
pfhp1  re TT GAATATTAAAGT TAATGATTTTAAAAGATATGT TAGAAGAAAGAAAAGTAGTAGAGGAAATAGAATAGT AATTAAAAATTTGCATAATGTAG 658  
pfhp1     GAGATGAATTATATATTTCGGTTATTCATAATATAAATAATAAAGAAATTCATAGTTTATATCCTTCCAAAGTTATTGAATATATTTATCCACA  752  
         G  D  E  L  Y  I  S  V  I  H  N  I  N  N   K  E  I  H  S  L  Y  P  S  K  V  I  E  Y  I  Y  P  Q   
pfhp1  re GAGATGAATTATATAT AAGTGTTATTCATAATATAAATAATAA GGAAATTCATAGTTTATATCCTTC AAAAGTAATAGAATATAT ATATCC TCA 752  
pfhp1     GGAACTCTTAAATTTTTTATTATCAAGACTAAGATACCGTACAGCT                                                  798  
           E  L  L  N  F  L  L  S  R  L  R  Y  R  T  A  
pfhp1  re AGAATTATTAAATTT CTTATT ATCAAGATTAAGATA TAGAACAGCA                                                 798  
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Figure S4 
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Supplementary Tables 
Table S1. Mass spectrometry results of the PfHP1-GFP immunoprecipitation experiments 
(Table not inserted into the thesis due to size. Data available on request (Gene 
Regulation Laboratory - Till S. Voss, Swiss TPH)).  
Table S2. Mass spectrometry results of the PfCK2 and PfGSK3 ADP-GloTM in vitro kinase 
assays  
(Table not inserted into the thesis due to size. Data available on request (Gene 
Regulation Laboratory - Till S. Voss, Swiss TPH)).  
Table S3. List of all oligonucleotides used in this study. 
Application Oligo name Sequence (5’-3’) 
Annealing  
  
  
  
F-g31 TATTATTTATTTAGTAAAATGGAA 
R-g31 AAACTTCCATTTTACTAAATAAAT 
F-g250 TATTCATAATAAAATTAAGCTGTA 
R-g250 AAACCAGGAACTCTTAAATTTTTT 
R107 CTTATATAAATAAATTTACTACAG 
F119 GTGTGTGTTTAAGAAAAAATATG 
F156 GCAATAAGAAAAAAAATGGGAGG 
R157 CATGTAGCCAAAATATGTG 
R265 TATTCATAATAAAATTAAGCTGTA 
F-cg6 GTTCATGCTCCTCAACAAAG 
R-cg6 GAACAAATACATAAGAGCGC 
PCR 
cloning 
transfection 
vectors 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
F71 TTTTATTATGCAAATATACATATATAC 
F91 GATAATGCATTAAAGAAAGCTGATGAAGAAGATAATGAATCTG 
F133 CAGTGAGCGAGGAAGCTTGTCGACAAAGGATATTCAGATGATGAG 
R134 CTTTTCTCTTGTGGATCCGAATTCGAGGTTAAAATTCTAAACTATATG 
R136 GTATATATGTATATTTGCATAATAAAATTATTTGTATAGTTCATCCATG 
R138 TATATCTTAATCTTGATAATAAGAAATTTAATAATTCCTGTGGATAAATATATTC 
R138.1 ATTTACCGCTGTTCTATATCTTAATCTTGATAATAAG 
R138.2 ATTTTTTTTATTTACCGCTGTTCTATATCTTAATC 
R138.3 GTTATTGTATATTATTTTTTTTATTTACCGCTGTTC 
F139 GTAAATAAAAAAAATAATATACAATAAC 
R143 CTAAAAGAATATAAAATATATAAATAT 
R144 CTTTTCTCTTGTGGATCCGAATTCTTCCTGTGGATAAATATATTC 
R145 GTTATTGTATATTATTTTTTTTATTTACCCATTTTACTAAATAAATAAAAC 
F146 ATATTTATATATTTTATATTCTTTTAGAAAGGATATTCAGATGATGAG 
F147 CAGTGAGCGAGGAAGCTTGTCGACACACCCCCAAAAGGCCGA 
R148 AGGGTATCACCTTCAAACTTGACTTCAGCACGTGTCTTGTAG 
F149 CAAGTTTGAAGGTGATACCCT 
F158 CGTTGGCCGATTCATTAATGAAAGGATATTCAGATGATGAG 
R159 GTTATTGTATATTATTTTTTTTATTTACTTACGCTGTTCTATATCTTAATC 
F162 ATGAGTAAAGGAGAAGAAC 
R163 CCTCTTCGCTATTACGCCAGGAGGTTAAAATTCTAAACTATATG 
F164 ATATTTATATATTTTATATTCTTTTAGAAAGGATATAGTGATGATGA 
R165 GTTCTTCTCCTTTACTCATTGCTGTTCTATATCTTAATC 
R168 TTTCTTTAATGCATTATCAGCTAATGACAAATTTTTCTTATTTTC 
F171 TGATGCAATAAAAGCTAAAGGTAGAAGTTCATTAG 
R172 CTTTAGCTTTTATTGCATCATCTTCTTGTGTTGGAG 
F173 TGAAGAAGATAATGAAGCAGTTAAACATGAAAATCATGTAAATG 
R174 CTGCTTCATTATCTTCTTCATCAG 
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F175 GCACCACAATGGGTTGAAGAAAC 
R176 CAACCCATTGTGGTGCTTCATTCTTTAAAGAAGCTAAAAATTC 
PCRA_F  CTGGCGTAATAGCGAAGAGG 
PCRA_R  CATTAATGAATCGGCCAACG 
PCR 
cloning 
expression 
vectors 
  
Bsa_His_f AAGGTCTCGGATCTCATCATCATCATCATCACGGG 
T7term TGCTAGTTATTGCTCAGCGG 
HP1_F ATGACAGGCTCAGATGAAGAATTTGAAATTGG 
HP1_Xho_R ATATTTGCATTCTCGAGTTAAGCTGTACGG 
CDH_Xho_R GTTCCTCGAGTTTATGTTTCTTCTACCCATTGTGG 
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3.1 Abstract 
The human malaria protozoan Plasmodium falciparum has a unique ortholog of 
heterochromatin protein 1, called PfHP1, which has been shown to cooperate in the 
regulation of various cellular processes through a sophisticated epigenetic 
mechanism. PfHP1 has been reported to play an important role in mitotic progression, 
transcriptional silencing of heterochromatin-associated genes and sexual 
differentiation. However, the precise functional contribution and conservation of 
each domain of PfHP1 protein have not been studied until now. Here, we employed 
CRISPR/Cas9-mediated genome editing and the DiCre/LoxP system to dissect the 
function of individual PfHP1 domains. First, we showed that the N-terminal 29 residues 
(aas 1-29) and the C-terminal 76 residues (aas 191-266) are responsible for targeting 
PfHP1 to nucleus, in which the later polypeptide has a stronger effect required for the 
efficient nuclear targeting. Second, we revealed that each of the three structural 
domains of the intact PfHP1 are required for proper heterochromatin binding, normal 
asexual proliferation and ap2-g gene silencing.  Third, we successfully generated a 
PfHP1 knock out cell line that highly produces gametocytes once inducted (more 
than 82% of sexual conversion rate). Finally, we discovered that the HP1 Hinge and 
CSD domains are functionally conserved between P. falciparum and P. berghei in 
terms of heterochromatin binding, normal asexual proliferation, var gene - and ap2-
g gene silencing. Our study not only represents a major insight into PfHP1 function and 
conservation but also provides a tool for further studies on gametocyte biology in the 
human malaria parasites.  
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3.2 Introduction 
Heterochromatin protein 1 (HP1) was initially described in Drosophila melanogaster as 
a non-histone chromosomal protein associated with heterochromatin and essential 
for gene silencing in position effect variegation (Eissenberg et al., 1990; James et al., 
1989; James and Elgin, 1986). The well-known function of HP1 lies in the formation and 
spreading of heterochromatin region via its recognition of methylated lysine 9 on 
histone 3 tails (H3K9me3) (Maison and Almouzni, 2004; Zeng et al., 2010). Chromatin-
bound HP1 serves as a platform for the recruitment of downstream chromatin 
modifiers including H3K9me-specific histone methyltransferases which methylate H3K9 
in neighbouring nucleosomes, facilitating the binding of further HP1 proteins (Maison 
and Almouzni, 2004). The self-propagation of HP1 results in the spread of regional 
heterochromatin, thereby promoting silencing of heterochromatin-associated genes 
(Grewal and Moazed, 2003; J. Wang et al., 2016).  
HP1 is a small protein and well conserved among eukaryotes (Zeng et al., 2010). Its 
orthologs have been identified in a broad range of organisms from fission yeast 
(Schizosacharomyces pombe) to humans (Lomberk et al., 2006; Zeng et al., 2010). In 
S. pombe, Switching 6 (Swi6) and Chromo domain-containing protein 2 (Chp2) are 
two important homologs of the HP1 protein family involved in gene silencing and 
heterochromatin formation (Zeng et al., 2010). In mammals, there are three HP1 
variants encoded by a class of genes called chromobox (cbx) genes. They are 
cbx5/HP1α, cbx1/HP1β and cbx3/HP1γ, which are highly similar in amino acid (aa) 
sequences (Vermaak et al., 2005). In general, HP1 is characterized by three structural 
domains: (1) a conserved chromo domain (CD) at the N-terminus, which binds 
H3K9me3; (2) a conserved chromo shadow domain (CSD) at the C-terminus, which 
mediates HP1 dimerization and HP1 interaction with other nuclear chromatin modifiers 
and (3) a variable intervening region or hinge domain linking CD and CSD, which 
interacts with Histone H1, DNA, RNA as well as native chromatin (Aasland and Stewart, 
1995; Kwon and Workman, 2011; Lomberk et al., 2006).  
HP1 has been well characterized in many eukaryotes. In mammalian models, 
localization of HP1 proteins has been shown to be variant-specific. While mammalian 
HP1α and HP1β are found at centromeric heterochromatin regions, HP1γ is found in 
both heterochromatic and euchromatic regions (Horsley et al., 1996; Minc et al., 1999; 
2000). The domain responsible for targeting HP1 to the nucleus has been reported to 
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be species-dependent. In Drosophila melanogaster, the nuclear targeting ability is 
highlighted in the C-terminal 54 residues of the protein (aas 152-206) (Powers and 
Eissenberg, 1993). This finding is surprising as the polypeptide does not bear a 
consensus nuclear localization signal (NLS) (Dingwall and Laskey, 1991; Powers and 
Eissenberg, 1993). In contrast, the hinge region of Swi6 demonstrates nuclear targeting 
function and carries canonical consensus NLS motifs (G. Wang et al., 2000). 
Additionally, the Swi6 C-terminus acts as a second, albeit weaker, nuclear targeting 
domain without predicted consensus NLS (G. Wang et al., 2000). Heterochromatin 
binding domains in HP1 also show inter-species difference. In fission yeast, the chromo 
domain (CD domain) was shown to direct Swi6 to heterochromatin (G. Wang et al., 
2000). Meanwhile, in mice this function additionally requires RNA binding by the hinge 
domain (Muchardt et al., 2002). Drosophila HP1 carries two redundant domains for 
pericentric heterochromatin targeting: the first lies in the N-terminal 95 residues (aas 
1-95) (Platero et al., 1995) and the second in the C-terminal 112 residues (aas 95-206) 
(Powers and Eissenberg, 1993).  
The human malaria parasite Plasmodium falciparum possesses only one HP1 homolog, 
designated as PfHP1 (Flueck et al., 2009; Pérez-Toledo et al., 2009). PfHP1 is mainly 
enriched at subtelomeric regions of all 14 chromosomes and some chromosome-
internal islands (Flueck et al., 2009) where H3K9me3 occupies (Lopez-Rubio et al., 2009; 
Salcedo-Amaya et al., 2009). However, PfHP1 is absent from peri-centromeric regions 
(Flueck et al., 2009), possibly because these regions lack H3K9me3 (Lopez-Rubio et al., 
2009; Salcedo-Amaya et al., 2009). This demarcated localization indicates that PfHP1 
might not contribute to the formation and maintenance of centromere structure and 
function as observed for HP1 proteins in other eukaryotes (Allshire et al., 1995; Bernard 
et al., 2001; Fischer et al., 2009; Nonaka et al., 2002; Yi et al., 2018). Further, PfHP1 covers 
a large number of protein-coding genes and most of them belong to gene families 
encoding exported virulence proteins specific for P. falciparum including var gene 
family (Flueck et al., 2009). The var gene family consists of 60 genes encoding 
antigenically and functionally distinct variants of erythrocyte membrane protein 1 
(PfEMP1) (Brancucci et al., 2014; Flueck et al., 2009; Pérez-Toledo et al., 2009). The 
interaction of PfEMP1 with receptors such as ICAM-1, CD-36 on blood endothelial cells 
and with uninfected RBCs (rosetting) results in cellular adherence and sequestration 
of infected red blood cells (iRBCs) (Cowman et al., 2016; Newbold et al., 1997; Reeder 
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and Brown, 1996; Rowe et al., 2009). Antigenic variation and diversity of PfEMP1 
contribute significantly to immune evasion and hence, to the establishment of chronic 
infection (Cowman et al., 2016; Reeder and Brown, 1996). At any given time, there is 
only one var gene expressed while the rest are simultaneously transcriptional silenced 
(Dzikowski et al., 2006; Voss et al., 2006). The mutually exclusive expression of var genes 
is regulated by sophisticated epigenetic mechanisms including repressive histone 
modification (Jiang et al., 2013; Lopez-Rubio et al., 2009; 2007), histone-modifying 
enzymes like HDACs (Duraisingh et al., 2005; Tonkin et al., 2009)and HKMTs (Jiang et 
al., 2013; Volz et al., 2012), dynamic remodelling of chromatin and perinuclear locus 
reposition (Dzikowski et al., 2006; Freitas-Junior et al., 2005; Ralph et al., 2005; Voss et 
al., 2006), repressive long non-coding RNAs (Amit-Avraham et al., 2015; Epp et al., 
2009) and PfHP1 (Brancucci et al., 2014).  
Additionally, the roles of PfHP1 in three important cellular processes have been 
inferred through the use of a conditional loss-of-function mutant by targeting pfhp1 
gene with a sequence encoding FKPB destabilization domain (Armstrong and 
Goldberg, 2007; Brancucci et al., 2014). First, a massive de-repression of most of var 
genes was observed in the PfHP1-depleted parasites, leading to 52 out of 60 genes in 
this family to be highly upregulated (Brancucci et al., 2014). PfHP1 interacts with the 
histone mark H3K9me3 to obtain repressive heterochromatic state as well as to 
maintain the repressive cluster of silenced var genes while permissive state of a var 
gene is achieved by being devoid of PfHP1 (Brancucci et al., 2014; Bunnik et al., 2018; 
Voss et al., 2014). The study identified a central role of PfHP1 in epigenetic regulation 
of the mutually exclusive expression and inheritance of var gene family (Brancucci et 
al., 2014). Second, PfHP1 has been showed to be indispensable for normal growth of 
asexual parasites (Brancucci et al., 2014). Nearly 50% of the PfHP1-depleted parasites 
were unable to enter schizogony stage because of defective DNA replication one 
generation after stimulation (Brancucci et al., 2014). Instead, these parasites entered 
a reversible arrested trophozoite stage (Brancucci et al., 2014). Finally, a remarkable 
induction in sexual conversion of approximately 52% was found in the PfHP1-depleted 
parasites (Brancucci et al., 2014). The sexual conversion resulted from the derepression 
of pfap2-g locus (Brancucci et al., 2014). pfap2-g is a member of the apiap2 family 
and encodes for PfAP2-G, the master transcriptional regulator of gametocytogenesis 
(Kafsack et al., 2014). pfap2-g was identified as a heterochromatic island covered by 
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H3K9me3 (Lopez-Rubio et al., 2009) and is the only PfHP1-regulated member of the 
apiap2 family (Flueck et al., 2009). In P. falciparum, GDV1 (gametocyte development 
1 protein) has been shown to bind PfHP1 in vivo and in vitro and form a putative 
regulatory complex that initiates gametocytogenesis (Filarsky et al., 2018). Using an 
ap2-g loss-of-function mutant in the gametocyte-non-producible P. falciparum clone, 
F12, the authors have revealed that ap2-g and some other genes that are occupied 
by PfHP1 was upregulated after the overexpression of GDV-1 (Filarsky et al., 2018). 
Together, GDV-1 was suggested to activate sexual commitment process by 
antagonizing HP1-dependent silencing of the ap2-g locus (Filarsky et al., 2018). The 
depletion of PfHP1 initiates de-repression of pfap2-g in committed schizonts, which 
then release sexually committed merozoites that re-invade and undergo full 
gametocyte maturation over the next 8-10 days (Brancucci et al., 2014). Thus, these 
studies have reinforced the central role of PfHP1 in controlling the differentiation 
switch from asexual to sexual stage of the human malaria parasites in its IDC.  
Here, we conducted the first in-depth functional analysis of PfHP1 domains using 
CRISPR/Cas9-mediated genome editing and the DiCre/LoxP system. First, we showed 
that the N-terminal 29 residues (aas 1-29) and the C-terminal 76 residues (aas 191-266) 
are responsible for targeting PfHP1 to nucleus. The later polypeptide presents a 
stronger effect required for the full delivery of PfHP1 to nucleus. Software analysis 
addressed KKKK (aas 17-20) at the N-terminus and RRKK (aas 201-204) at the C-
terminus as putative functional NLSs.  Second, we found that intact PfHP1 containing 
all three structural domains is required for heterochromatin localization and the 
normal asexual growth of blood stage malaria parasites. Our results indicate that 
individual domains of PfHP1 confer precise functional contribution and/or have 
specific interaction with heterochromatin. Third, we successfully generated a PfHP1 
knock out cell line with more pronounced morphological phenotype that allows 
massive production of more than 82% gametocytes once induced. Finally, we 
addressed that the HP1 Hinge and CSD domains are functionally conserved between 
P. falciparum and P. berghei.  
3.3 Results 
Investigation of the roles of PfHP1 domains in PfHP1 localization 
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To begin studying the functional contribution of individual PfHP1 domains, we 
engineered parasites that allow conditional expression of PfHP1 mutants based on the 
DiCre-loxP system (Collins et al., 2013) using CRISPR-Cas9-based gene editing. In these 
parasites, the endogenous pfhp1 gene is excised upon rapamycin (RAP)-induced 
activation of the DiCre recombinase and replaced with a recodonised pfhp1 gene 
encoding a mutated PfHP1 protein carrying a C-terminal GFP tag (Figures 1 and S1). 
We generated four such conditional PfHP1 mutant cell lines called 3D7/HP1-KO, 
3D7/HP1-∆CD, 3D7/HP1-∆Hinge, 3D7/HP1-∆CSD, where aas 30-266 (full-length PfHP1 is 
266 aas), 30-58 (CD domain), 75-177 (hinge domain) or 191-266 (CSD domain), 
respectively, have been deleted (Figure 1B). In the 3D7/HP1-∆Hinge cell line, aas 75-
177 is substituted by a peptide representing aas 232-254 of PfSIP2, a member of the 
ApiAP2 family of transcription factors specific for Plasmodium and related 
Apicomplexan parasites (Flueck et al., 2009). In PfSIP2, this short polypeptide links two 
adjacent AP2-binding domains (Flueck et al., 2010) and was used in the 3D7/HP1-
∆Hinge mutant line as a linker separating the CD and CSD domains (Figure 1C). We 
also used a control cell line where endogenous pfhp1 is replaced by a recodonized 
pfhp1 wild type sequence (3D7/HP1-Control) (Bui et al., manuscript submitted) (Figure 
1C). The CRISPR-Cas9-based gene editing strategy used to generate these parasite 
lines is explained in detail in the Materials and Methods section and Figure S1. 
PCR on parasite genomic DNA (gDNA) was performed to confirm the correct 
integration of the recodonised pfhp1-gfp gene variants directly downstream of the 
endogenous pfhp1 gene and the successful DiCre-mediated excision of the floxed 
endogenous pfhp1 gene upon RAP treatment in all five cell lines (Figure S2A). After 
RAP treatment, GFP-tagged PfHP1 mutants were expressed under the control of the 
endogenous pfhp1 promoter (Figure S1). The conditional expression of PfHP1-GFP 
fusions allowed us to identify the roles of each of the three PfHP1 domains in targeting 
PfHP1 to nucleus and peri-nuclear heterochromatin. Live cell fluorescence imaging at 
40-48 hpi in the same intra-erythrocytic cell cycle (generation 1, 40 hrs post RAP 
treatment) showed that RAP treatment resulted in the highly efficient excision of the 
endogenous pfhp1 gene and expression of PfHP1-GFP fusion proteins in ~86% to 99% 
of parasites in the populations (Figures 2 and S2B).  In contrast, parasites in the DMSO-
treated control populations did not express the GFP-tagged PfHP1 mutants as 
expected (Figures 2 and S2B). Consistent with the live fluorescence imaging results, 
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analysis of whole parasite protein lysates by Western Blot showed that the RAP-treated 
parasites exclusively expressed the truncated PfHP1-GFP fusions while DMSO-treated 
control parasites exclusively expressed untagged wild-type PfHP1 (~31KDa) (Figure 
S2C). The expression levels of GFP fusions from PfHP1 mutant lines were similar to that 
of GFP fusion from PfHP1 control cell line, with the exception of GFP fusions from 
3D7/HP1-∆Hinge and 3D7/HP1-∆CD lines (Figure S2C). Since all GFP fusion proteins 
were expressed under control of the endogenous pfhp1 promoter, the lower 
expression of GFP fusions observed in 3D7/HP1-∆Hinge and 3D7/HP1-∆CD lines was 
likely result of mRNA instability, inefficient protein translation because of mRNA 
secondary structures or reduced protein stability. However, we were able to obtain a 
sufficient level of GFP signal in 3D7/HP1-∆CD and 3D7/HP1-∆Hinge cell lines at schizont 
stage when protein expression peaks (Figure 2D-E). 
The PfHP1 domain(s) responsible for nuclear targeting was determined as below. First, 
the ∆CD-GFP (deletion of aas 30-58) and ∆Hinge-GFP (deletion of aas 75-177) 
localized to the nucleus (Figure 2D-E), suggesting that the sequences they share, i.e. 
aas 1-29, 59-74 and 178-266, are responsible for this function. Second, the ∆CSD-GFP 
in which the aas 191-266 are deleted, localized to both cytosol and preferably to 
nucleus (Figure 2C). Thus, the C-terminal polypeptide (aas 191-266) is required for 
efficient nuclear delivery. Third, GFP signal in 3D7/HP1-KO (deletion of aas 30-266) 
localized to both compartments (Figure 2B). Hence, the short N-terminal polypeptide 
(aas 1-29) is likely insufficient to target PfHP1 to nucleus.  
We next used the NuPred (Brameier et al., 2007) and PSORTII 
(https://psort.hgc.jp/form2.html) algorithms to identify putative NLS elements. These 
analyses demonstrated NLSs in each of PfHP1 domains (Figure 1A):  a KKKK motif (aas 
17-20) in CD domain, a RRKK motif (aas 201-204) in CSD domain and PRRK motif (aas 
100-103) or/and PRRKMSR motif (aa 100-106) in Hinge domain. These NLSs match 4-
residue or 7-residue pattern of the PKKKRKV NLS motif exemplified from simian virus 40 
(SV-40) (Kalderon et al., 1984). There was no potential NLSs predicted in the PfSIP2 
linker sequence, thus, the localization of ∆Hinge-GFP lies in PfHP1 intrinsic sequence 
(aas 1-78 and 178-266). Since the fusion ∆Hinge-GFP protein was still imported into 
nucleus (Figure 2D), predicted NLSs within Hinge domain are not necessary for this 
function. 
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From our approach, only GFP fusion of 3D7/HP1-Control cell line localized to 
heterochromatin foci, representing by punctuated patterns at nuclear periphery 
(Figure 2A). Although the GFP fusions of 3D7/HP1-∆CD and 3D7/HP1-∆Hinge cell lines 
localize to the nucleus, their ability to target heterochromatin is abolished (Figure 2D-
E). Thus, an entire CD domain and Hinge domain are obligatory for heterochromatin 
targeting. Furthermore, GFP-∆CSD fusion expressing CD-Hinge domains was partially 
diffused from nucleus to cytosol and was not concentrated in perinuclear foci (Figure 
2C, 3D7/HP1-∆CSD).   Together, CD-Hinge domain is insufficient for targeting PfHP1 to 
heterochromatin but additionally requires CSD domain.  
In summary, our live imaging data indicated that the N-terminal 29 aas (1-29) and C-
terminal 76 aas (191-266) are responsible for targeting PfHP1 to nucleus. The later 
polypeptide presents a stronger effect required for the full delivery of PfHP1 to nucleus. 
Software analysis addressed KKKK (aas 17-20) in CD and RRKK (aas 201-204) in CSD as 
putatively functional NLSs. As only intact PfHP1 is able to bind heterochromatin, our 
result implied essential and precise functional contribution and/or specific interaction 
of each structural domain with heterochromatin components. 
Each of PfHP1 domains is indispensable for normal asexual growth  
In a recent study, we showed that PfHP1 is required for (1) progression through 
schizogony and thus parasite multiplication; (2) silencing of the pfap2-g locus and thus 
inhibition of sexual commitment; and (3) var mutually exclusive expression and thus 
the PfEMP1 expression (Brancucci et al., 2014). Here, we asked if the individual 
domains of PfHP1 are required for any of these processes. The 3D7/HP1-Control (Bui et 
al., manuscript submitted, Chapter 2) was used as a control to evaluate the function 
of PfHP1 mutants.  
First, we investigated the proliferation of the four PfHP1 truncation cell lines and the 
control cell line. As shown in Figure 3A, in the 3D7/HP1-Control cell line, the 
multiplication of DMSO- and RAP-treated parasites was highly comparable. As 
expected, the multiplication of DMSO-treated parasites from four PfHP1 truncation 
mutant lines was also comparable to that of the control. In contrast, the RAP-treated 
parasites of four PfHP1 truncation mutant lines consistently drew a same pattern of 
proliferation defect in the following cycle after RAP treatment, showing a failure in 
entering schizogony in generation 2 (Figure 3A). In generation 3 of the RAP-treated 
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population (112 hrs post RAP treatment), we were able to select a relative fraction of 
about ~4.5 to 18% of total infected parasites as proliferating asexual subpopulation 
(RAPSUR subpopulations) (Figure S3). However, these proliferating asexual 
subpopulations did not display GFP signal (data not show), indicating that the DNA 
excision did not occur after RAP treatment. Further examination of RAPSUR 
subpopulations revealed the lack of Cre recombinase activity, thus, resulting in the 
failure of DNA excision and presence of proliferating asexual parasites (Figure S3). 
Although the mechanism how PfHP1 regulates asexual mitosis is unknown, the results 
indicated that individual domains of PfHP1 are required for proper function of PfHP1 
in controlling the virtual proliferation of asexual blood stage parasites. This data is 
consistent with previously reported data (Brancucci et al., 2014). 
Second, we examined a possible role of individual PfHP1 domains in controlling pfap2-
g silencing by comparing the sexual commitment rates between DMSO- and RAP-
treated parasites for all PfHP1 truncation mutant lines. As shown in Figure 3B, left panel, 
RAP-treated 3D7/HP1-KO, 3D7/HP1-DCD, 3D7/HP1-DHinge and 3D7/HP1-DCSD 
parasites showed significantly higher sexual conversion rates compared to the DMSO-
treated populations (p-value < 0.01, unpaired two-tailed Student’ t-test). The result is 
consistent with previously described result (Brancucci et al., 2014) except that we 
obtained extremely higher conversion rate of approximately 82-95% in RAP treated 
populations in these PfHP1 truncation lines. However, we also found a significant 
increase in sexual conversion rate for the RAP-treated 3D7/HP1-Control parasites 
expressing a recodonised wild-type pfhp1 gene (p-value < 0.01, unpaired two-tailed 
Student’ t-test) (Figure 3B, left panel). Comparing the fold changes of sexual 
conversion rates between RAP- versus DMSO-treated parasites showed significant 
differences between parasites expressing truncated PfHP1 variants compared to the 
3D7/HP1-Control cell line (Figure 3B right panel).  
An α-Pfs16 IFA study (30-38 to 40-48 hpi, generation 2) and overview images of a 
Giemsa-stained blood smear (10 days post invasion) confirmed high proportion of 
stage I and stage IV/V gametocytes, respectively, in 3D7/HP1-KO cell line (Figures 3C). 
Gametocytes in the RAP-treated sample of 3D7/HP1-KO and other PfHP1 mutant cell 
lines completed sexual development within 8–10 days, similar to DMSO-treated 
gametocytes. Together, the result suggested that each of PfHP1 individual domains is 
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essential for controlling ap2-g silencing and reinforced the central role of PfHP1 in 
epigenetic regulation of sexual commitment process in the human malaria parasites.  
The function of the HP1 Hinge and Chromo shadow domains is conserved between P. 
falciparum and P. berghei 
It has been shown that in S. pombe, replacement of Swi6 CD domain by CD domain 
of mouse HP1-like protein, M31 retained Swi6 function in sporulation phenotype, 
normal zygote asci formation and mitotic stability ability while CSD substitution did not 
(G. Wang et al., 2000). Thus, chromodomain function is conserved between fission 
yeast and mouse (G. Wang et al., 2000). We also pointed out if such conservation 
occurs within Plasmodium using a domain swap experiment. Among HP1 orthologs 
within Plasmodium genus, we chose P.berghei HP1 (PbPH1) to perform domain swap 
experiment with P.falciparum HP1 because of the similarity in controlling sexual 
conversion switch through ap-2g derepression in the two malaria parasites (Brancucci 
et al., 2014; Kafsack et al., 2014; Sinha et al., 2014). 
To this end, we generated three HP1-hybrid cell lines namely 3D7/HP1-hyb-PbHinge, 
3D7/HP1-hyb-PbCSD, 3D7/HP1-hyb-PbHP1 in which the PfHP1 Hinge, CSD or full length 
PfHP1 were conditionally substituted by PbHP1 Hinge, CSD domain and full length 
PbHP1, respectively using similar approach described above (Figures 4A-B and S1). A 
CD domain swap was not performed because of high degree in identity and similarity 
between PfHP1- and PbHP1 CD sequences after RAP induction (only six residues 
different) [Figure S4B and (Fraschka et al., 2018)]. We successfully generated two 
PfHP1 hybrid mutant lines, 3D7/HP1-hyb-PbHinge and 3D7/HP1-hyb-PbCSD. Despite a 
number of efforts, we failed to obtain the 3D7/HP1-hyb-PbHP1 line. The 3D7/HP1-
Control cell line was also used as a control to evaluate the function of the PfHP1 hybrid 
mutants in three PfHP1-dependent processes mentioned above. 
To assess the ability of hybrid HP1s in heterochromatin binding, we performed live 
imaging at 40-48 hpi in generation 1 and at 16-24 hpi in generation 2 to observe the 
localization of GFP fusion proteins after RAP treatment. None of the DMSO-treated 
parasites expressed the GPF-tagged proteins as expected, whereas in the RAP-
treated populations, the GFP-tagged PfHP1-hyb-PbHinge and PfHP1-hyb-PbCSD 
hybrids localized to nucleus and to heterochromatin loci indistinguishable to the GFP-
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tagged PfHP1 control (Figures 4C, 2A and S2A). Thus, replacement of PfHP1 Hinge or 
CSD domain by that of PbHP1 retains proper heterochromatin localization of PfHP1. 
We next evaluated proliferation rates of the HP1 hybrid cell lines and control cell line 
over three consecutive generations after RAP treatment. In our static culture 
condition, DMSO- and RAP-treated parasites in both 3D7/HP1-hyb-PbHinge, 3D7/HP1-
hyb-PbCSD and 3D7/HP1-Control lines proved highly comparable rate of 
multiplication (Figures 5A and 3A), revealing proper function of the PfHP1-PbHP1 
hybrids in controlling cell cycle progression and growth.  
To study the possible role of HP1 hybrid mutants in regulating pfap2-g silencing, sexual 
conversion rate between DMSO- and RAP- treated parasites were examined. As 
shown in Figure 5B, left panel, RAP-treated population always revealed higher sexual 
conversion rate compared to DMSO-treated population. Comparing the fold 
changes of sexual conversion rates between RAP- versus DMSO-treated parasites 
showed insignificant differences between mutant lines expressing PfHP1-PbHP1 
hybrids compared to the 3D7/HP1-Control line (Figure 5B, right panel) (p value > 0.05, 
unpaired two-tailed Student’ t-test). Hence, the Hinge and CSD domain exchange 
between PfHP1 and PbHP1 does not affect the regulation of ap2-g silencing in the 
human malaria parasites. 
Finally, to probe the ability of HP1 hybrids in maintaining singular var gene expression, 
immunofluorescence study was performed to compare the expression of PfEMP1 in 
the progeny of DMSO- and RAP-treated 3D7/HP1-hyb-PbHinge, 3D7/HP1-hyb-PbCSD 
and the control cell lines at 16-24 hpi, generation 2. IFAs showed comparable intensity 
for PfEMP1 signal between RAP-treated and DMSO-treated paired samples from these 
three cell lines (Figure 5C), implying a preserved function of the PfHP1-PbHP1 hybrids 
in regulating var gene expression.  
Taken together, these data reflect the functional conservation of Hinge and CSD 
domains in PfHP1 and PbHP1. However, our study did not rule out if HP1 function is 
conserved between the two parasites because of the failure in obtaining 3D7/HP1-
hyb-PbHP1 line expressing full length PbHP1.  
3.4 Discussion 
Previous studies have indicated that domains targeting HP1s to nucleus are species-
dependent and do not always possess canonical NLS sequences (Powers and 
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Eissenberg, 1993; G. Wang et al., 2000). Therefore, we could not rely on sequence 
homology to predict the nuclear targeting sequence within PfHP1. Instead, we had 
to determine the nuclear localization sequence empirically. We identified that the C-
terminal 76 residue-polypeptide (aas 191-266) presents strong and effective nuclear 
targeting ability while the N-terminal 29 residue-polypeptide (aas 1-29) expresses 
weaker ability. Fusion proteins lacking the C-terminal polypeptide (aas 191-266) were 
not fully imported into nucleus. Although the N-terminal 29 residue-polypeptide was 
insufficient for fully targeting PfHP1 to nucleus, our results cannot indicate whether the 
CSD alone is sufficient for this function because the former polypeptide was always 
present in all of PfHP1 truncation variants.    
Heterochromatin binding function has been well studied in many model organisms 
(Muchardt et al., 2002; Platero et al., 1995; Powers and Eissenberg, 1993; G. Wang et 
al., 2000). Studies employing different experimental systems have highlighted the 
contribution of more than one structural HP1 domain for proper heterochromatin 
targeting. In mouse, heterochromatin-targeting ability of HP1a is underlined by RNA 
binding via a conserved region of Hinge together with the binding to methylated 
histone via CD (Muchardt et al., 2002). Additionally, in Drosophila, the domain 
directing HP1 to heterochromatin was first assigned to the C-terminal half of the 
protein (aas 95-206) that contains the CSD region (aas 142-206) and a substantial 
length of the hinge domain (Powers and Eissenberg, 1993). In the study of J. A. Powers 
and C. Eissenberg, in order to determine the domain targeting HP1 to nucleus, a 
number of lacZ/hp1 gene fusion sequences were used to express HP1 deletions that 
were N-terminally tagged with β-galactosidase (Powers and Eissenberg, 1993). Protein 
fusions containing CD and/or Hinge domain failed to target nucleus while protein 
fusions containing majority of CSD region (aas 152-206; CSD domain is from aas 142 to 
206) showed nuclear localization (Powers and Eissenberg, 1993). However, 
heterochromatin localization was only found in the protein fusions that contained at 
least a substantial length/part of the Hinge domain plus CSD region (aas 95-206) 
(Powers and Eissenberg, 1993).  Specify that β-galactosidase fusion HP1 variants were 
expressed in a wild-type HP1 background in vivo in the study of J. A. Powers and C. 
Eissenberg, heterochromatin-binding function in this scenario could result from 
dimerization between CSD-containing fusion protein and endogenous HP1 protein. In 
our approach, HP1-GFP fusions were expressed in a null PfHP1 background. We found 
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that only full length PfHP1 was properly recruited to heterochromatin foci and that 
CD-Hinge was insufficient for this function. Although CD-Hinge region is able to bind 
existing H3K9me3 (Bannister et al., 2001; Lachner et al., 2001), it is possible that the lack 
of CSD domain has prevented PfHP1 homo-dimerization as well as the recruitment of 
histone lysine methyl transferase (HKMT).  In turns, these events impede PfHP1 self-
propagation and de novo H3K9me3 establishment during cell division, resulting in 
deficiency in heterochromatin compaction and cohesion in schizont stage of 
generation 1 and the ring progeny in generation 2. In consequence, parasites 
expressing truncated PfHP1 variants were unable to enter schizogony and committed 
to gametocytes, emphasising that PfHP1 is indispensable for normal growth of asexual 
blood-stage malaria parasites. 
By successful generating an inducible pfhp1 knockout cell line, we obtained 
interesting pronounced morphology with (1) exiguous number/ exclusion of arrested 
trophozoite population and (2) more than 82% of the population synchronously switch 
to sexual commitment pathway. Notably, while gametocyte production is labouring 
(S. Duffy et al., 2016; Saliba and Jacobs-Lorena, 2013), the gametocyte highly 
producible line in our study presents a robust tool for further studies on 
gametocytogenesis, gametocyte development and biology, anti-malaria 
gametocyte drug discovery as well as transmission-block strategies. 
Although HP1 has been studied in P. falciparum (Brancucci et al., 2014; Flueck et al., 
2009; Pérez-Toledo et al., 2009), function of HP1 in P. berghei is still little known. It has 
been reported that HP1 was enriched at all subtelomeric regions of 14 chromosomes 
in all Plasmodium species (Fraschka et al., 2018). However, heterochromatin 
organization is different between P. falciparum and P. berghei during parasite 
developments (Fraschka et al., 2018; Witmer et al., 2019). During progression from 
asexual developmental stages to sexual conversion process, subtelomeric 
heterochromatin expansion was observed in P. falciparum while heterochromatin 
landscape was remained between developmental stages in P. berghei (Fraschka et 
al., 2018; Witmer et al., 2019). Genes driving iRBC remodeling become 
heterochromatic during gametocytogenesis in P. falciparum (Fraschka et al., 2018). 
The difference is explained by the fact that P. berghei does not encode for such similar 
orthologues.  Intriguingly, ap2-g locus was enriched in HP1 in all Plasmodium species 
(Fraschka et al., 2018). Additionally, ap2-g has been identified as a conserved master 
Chapter 3|      In-depth functional analysis of PfHP1
   
 93 
regulator of gametocytogenesis in both of P. falciparum and P. berghei (Brancucci et 
al., 2014; Kafsack et al., 2014; Sinha et al., 2014). The removal of H3K9me3-bound PfHP1 
from ap2-g locus is mediated by the upstream regulator of sexual commitment, 
PfGDV1, thus triggering sexual commitment (Filarsky et al., 2018). The similarity in 
controlling gametocytogenesis through ap2-g derepression in P. falciparum and P. 
berghei has prompted us to investigate on the functional conservation of HP1 
domains in the two parasites. However, there is no GDV-1 ortholog in P. berghei, 
suggesting an alternative regulatory mechanism in controlling the pbap2-g silencing 
in this rodent malaria parasites (Eksi et al., 2012). From our study, the PbHP1-PfHP1 
hybrids are inferred to interact with PfGDV-1 to evict HP1 hybrids from pfap2-g locus. 
These results are possibly explained by the high conservation in PfHP1 and PbHP1 
sequences as well as individual domain sequences (Figure S5, >82% similarity in protein 
sequences and (Fraschka et al., 2018)). Although we do not know the exact domain(s) 
of PfHP1 interacting with GDV-1, such interaction was likely retained in our domain 
swapping experiment, emphasizing the functional conservation of HP1 between the 
human and rodent malaria parasites.  
In conclusion, our study identified that the N-terminal 29 residues (aas1-29) and C-
terminal 76 residues (aas 191-266) are responsible for targeting PfHP1 to nucleus. In 
parallel, we revealed that each of the three structural domains of PfHP1 protein is 
required for PfHP1 proper function in heterochromatin binding, normal asexual 
proliferation and ap2-g gene silencing.  Finally, we discovered that the Hinge and CSD 
domains are functionally conserved between the P. falciparum and P. berghei. Our 
study not only represents a major insight into PfHP1 function and conservation but also 
provides a tool for robust production of gametocytes used in further studies on 
gametocyte biology or high-throughput anti-malaria gametocyte drug screen. 
3.5 Materials and Methods 
Parasite culture and transfection 
The transgenic cell lines generated in this study were cultured at 5% hematocrit in 
RPMI-1640 medium supplemented with 25 mM HEPES, 100 mM hypoxanthine, 24 mM 
sodium bicarbonate, 0.5% Albumax II supplemented with 2mM choline to reduce 
background sexual conversion rates as demonstrated recently (Brancucci et al., 2014; 
Trager and Jensen, 1976). Parasite cultures were synchronized using 5% sorbitol as 
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described previously (Lambros and Vanderberg, 1979). Cotransfection of 
CRISPR/Cas9 and donor plasmids into the DiCre-expressing line 3D7/1G5DiCre (Collins 
et al., 2013) and selection of transfected populations were performed as described 
recently (Filarsky et al., 2018) and (Bui et al, submitted). 
Transfection constructs 
We applied CRISPR/Cas9-mediated genome editing and the DiCre/LoxP system 
(Collins et al., 2013) to generate cell lines conditionally expressing truncated PfHP1 
and hybrid PfHP1 variants. We engineered (1) 3D7/HP1-KO for expression of full-length 
PfHP1 deletion (deletion of aas 30- 266. The PfHP1 is 266 aas in length 
(PF3D7_1220900)); (2) 3D7/HP1-∆CD for expression of PfHP1 CD deletion (deletion of 
aas 30-58); (3) 3D7/HP1-∆Hinge for the expression of PfHP1 Hinge deletion (aas 75-177 
of PfHP1 was replaced with a peptide representing aas 232-254 of PfSIP2. The PfSIP2 is 
1979 aas in length (PF3D7_0604100)); (4) 3D7/HP1-∆CSD for the expression of PfHP1 
CSD deletion (deletion of aas 191-266); (4) 3D7/hyb-PbHinge for the expression of 
chimeric PfHP1 in which PfHP1 Hinge domain (aas 75-177) was replaced by PbHP1 
Hinge domain (aas 75-192); (6) 3D7/hyb-PbCSD for the expression of chimeric PfHP1 
in which PfHP1 CSD domain (aas 191-266) was replaced by PbHP1 CSD domain (aas 
206-281). The PbHP1 is 281 aas in length (PBANKA_1436100); (7) 3D7/HP1-hyb-PbHP1 
for expression of full length PbHP1 (aas 30-266) and (8) 3D7/HP1-Control for expression 
of wild type PfHP1 [Bui et al, manuscript submitted] (See Figs S1, 1C and 3A for 
schematic illustrations). To obtain these cell lines, we performed two subsequent 
transfection steps.  
In the primary transfection, the mother cell line 3D7-1G5DC/5’-loxPint-g31 (or 
3D7/N31DC) which carries a sera2 intron:loxP element (Jones et al., 2016) inserted into 
the 5’of pfhp1 coding sequence was generated as described previously [Bui et al, 
manuscript submitted, Chapter 2].  
In the second transfection, the mother cell line 3D7/N31DC parasites were transfected 
again to generate seven parasite lines: 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge, 
3D7/HP1-∆CSD, 3D7/hyb-PbHinge, 3D7/hyb-PbCSD, 3D7/HP1-Control. These 
transgenic parasite lines carry a second sera2 intron: loxP sequence directly 
downstream of the endogenous pfhp1 stop codon, followed by GFP coding 
sequence (HP1-KO), a recodonised mutated PfHP1 (HP1-∆CD, HP1-∆Hinge, HP1-∆CSD, 
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HP1-hyb-PbHinge, HP1-hyb-PbCSD) or wild type (HP1-Control) pfhp1-gfp sequence. 
The transgenic parasite lines were generated using the following cloning steps. 
First, we constructed the pBF-gC-guide250 plasmid carrying the sgRNA target 
sequence at the 3’ end of the pfhp1 coding sequence [Bui et al., manuscript 
submitted].  
Second, we constructed the seven donor plasmids.  
The pD-PfHP1-Control donor plasmid and pD-PfHP1-KO were constructed as 
described previously [Bui et al., manuscript submitted]. 
The pD-PfHP1-∆CD donor plasmid was constructed by Gibson assembly joining three 
PCR fragments encoding (1) the pD plasmid backbone amplified from pUC19 using 
primers PCRA_F and PCRA_R (Brancucci et al., 2017), (2) a 5` homologous region (HR) 
followed by a 103bp- sera2 intron:loxP sequence amplified from pD-PfHP1-Control 
using primers F158 and R143, (3) a fragment amplified from pD-PfHP1-Control using 
primers F177 and R163 spanning, in the following order, base pairs (bps) +175 to +798 
of a synthetic recodonized pfhp1 coding sequence (re-pfhp1, GenScript™) omitting 
the stop codon (the pfhp1 coding sequence is 798 bp long), a gfp coding sequence 
ending with stop codon and a 3`HR spanning 824 bps downstream of the pfhp1 stop 
codon.  
The pD-PfHP1-∆Hinge donor plasmid was constructed by Gibson assembly joining four  
PCR fragments encoding (1) the pD plasmid backbone amplified from pUC19 using 
primers PCRA_F and PCRA_R (Brancucci et al., 2017), (2) 5` HR  followed by the sera2 
intron: loxP sequence amplified from pD-PfHP1-Control using primers F158 and R143, 
(3) a fragment amplified from the pBCam-∆Hinge-3HA-Cherry plasmid 
(supplementary method) using primers F164 and R165 spanning, in the following order, 
bps +88 to +222 of the re-pfhp1 coding sequence, bps +694 to +762 of the pfsip2 
coding sequence (the pfsip2 coding sequence is 5937 bp long) and bps +532 to +798 
of the re-pfhp1 coding sequence omitting stop codon, (4) a fragment amplified from 
pFdon C-loxP-g250 [Bui et al, manuscript submitted] using primers F162 and R163 
spanning, in the following order, a gfp coding sequence ending with stop codon and 
the 3`HR. 
The pD-PfHP1-∆CSD donor plasmid was constructed by Gibson assembly joining three 
PCR fragments encoding (1) the pD plasmid backbone amplified from pUC19 using 
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primers PCRA_F and PCRA_R (Brancucci et al., 2017), (2) a fragment amplified from 
pD-PfHP1-Control using primers F158 and R178 spanning, in the following order, the 
5`HR, the sera2 intron: loxP, bps +88 to +570 of the re-pfhp1 coding sequence (3) a 
fragment amplified from pFdon C-loxP-g250 [Bui et al, manuscript submitted] using 
primers F162 and R163 spanning, in the following order, a gfp coding sequence 
ending with stop codon and the 3’ HR.  
The pD-hyb-PbHinge donor plasmid was constructed by Gibson assembly joining two 
PCR fragments encoding (1) the pD-HP1-KO plasmid backbone was amplified from its 
own template using primers F162 and R143, (2) a fragment amplified from the pBCam-
hyb-PbHinge-3HA-Cherry (supplementary method) using primers F164 and R165 
spanning, in the following order, bps +88 to +222 of the re-pfhp1 coding sequence, 
bps +223 to +576 of the hp1 from P. berghei coding sequence (pbhp1, the pbhp1 
coding sequence is 843 bp long), bps +532 to +798 of the re-pfhp1 coding sequence 
omitting the stop codon. 
The pD-hyb-PbCSD donor plasmid was constructed by Gibson assembly joining two 
PCR fragments encoding (1) the pD-HP1-KO plasmid backbone was amplified from its 
own template using primers F162 and R143, (2) a fragment amplified from the pBCam-
hyb-PbCSD-3HA-Cherry (supplementary method) using primers F164 and R161 
spanning, in the following order, bps +88 to +570 of the re-pfhp1 coding sequence, 
bps +616 to +843 of the pbhp1 omitting the stop codon. 
Finally, the pD-hyb-PbHP1 donor plasmid was constructed by Gibson assembly joining 
five PCR fragments encoding (1) the 5’ HR spanning bps +88 to +798 of the pfhp1 
coding sequence ending with a stop codon amplified from pFdon C-loxP-g250 [Bui et 
al, manuscript submitted] using primers F158 and R159; (2) 103 bp sera2 intron:loxP 
element was amplified from  pD-SIP2-loxP-GFP   plasmid (I. Niederwieser, unpublished; 
see also Hai BUI et al, manuscript submitted, Chapter 2) using primers F139 and R143; 
(3)  bps +88 to +843 of the pbhp1 amplified from P. berghei gDNA using primers F160 
and R161; (4) a fragment containing the gfp sequence ending with a stop codon 
followed by the 3’ HR was  amplified from pFdon C-loxP-g250 [Bui et al, manuscript 
submitted] using primers F162 and R163 and (5) the pD plasmid backbone amplified 
from pUC19 using primers PCRA_F and PCRA_R (Brancucci et al., 2017). 
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For each of the seven transfections, 50 µg of the pBF-gC-guide250 plasmid was mixed 
with 50 µg of a donor plasmid above and electroporated into the 3D7/N31DC mother 
parasite line. Transfected parasites were selected as described previously [(Filarsky et 
al., 2018) and (Bui et al, manuscript submitted)].  
All oligonucleotide sequences used for the cloning of the CRISPR/Cas9 and donor 
plasmids are provided in Table S1. The nucleotide sequence of recodonized pfhp1 
and pbhp1 are provided in Figure S4. 
Induction of DiCre recombinase mediated DNA excision by Rapamycin 
Parasites were synchronized twice 16 hours apart to obtain an eight-hour growth 
window (16-24 hpi). After re-invasion parasites were synchronized again at 0-8 hpi 
(generation 1) and split into two equal populations, of which one half was treated 
with 0.02%v/v of DMSO (negative control) and the other half was treated with 100 nM 
RAP for 1 hour (Knuepfer et al., 2017). The cultures were then spun down, washed with 
an equal volume of culture medium, resuspended in culture medium and returned to 
culture. 
Live cell imaging and indirect immunofluorescence assay (IFA) 
To quantify the efficiency of pfhp1 excision after RAP treatment, live cell fluorescence 
microscopy was performed as described before [Witmer et al., 2012] with minor 
modification using 5 µg/ml Hoechst (supplied by Merk, Darmstadt, DE) to stain the 
nuclei. Excision efficiency was determined as the percentage of GFP-positive 
schizonts at 40-48 hpi in generation 1 (>200 schizonts counted per experiment).  
IFAs were performed on methanol-fixed cells using mouse IgG1 mAb α-ATS (M. F. Duffy 
et al., 2002),1:150; mouse mAb α-Pfs16 (kind gift from Robert W. Sauerwein), 1:250; and 
Alexa Fluor 488-conjugated α-mouse IgG (Molecular Probes), 1:250. Images were 
taken at 63-fold magnification on a Leica DM 5000B microscope with a Leica DFC 300 
FX camera, acquired via the Leica IM 1000 software, processed using ImageJ 
software [https://imagej.nih.gov/ij/]. For each experiment, images were acquired and 
processed with identical settings.   
Parasite multiplication assay  
Parasites were tightly synchronized twice 16 hours apart. At 0-8 hpi, generation 1, 
parasites were split into two equal populations, of which one half was treated with 
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DMSO (negative control) and the other half was induced for DiCre recombinase-
mediated DNA excision by RAP treatment as described above. Giemsa smears were 
prepared to determine the parasitaemia at 16-24 hpi (generation 1).  Giemsa-stained 
smears were prepared every second day onwards for three generations. 
Parasitaemia was counted by visual inspection of Giemsa-stained blood smears (≥ 
3’000 RBCs counted per experiment). Multiplication rates were determined as the 
parasitaemia observed in the following generation divided by the parasitaemia 
observed in the previous generation. The extrapolative growth cure was generated 
using starting parasitaemia at 0.1%. 
Gametocyte conversion assay 
After DMSO or RAP treatment in generation 1, parasites were allowed to complete 
schizogony and re-invasion. At 16-24 hpi in generation 2, each pair of cultured (DMSO- 
and RAP-treated) were treated with 50 mM N-acetyl-D-glucosamine (GlcNAc) for five 
days to eliminate asexual parasites (Ponnudurai et al., 1986) and then cultured with 
normal culture medium for another 4-6 days to observe the maturation of 
gametocytes. Gametocytaemia was determined on day 6 of GlcNAc treatment by 
visual inspection of Giemsa-stained blood smears. Sexual conversion rates were 
determined as the gametocytaemia observed on the day 6 as a proportion of the 
total parasitaemia observed on day 1 of GlcNAc treatment. 
SDS-PAGE and immunoblotting 
After DMSO or RAP treatment in generation 1, parasites were allowed to complete 
schizogony and re-invasion. At 16-24 hpi in generation 2 parasites were released from 
infected RBCs (iRBCs) by 0.15% saponin/PBS complemented with 1X protease inhibitor 
(Roche Diagnostics). After washing 2-3 times in ice-cold PBS, parasite pellets were 
lysed in 70°C pre-heated Urea/SDS buffer (8 M Urea, 5% SDS, 50 mM Bis-Tris, 2 mM EDTA, 
25 mM HCl at pH 6.5 supplemented with 2 mM DTT and 1X protease inhibitor). Whole 
parasite protein lysates were separated on NuPage 4-12% Bis-Tris gels (Novex) and 
analyzed by Western blot using mouse mAb α-GFP (Roche Diagnostics 
#11814460001), 1:1000; rabbit α-PfHP1(Brancucci et al., 2014), 1:5’000; rabbit α-Histone 
4 (Abcam ab10158). 
Nucleic acid isolation and polymerase chain reaction 
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To evaluate the correct editing of the pfhp1 locus, we performed PCRs on genomic 
DNAs (gDNAs) of transgenic cell lines, which were sampled and isolated as described 
previously (Witmer et al., 2012). 
To evaluate the DNA excision efficiency after RAP treatment, diagnostic PCRs were 
performed on gDNAs after 24-36 hours post treatment. Primers were designed to allow 
the PCR amplification to span over the 5`to 3` homologous regions.  
All transfection plasmids generated in this study have been validated by Sanger 
sequencing. All transfection plasmids have been designed and Sanger sequencing 
results analysed using the SnapGene software (from GSL Biotech; available at 
snapgene.com). All primer sequences used for PCR are listed in Table S1. 
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Figure 1. Generation of DiCre-inducible PfHP1 truncation mutants. (A) Organization of 
PfHP1 (Flueck et al 2009). The amino acid sequence of CD and CSD domains are 
indicated. Red letters indicate predicted functional NLS motifs in CD and CSD 
domains by NucPred and PSORTII. (B) Schematics of the CRISPR/Cas9-edited pfhp1 
locus (upper panel) and corresponding PfHP1 protein products (lower panel) before 
(DMSO) and after (RAP) rapamycin-induced DiCre-dependent excision of the wild 
type pfhp1 locus. Blue arrowheads indicate the position of sera2 intron:loxP elements. 
Red stars indicate STOP codons. Brown and blue boxes represent the wild type 
pfhp1/PfHP1 and the replacing cassette sequences/replacing protein sequences, 
respectively. Green boxes represent gfp/GFP sequence. Numbers in the gene and 
protein schematics refer to nucleotide and amino acid positions, respectively. RAP, 
rapamycin. (C) Diagrams showing organization of recodonized PfHP1 (top panel) and 
PfHP1 protein products expressed in the 3D7/HP1-Control, 3D7/HP1-KO, 3D7/HP1-∆CD, 
3D7/HP1-∆Hinge and 3D7/HP1-∆CSD after RAP-treatment (lower panels). Dashed lines 
represent corresponding deletion in PfHP1 protein sequence. Purple curve represents 
a short polypeptide of the PfSIP2 protein known to link two adjacent Ap2-binding 
domains of the protein. The amino acid sequence and position of this polypeptide 
are indicated. Localization and heterochromatin binding function of corresponding 
PfHP1 control- and truncated PfHP1 proteins are summarized on the right. N: nuclei. C: 
cytosol. 
Figure 2. Subcellular localization of PfHP1 truncation mutants. (A – E) Representative 
live cell fluorescence images showing localization of the GFP-fusions in (A) 3D7/HP1-
Control, (B) 3D7/HP1-KO, (C) 3D7/HP1-∆CSD, (D) 3D7/HP1-∆Hinge and (E) 3D7/HP1-
∆CD in late schizonts (LS, 40-48 hpi, generation 1; 40 hrs after rapamycin treatment). 
Nuclei were stained with Hoechst. DIC, differential interference contrast. Scale bar 
(black), 5 µm. Magnificent bar (white), 2.5 µm. 
Figure 3. Phenotypes of PfHP1 truncation mutants. (A) Growth curves of the DMSO- and 
RAP-treated PfHP1 truncation mutant lines and control cell line over three consecutive 
generations. Values are the mean of four replicates for 3D7/HP1-Control and three 
biological replicates for other cell lines (>3.000 RBCs counted per sample). Error bars 
indicate SD. (B) Sexual conversion rate of the 3D7/HP1-Control and PfHP1 truncation 
mutant lines accessed by GlucNAc assay and inspected by Giemsa at day 6 of the 
treatment (left panel) and the corresponding fold change in sexual conversion rates 
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between the RAP-treated versus DMSO-treated control populations (right panel). 
Results are the mean of at least three replicates (>3.000 RBCs counted per sample. n 
indicates number of replicates). Error bars indicate SD. Asterisks indicate significant 
differences in sexual commitment rates between RAP-treated and DMSO-treated 
parasites (right panel, p<0.01; unpaired two-tailed Student’s t-test). (C) Overview 
images of IFAs and Giemsa stains of DMSO- and RAP- treated population of 3D7/HP1-
KO (left panel). IFAs were performed on methanol-fixed cultures at 30-38 hpi, 
generation 2 using α-Pfs16 antibodies. Giemsa stains were taken at 10 days post 
invasion (10dpi). Images of IFAs and Giemsa stains highlight the large proportion of 
stage I gametocytes (green) and stage IV-V gametocytes in RAP-treated population 
compared to DMSO-treated population of 3D7/HP1-KO.  Sexual conversion rate of 
3D7/HP1-KO and 3D7/HP1-Control was accessed by Pfs16 IFAs at 30-38 to 40-48 hpi, 
generation 2 (right panel). Results are the mean of replicates (>200 iRBCs counted per 
sample. n indicates number of replicates). Error bars indicate SD. 
Figure 4. Generation of DiCre-inducible PfHP1-PbHP1 hybrid mutants. (A) Organization 
of PfHP1 and PbHP1 based on protein sequence alignment using Global Alignment 
EMBOSS Needle (https://www.ebi.ac.uk/Tools/psa/emboss_needle/)(see also Figure 
S4B). (B) Diagrams showing GFP-tagged PfHP1 hybrid protein products expressed in 
the 3D7/HP1-hyb-PbHinge, 3D7/HP1-hyb-PbCSD and 3D7/HP1-hyb-PbHP1 cell lines 
after RAP-treatment. (C) Representative live cell fluorescence images showing the 
localization of GFP-fusions in 3D7/HP1-hyb-PbHinge and 3D7/HP1-hyb-PbCSD cell lines 
in late schizonts (LS, 40-48 hpi, generation 1, 40 hrs after DMSO/RAP- treatment) and in 
late ring (LR, 16-24 hpi, generation 2, 64 hrs after DMSO/RAP treatment). Scale bar 
(black), 5µm. Magnificent bar (white), 2.5 µm. 
Figure 5. Phenotype of PfHP1-PbHP1 hybrid mutant lines. (A) Growth curves of the 
DMSO- and RAP-treated 3D7/HP1-hyb-PbHinge and 3D7/HP1-hyb-PbCSD parasites 
over three consecutive generations.  Values are the mean of three (3D7/HP1-hyb-
PbHinge) and four (3D7/HP1-hyb-PbCSD) independent replicate experiments. Error 
bars represent SD. (B) Sexual conversion rates of the DMSO- and RAP-treated PfHP1-
PbHP1 hybrid mutants and the control cell line (left panel) and the corresponding fold 
change in sexual conversion rates between the RAP-treated versus DMSO-treated 
control population (right panel). Values represent the mean of three (3D7/HP1-hby-
PbHinge) and four (3D7/HP1-Control and 3D7/HP1-hyb-PbCSD) independent 
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replicate experiments. Error bars represent SD. There is no significant difference in the 
fold induction in sexual conversion rates of the 3D7/HP1-hyb-PbHinge and 3D7/HP1-
hyb-PbCSD compared to the 3D7/HP1-Control cell line (right panel, p value > 0.05; 
unpaired two-tailed Student’ t-test). (C) PfEMP1 expression in DMSO- and RAP-treated 
PfHP1-PbHP1 hybrid mutants and control cell lines in the progeny at late ring stage 
(LR, 16-24 hpi, generation 2; 64 hrs after rapamycin treatment) as determined by IFA 
using α-ATS antibodies recognizing the conserved ATS domain of PfEMP1 (M. F. Duffy 
et al., 2002). The percentages of PfEMP1-positive iRBCs are indicated for each 
population. Values represent the mean of two independent experiments (+/-SD) 
(3D7/HP1-Control) and a single experiment (3D7/HP1-hyb-PbHinge and 3D7/HP1-hyb-
PbCSD). At least 200 iRBCs counted per sample. Nuclei were stained with DAPI. DIC, 
differential interference contrast. Scale bar, 5µm.  
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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3.7 Supplementary Information 
This Supplementary Information includes: 
Supplementary method 1 
Figure S1 to S5 
Tables S1  
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Supplementary method 1. The generation of pBCam-∆Hinge-3HA-Cherry, pBCam-
hyb-PbHinge-3HA-Cherry and pBCam-hyb-PbCSD-3HA-Cherry plasmids 
The pBCam-∆Hinge-3HA-Cherry was constructed as follows. The fragment PfCD 
spanning bps +1 to +222 of the re-pfhp1 sequence was amplified from a pUC57 
plasmid containing a synthetic recodonized pfhp1 coding sequence (pUC57-re-
pfhp1) (GenScript™) using primers F11 and R148. The fragment PfSIP2.linker spanning 
bps +694 to +762 of the pfsip2 coding sequence was amplified from 3D7 gDNA using 
primers F4 and R5. The fragment PfCSD spanning bps +532 to +798 of the re-pfhp1 
sequence, omitting stop codon was amplified from pUC57-re-pfhp1 using primers F2 
and R3. A hybrid fragment of PfSIP2.linker/PfCSD was amplified by fusion PCR from a 
mixture of PfSIP2.linker and PfCSD PCR templates using primer F4 and R3. The final 
hybrid fragment of PfCD/PfSIP2.linker/PfCSD was amplified by fusion PCR from a 
mixture of PfCD and PfSIP2.linker/PfCSD PCR templates using primers F11 and R3 and 
cloned into pBCam-3HA –Cherry using BamHI and NheI and T4 DNA ligase. 
The pBCam-hyb-PbHinge-3HA-Cherry was constructed as follows. The fragment PfCD 
spanning bps +1 to +222 of the re-pfhp1 sequence was amplified from pUC57-re-
pfhp1 using primers F11 and R1. The fragment PbHinge spanning bps +223 to +576 of 
the pbhp1 sequence was amplified from P. berghei gDNA using primers F35 and R36.  
The fragment PfCSD spanning bps +532 to +798 of the re-pfhp1 sequence, omitting 
stop codon was amplified from pUC57-re-pfhp1 using primers F2 and R42. A hybrid 
fragment of PfCD/PbHinge was amplified by fusion PCR from a mixture of PfCD and 
PbHinge PCR templates using primer F11 and R36. The final hybrid fragment of 
PfCD/PbHinge/PfCSD was amplified by fusion PCR from a mixture of PfCD/PbHinge 
and PfCSD PCR templates using primers F11 and R42 and cloned into pBCam-3HA –
Cherry using BamHI and NotI. 
The pBCam-hyb-PbCSD-3HA-Cherry was constructed as follows. The fragment 
PfCD.Hinge spanning bps +1 to +570 of the re-pfhp1 sequence was amplified from 
pUC57-re-pfhp1 using primers F11 and R12. The fragment PbCSD spanning bps +616 
to +843 of the pbhp1 sequence, omitting stop codon was amplified from P. berghei 
gDNA using primers F38 and R41. A hybrid fragment of PfCD.Hinge/PbCSD was 
amplified by fusion PCR from a mixture of PfCD.Hinge and PbCSD PCR templates using 
primers F11 and R41 and cloned into pBCam-3HA–Cherry using BamHI and NotI. 
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Supplementary Figures 
Figure S1. Two-step CRISP/Cas9-based gene editing strategy to generate DiCre-
inducible PfHP1 truncation and PfHP1-PbHP1 hybrid cell lines.  
(A) First gene editing step: Schematic maps of the pfhp1 locus (PF3D7_1220900) in 
3D7/1G5DiCre parasites (top), the co-transfected pFDon-N31 donor plasmid and 
pHF_gC-guide31 CRISPR/Cas9 transfection vector (center), and the modified pfhp1 
locus after CRISPR/Cas9-based gene editing in 3D7/N31DC parasites (bottom). The 
nucleotide positions of the sgt_pfhp1-5’ sgRNA target sequence is indicated 
(chromosome 12 coordinates).  The pFDon-N31 donor plasmid contains a 103 bp sera2 
intron:loxP element (light blue triangle) (Jones et al., 2016) flanked by two homology 
regions (HR) (brown, black) for homology-directed repair. The pHF_gC-guide31 
plasmid contains expression cassettes for SpCas9 (dark grey), the sgRNA (purple) and 
the hdhfr-yfcu fusion selection marker (light grey-dark brown). Second gene editing 
step: Schematic maps of the pfhp1 locus in 3D7/N31DC parasites (top), the co-
transfected pD_HP1 donor plasmids and pBF_gC-guide250 CRISPR/Cas9 transfection 
vector (center), and the modified pfhp1 locus after CRISPR/Cas9-based gene editing 
in 3D7/HP1-Control, 3D7/HP1-KO and 3D7/HP1-hyb-PbCSD are shown as examples 
(bottom). The nucleotide positions of the sgt_pfhp1-3’ sgRNA target sequence is 
indicated (chromosome 12 coordinates).  The pD_HP1 donor plasmids contain an 
assembly of the 103 bp sera2 intron:loxP element (light blue triangle) and the 
replacing cassette (dark blue) fused to gfp (green) flanked by two homology regions 
(HR) (brown, black) for homology-directed repair. The pBF_gC-guide250 plasmid 
contains expression cassettes for SpCas9 (dark grey), the sgRNA (purple) and the bsd-
yfcu fusion selection marker (light grey-brown). Red stars represent STOP codons. 
Numbers refer to the nucleotide position within the pfhp1 coding sequence. The black 
arrowheads indicate the binding sites of the F119 and R157 primers used to confirm 
correct gene editing of the pfhp1 locus and efficient DiCre-mediated excision upon 
rapamycin treatment by PCR on genomic DNA.  
Figure S2. Confirmation of successful generation of DiCre-inducible PfHP1 truncation 
and hybrid cell lines. (A) PCR confirmation of correct editing of the pfhp1 locus and 
efficient excision of the endogenous pfhp1 gene after RAP treatment. PCRs were 
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amplified from gDNA of 3D7/HP1-Control, 3D7/HP1-hyb-PbHinge, 3D7/HP1-hyb-
PbCSD, 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge, 3D7/HP1-∆CSD cell lines in 
DMSO (-) and RAP (+) treated conditions. Using primers F119 and R157 (see Figure S1), 
correct editing of the pfhp1 locus delivers a PCR product of 2250 bps in the 
3D7/N31DC mother line prior to insertion of a replacing cassette-gfp fusion sequence. 
The length of the correctly edited pfhp1 locus (-) and the length of the locus after 
efficient excision upon RAP treatment (+) from PfHP1 mutant cell lines were indicated 
at the bottom of the figure. The correct excision of floxed DNA after RAP treatment 
resulted in a decrease in the size of the corresponding PCR fragments in DMSO treated 
condition (-). (B) The efficiency of DiCre-mediated excision and resulting expression of 
GFP-tagged PfHP1s were quantified by the proportion of GFP-positive parasites in the 
paired DMSO- and RAP-treated samples in late schizonts (40-48 hpi, generation 1, 40 
hrs after RAP-treatment). Values represent the mean of three independent biological 
replicates (>140 iRBCs scored for 3D7/HP1-hyb-PbHinge and 3D7/HP1-hyb-PbCSD 
populations and >200 iRBCs scored for other cell lines). Error bars indicate SD. The GFP-
positive parasites in the DMSO- and RAP-treated populations of the 3D7/HP1-∆CD and 
3D7/HP1-∆Hinge were not determined. (C) Expression of GFP fusion from PfHP1 mutant 
cell lines were examined by Western blot in the ring progeny of DMSO- and RAP-
treated populations from all seven transgenic cell lines (16-24 hpi, generation 2, 64 hrs 
after DMSO/RAP treatment). Immunoblot using α-PfHP1 antibodies revealed 
untagged wild type PfHP1 (~31 KDa) expressed in all DMSO treated samples. 
Immunoblot using α-GFP antibodies revealed GFP fusion proteins expressed in all RAP 
treated samples of 3D7/HP1-Control (57.87 KDa), 3D7/HP1-∆CD (54.45 KDa), 3D7/HP1-
∆Hinge (47.51 KDa), 3D7/HP1-∆CSD (47.70 KDa), 3D7/HP1-KO (30.09 KDa), 3D7/HP1-
hyb-PbHinge (57.72 KDa) and 3D7/HP1-hyb-PbCSD (56.77 KDa). The molecular weight 
of GFP fusion proteins were predicted using Protein Molecular Weight tool at 
genecorner.ugent.be. α-histone 4 (H4) antibodies were used as loading control. 
Figure S3. Lack of Cre recombinase activity in a small subpopulations of transgenic 
cell lines. (A) The relative proportion of sexual and asexual subpopulation (RAPSUR) of 
RAP-treated 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge, 3D7/HP1-∆CSD populations 
in generation 3 (112 hrs after RAP treatment). Results are the mean of three 
independent replicates (>100 iRBCs counted per sample). Error bars indicate SD. (B) 
Examination of the pfhp1 locus and the presence of DiCre cassette at sera5 locus in 
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3D7/1G5DiCre, 3D7/N31DC lines and RAPSUR subpopulation of 3D7/HP1-KO, 3D7/HP1-
∆CD, 3D7/HP1-∆Hinge and 3D7/HP1-∆CSD. PCR amplification using F119 and R157 
revealed the correctly edited pfhp1 locus in tested RAPSUR subpopulations. Primers 
sera5 +27 and -25 confirmed wild type sera5 locus, i.e absence of DiCre cassette (1.7 
kb PCR products) while the primers sera5 +27 and -11 confirmed correctly edited sera5 
locus, i.e presence of the DiCre cassette (1.9 kb PCR products) (Collins et al., 2013) in 
tested cell lines. The lack of DiCre cassette and/or ineffective activity of Cre 
recombinase resulted in the failure of DNA excision, thus, generating a proliferating 
asexual subpopulation in PfHP1 truncation cell lines after RAP treatment.  
Figure S4. PfHP1 and PbHP1 are highly conserved in protein sequence. (A) Nucleotide 
sequences of the wild type (pfhp1) and recodonised (pfhp1 re) pfhp1 genes and 
amino acid sequence of PfHP1. Bases altered in the pfhp1 re are highlighted in red 
letters. Numbers refer to the nucleotide position within the pfhp1 coding sequence. 
(B) Alignment of PfHP1 and PbHP1 by EMBOSS Needle 
(https://www.ebi.ac.uk/Tools/psa/emboss_needle/). Conserved residues are marked 
by asterisks. The positions of the PfHP1 chromo- and chromoshadow domains are 
indicated (Flueck et al., 2009). 
 
 
 
 
  
Chapter 3|      In-depth functional analysis of PfHP1
   
 118 
Figure S1 
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Figure S3 
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Figure S4 
 
 
 
 
 
 
  
PfHP1 MTGSDEEFEIGDILEIKKKKNGFIYLVKWKGYSDDENTWEPESNLIHLTTFKKKMESLKT 60       
PbHP1 MTGSDEEFEIGDILDVKRKKNGFIYLVKWKGYSDDENTWEPESNLLHLTDFKKKMEYLKS 60           
      **************::*:***************************:*** ****** **:           
 
PfHP1 NFLSKANETNGDGKILKNHILAPTQED----DSIKSKGRSSLAPRRKMSRKSLTNKLEN- 115       
PbHP1 IYLNKIDRTSSDSKIMKKNNVQLFDQDDMGNTLMKPKGRTTLISRKRGHKRGMRNRMRNR 120           
       :*.* :.*..*.**:*:: :   ::*      :* ***::*  *::  ::.: *::.*                 
 
PfHP1 --------KKNLSLSDNSLKKSDEEDNESVKHENHVN--DGNLLNVEDVYSVRIKNKKLE 165       
PbHP1 MRNRIGNKSSASSVTDGSLKKSDDDDNQSIKKESSSNNYNNTLLNIEDVYSVRIKNRKME 180                                      
         ..  *::*.******::**:*:*:*.  *  :..***:**********:*:* 
 
PfHP1 FLASLKNESPQWVEETNIRRTGHLNIKVNDFKRYVRRKKSSRGNRIVIKNLHNVGDELYI 225       
PbHP1 FLASLKNASPQWVEESNIRSTGHLNIKVNDFKKYIKRKKTSKGSRIVIKNLHNVGDELYI 240           
      ******* *******:*** ************:*::***:*:*.****************  
          
PfHP1 SVIHNINNKEIHSLYPSKVIEYIYPQELLNFLLSRLRYRTA 266 
PbHP1 SVIHNINNKEIHSLYPSKVIEYIYPQELLNFLLSRLRYRTV 281       
  ****************************************. 
Chromo domain
Chromoshadow domain
pfhp1     ATGACAGGGTCAGATGAAGAATTTGAAATTGGTGATATACTTGAAATAAAAAAAAAGAAGAATGGTTTTATTTATTTAGTAAAATGGAAAGGAT   94  
          M  T  G  S  D  E  E  F  E  I  G  D  I  L  E  I  K  K  K  K  N  G  F  I  Y  L  V  K  W  K  G     
pfhp1  re ATGACAGGTAGT GATGAAGAATTTGAAATTGG AGATATA TT AGAAATTAAAAAGAAGAAAAATGGTTTTAT CTACTTAGTAAAATGGAAAGGAT   94  
pfhp1     ATTCAGATGATGAGAATACTTGGGAACCCGAAAGTAATTTAATACATTTGACAACATTTAAGAAAAAGATGGAAAGCTTAAAAACGAATTTTTT  188  
         Y  S  D  D  E  N  T  W  E  P  E  S  N  L  I  H  L  T  T  F  K  K  K   M  E  S  L  K  T  N  F  L  
pfhp1  re ATAGTGATGATGAAAATACATGGGAACCAGAATCA AATTT GATTCATTTGACAAC TTTTAA AAAGAAAATGGAATCA TTAAAAAC AAATTT CTT  188  
pfhp1     ATCGAAAGCTAATGAGACAAATGGTGATGGGAAAATTTTGAAAAATCATATATTAGCACCAACACAAGAAGACGATAGTATTAAATCAAAAGGT  282  
           S   K  A  N  E  T  N  G  D  G  K  I  L  K  N  H  I   L   A  P  T   Q  E   D  D  S   I   K  S   K  G 
pfhp1  re ATC TAAAGCAAATGAAACAAATGGAGATGGTAAAATATT AAAGAATCATAT T TTAGC TCCAACACAAGAAGATGATAGTAT AAAATCAAAAGGT 282  
pfhp1     AGAAGTTCCTTAGCACCCCGACGAAAAATGAGTAGAAAAAGTTTAACGAACAAACTAGAAAATAAAAAGAACTTATCTTTATCAGACAATTCTT  376  
          R  S   S   L   A  P  R  R  K  M  S   R  K  S   L   T   N  K  L   E   N  K  K  N  L   S   L   S   D  N  S   
pfhp1  re AGAAGTTCATTAGCACC TAGAAGAAAAATGTC TAGAAAAAGTTTAAC AAATAAGTTAGAAAATAAGAAAAATTT GTC ATTATC T GATAATTC AT 376  
pfhp1     TAAAAAAAAGTGATGAAGAAGATAATGAATCTGTAAAACATGAGAATCACGTTAATGATGGAAATTTATTAAATGTTGAAGATGTATATAGCGT  470  
         I  K  K  S  D  E  E  D  N  E  S  V  K  H  E  N  H  V  N  D  G  N  L  L   N  V  E  D  V  Y  S  V   
pfhp1  re TAAAGAAAAGTGATGAAGAAGATAATGAATCTGT TAAACATGAAAATCATGTAAATGATGGAAATTT GTTAAATGT AGAAGATGTTTATAG TGT 470  
pfhp1     TCGTATTAAAAATAAGAAATTGGAGTTTTTGGCTAGCTTGAAAAATGAATCTCCACAATGGGTAGAAGAAACAAATATTAGAAGAACTGGACAT  564  
           R  I  K  N  K  K  L  E  F  L  A  S  L  K  N  E  S  P  Q  W  V  E  E  T  N  I  R  R  T  G  H      
pfhp1  re AAGAATTAAAAATAAGAAATT AGAATTTTT AGCTTCT TT AAAGAATGAAAGTCCACAATGGGT TGAAGAAACAAATATTAGAAGAACAGGT CAT  564  
pfhp1     TTAAATATTAAAGTCAATGATTTTAAAAGATATGTAAGAAGAAAAAAAAGTTCTAGGGGTAATAGAATAGTTATCAAAAATCTACACAACGTTG  658  
          L  N  I  K  V  N  D  F  K  R  Y  V  R  R  K  K  S  S  R  G  N  R  I  V  I  K  N  L  H  N  V   
pfhp1  re TT GAATATTAAAGT TAATGATTTTAAAAGATATGT TAGAAGAAAGAAAAGTAGTAGAGGAAATAGAATAGT AATTAAAAATTTGCATAATGTAG 658  
pfhp1     GAGATGAATTATATATTTCGGTTATTCATAATATAAATAATAAAGAAATTCATAGTTTATATCCTTCCAAAGTTATTGAATATATTTATCCACA  752  
         G  D  E  L  Y  I  S  V  I  H  N  I  N  N   K  E  I  H  S  L  Y  P  S  K  V  I  E  Y  I  Y  P  Q   
pfhp1  re GAGATGAATTATATAT AAGTGTTATTCATAATATAAATAATAA GGAAATTCATAGTTTATATCCTTC AAAAGTAATAGAATATAT ATATCC TCA 752  
pfhp1     GGAACTCTTAAATTTTTTATTATCAAGACTAAGATACCGTACAGCT                                                  798  
           E  L  L  N  F  L  L  S  R  L  R  Y  R  T  A  
pfhp1  re AGAATTATTAAATTT CTTATT ATCAAGATTAAGATA TAGAACAGCA                                                 798  
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Table S1. Primers and primer sequences used in the study of in-depth functional 
analysis of heterochromatin protein 1 in Plasmodium falciparum 
Application Primer Sequence 5’-3’ 
PCR 
cloning 
transfection 
vectors 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
R1 TTT ACC ATC TCC ATT TGT TTC ATT TG 
F2  GTTGAAGAAACAAATATTAGAAGAAC 
R3 CAGT GCTAGC TGC TGT TCT ATA TCT TAA TCT TG 
F4  GAA ACA AAT GGA GAT GGT AAA GGA ATA ACC TTT GAA CAA TTA TAT C 
R5 CTA ATA TTT GTT TCT TCA AC ACC TAC ATT TTC AAA TAC TCG TAC 
F11  CAGT GGATCC AAAAA ATGACAGGTAGTGATGAAG 
R12 ATT CAA ATG ACC TGT TCT TC 
F35  CAAATGAAACAAATGGAGATGGTAAAATTATGAAAAAAAACAATGTACAG 
R36 GTT CTT CTA ATA TTT GTT TCT TCA ACC CAT TGT GGT GAT GCA TTT TTT AAG 
F38  GAAGAACAGGTCATTTGAATATAAAAGTTAACGATTTTAAAAAA 
R41 CAATGCGGCCGCAACCGTTCTATATCTAAGTCTTG 
R42 CAATGCGGCCGCTGCTGTTCTATATCTTAATCTTG 
F119 GTGTGTGTTTAAGAAAAAATATG 
F139 GTAAATAAAAAAAATAATATACAATAAC 
R143 CTAAAAGAATATAAAATATATAAATAT 
R148 AGGGTATCACCTTCAAACTTGACTTCAGCACGTGTCTTGTAG 
R157 CATGTAGCCAAAATATGTG 
F158 CGTTGGCCGATTCATTAATGAAAGGATATTCAGATGATGAG 
R159 GTTATTGTATATTATTTTTTTTATTTACTTACGCTGTTCTATATCTTAATC 
F160 ATATTTATATATTTTATATTCTTTTAGAAAGGCTATTCAGATGATG 
R161  GTTCTTCTCCTTTACTCATAACCGTTCTATATCTAAGTC 
F162  ATGAGTAAAGGAGAAGAAC 
R163 CCTCTTCGCTATTACGCCAGGAGGTTAAAATTCTAAACTATATG 
F164  ATATTTATATATTTTATATTCTTTTAGAAAGGATATAGTGATGATGA 
R165  GTTCTTCTCCTTTACTCATTGCTGTTCTATATCTTAATC 
F177  ATATTTATATATTTTATATTCTTTTAGAAAACAAATTTCTTATCTAAAG 
R178  GTTCTTCTCCTTTACTCATATTCAAATGACCTGTTCTTC 
PCRA_F CTGGCGTAATAGCGAAGAGG 
PCRA_R CATTAATGAATCGGCCAACG 
Annealing  
  
  
  
F-g31 TATTATTTATTTAGTAAAATGGAA 
R-g31 AAACTTCCATTTTACTAAATAAAT 
F-g250 TATTCATAATAAAATTAAGCTGTA 
R-g250 AAACCAGGAACTCTTAAATTTTTT 
PCR gDNA 
  
  
  
  
  
  
F-cg6 GTTCATGCTCCTCAACAAAG 
R-cg6 GAACAAATACATAAGAGCGC 
F119 GTGTGTGTTTAAGAAAAAATATG 
R157 CATGTAGCCAAAATATGTG 
sera5+27 CAATATCATTTGAATCAAACAGTGGT 
sera5 -11 CTTTGCCATCCAGGCTGTTC 
sera5 -25 CCATTGGACTAGAACCTTCAT 
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Chapter 4. Preliminary results about the roles of individual PfHP1 
domains in regulating var gene silencing 
4.1 Aim of study 
As mentioned before, Brancucci and colleagues have employed a PfHP1 knock-
down cell line to show that PfHP1 is required for three important cellular processes: (1) 
progression through schizogony and thus, normal parasite replication; (2) silencing of 
the pfap2-g locus and thus, inhibition of sexual commitment; and (3) var gene 
silencing and thus, ensuring the singular choice of var gene expression (Brancucci et 
al., 2014). In Chapter 3, I have shown that each of three PfHP1 domains is essential for 
(1) the proliferation of asexual blood stage parasites and (2) the silencing of ap2-
g/inhibition of the sexual conversion, which is consistent with the previous results 
(Brancucci et al., 2014).  
Here, I aimed to investigate if individual domains of PfHP1 also play a role in regulating 
var gene silencing, as previously shown for full length PfHP1 (Brancucci et al., 2014). 
My preliminary results showed that an extremely high percentage of stage I 
gametocytes in the generation after rapamycin treatment did not express PfEMP1 in 
all four mutant cell lines: 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge and 3D7/HP1-
∆CSD. My preliminary data suggest a possibility that sexual committed parasites might 
execute alternative mechanism to regulate var gene silencing independent to PfHP1.  
4.2 Methods 
Cell lines used in this study 
The following cell lines were used in this study: 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-
∆Hinge, 3D7/HP1-∆CSD and 3D7/HP1-Control. These cell lines have been generated, 
cultured and induced to express GFP-tagged PfHP1 mutants as described in Chapter 
3 of this thesis. 
Indirect immunofluorescence assay (IFA) 
IFAs were performed on methanol-fixed cells in the progeny of rapamycin-treated 
parasites (30-38h to 40-48 hpi, generation 2) using mouse IgG or IgG1 mAb α-ATS 
(Duffy et al., 2002),1:150; mouse mAb α-Pfs16 (kind gift from Robert W. Sauerwein), 
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1:250; and Alexa Fluor 488-conjugated α-mouse IgG or IgG1 (Molecular Probes), 1:250. 
Images were taken at 63-fold magnification on a Leica DM 5000B microscope with a 
Leica DFC 300 FX camera, acquired via the Leica IM 1000 software, processed using 
ImageJ software [https://imagej.nih.gov/ij/]. For each experiment, images were 
acquired and processed with identical settings. 
4.3 Results  
To address the functional contribution of individual domains of PfHP1 in controlling var 
gene expression, parasites were split at 0-8 hpi in generation 1 and treated either with 
DMSO or RAP. Immunofluorescence imaging was performed to compare the 
expression of PfEMP1 in the progeny of DMSO- and RAP-treated parasites (40-48 hpi, 
generation 2).   
In the 3D7/HP1-Control cell line, the majority of both RAP- and DMSO-treated parasites 
were schizonts and comparable in fluorescence intensity signals for PfEMP1 (Figure 
4.1A). Similarly, approximately 100% of DMSO-treated 3D7/HP1-KO, 3D7/HP1-∆CD, 
3D7/HP1-∆Hinge and 3D7/HP1-∆CSD parasites were schizonts and PfEMP1-positive as 
expected (Figure 4.1A and C). Notably, the proportion of schizonts in the 
corresponding RAP-treated samples dropped to 0.7 - 2.58% and these were also 
positive for PfEMP1. In contrast, undetectable PfEMP1 signal was observed in the rest 
of the parasites in the RAP-treated populations (Figure 4.1A and C).   
In order to characterize if the PfEMP1-negative parasites in these RAP-treated 
populations indeed correspond to early gametocytes, I performed independent Pfs16 
IFAs since the α-ATS and α-Pfs16 antibodies are both mouse-derived monoclonal 
antibodies. The Pfs16 IFAs showed that only ~ 4 to 6% of the progeny of DMSO-treated 
parasites were Pfs16-positive in 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge and 
3D7/HP1-∆CSD cell lines. In contrast, this population was observed at ~85 to 98% in the 
corresponding RAP-treated parasites (Figure 4.1B-C). These extremely high 
percentage of early gametocytes is very similar to the proportion of PfEMP1-negative 
parasites observed in the RAP-treated samples of 3D7/HP1-KO, 3D7/HP1-∆CD, 
3D7/HP1-∆Hinge and 3D7/HP1-∆CSD cell lines. 
Together, two independent immunofluorescence studies showed that at early stage 
of gametocytogenesis, PfEMP1 expression is strongly reduced even in the absence of 
PfHP1.  
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Figure 4.1. PfEMP1 expression is reduced at early stage of gametocytogenesis. (A) 
Representative images showing PfEMP1 expression in the progeny of DMSO- and RAP-
treated PfHP1 truncation mutant and control cell lines (40-48 hpi, generation 2) as 
determined by IFA using α-ATS antibodies recognizing the conserved ATS domain of 
PfEMP1. Nuclei were stained with DAPI. DIC, differential interference contrast. Scale 
bar 5 µm. (B) Representative examples of independent PfEMP1 and Pfs16 IFAs in the 
progeny of DMSO- and RAP-treated 3D7/HP1-KO parasites (40-48 hpi, generation 2) 
as determined by IFA using α-ATS antibodies and α-Pfs16 antibodies. Scale bar 10 µm. 
(C) Proportion of PfEMP1-positive parasites and proportion Pfs16-positive parasites in 
DMSO- and RAP-treated PfHP1 truncation mutant lines (40-48 hpi, generation 2) as 
determined by independent IFAs using α-ATS antibodies and α-Pfs16 antibodies. 
Values were obtained from a single experiment each (>200 iRBCs counted per sample 
except for 3D7/HP1-∆CSD DMSO with >150 iRBCs counted). 
 
In order to better study the expression of PfEMP1 in the early stage I gametocytes, I 
performed a double labelling IFA using α-Pfs16 and α-ATS antibodies simultaneously 
using 3D7/HP1-∆CD parasites as a representative cell line. Although both of α-Pfs16 
and α-ATS antibodies are mouse-derived, α-Pfs16 antibodies mark the 
parasitophorous vacuole membrane (PVM) (Bruce et al., 1994; Eksi and Williamson, 
2011; Kongkasuriyachai et al., 2004; Maier et al., 2009) while α-ATS antibodies visualize 
PfEMP1 that is exported beyond the parasite boundaries (Horrocks et al., 2005; Marti 
and Spielmann, 2013). Hence, using a single secondary labelled anti-mouse IgG 
antibody type still allows the differentiation the two labelling patterns, of which one 
comes from PfEMP1 and the other comes from Pfs16 antigens. As shown in Figure 4.2, 
only schizonts expressed PfEMP1 in both DMSO-/RAP-treated conditions. In contrast, 
neither gametocytes with wild type PfHP1 background (DMSO-treated condition, 
Pfs16-positive parasites) nor the induced gametocytes with mutant PfHP1 background 
(RAP-treated condition, Pfs16-positive parasites) expressed PfEMP1. This result was 
consistent with the observation from the two independent IFAs shown above.  
This preliminary result is somehow contradictory to the result described previously 
where the progeny of PfHP1-GFP-DD knockdown parasites showed increased PfEMP1 
expression because of de-repression of the var gene family (Brancucci et al., 2014). 
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However, in the previous study, the proportion of PfHP1-depleted parasites in the 
population showing upregulated PfEMP1 was not specified. It has been reported that 
approximately 50% of the ring progeny from PfHP1-depleted parasites were early 
stage I- gametocytes (Pfs16-positive) and the rest was arrested trophozoites 
(Brancucci et al., 2014). Hence, this gametocyte subpopulation in the PfHP1-depleted 
parasites was speculated to not express PfEMP1 while the arrested asexual 
trophozoites was speculated to highly express PfEMP1. I have repeated the PfEMP1 
IFA on the 3D7/HP1-GFP-DD line in ON and OFF Shield-1 conditions in order to quantify 
the proportion of parasites that expressing high level of PfEMP1. However, I was 
unsuccessful to generate these results since there have been high background or very 
faint PfEMP1 signal intensity obtained from IFA samples that interfered with evaluation 
of bona fide PfEMP1 signal as well as the quantification. The possible reasons for this 
failure could be the differences in experimental conditions compared to the previous 
study, including the use of different Shield-1 stocks and especially different batches of 
α-ATS antibodies for which I indeed experienced large variabilities in quality (for 
example, one batch with aggregation of antibodies in -20oC storage condition) (data 
not shown).  
Although the results presented in this chapter are preliminary and need to be 
repeated in biological replicates, the PfEMP1 and Pfs16 expression patterns were very 
consistent in all four cell lines, the 3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge and 
3D7/HP1-∆CSD. This initial result therefore suggests that var gene expression during the 
onset of gametocytogenesis is downregulated independently of PfHP1, probably 
because of the low abundance/absence of transcription factor(s) that previously 
activated permissive var locus in asexual stage parasites.  
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Figure 4.2. PfEMP1 and Pfs16 co-labelling in 3D7/HP1-∆CD cell line. (A) Representative 
overview images showing PfEMP1 expression in the progeny of DMSO- and RAP-
treated 3D7/HP1-∆CD at 40-48 hpi, generation 2 as determined by IFA using α-ATS 
antibodies recognizing the conserved ATS domain of PfEMP1. Nuclei were stained with 
DAPI. DIC, differential interference contrast. Scale bar 10 µm. (B) Double labelling IFA 
using α-Pfs16 and α-ATS antibodies for 3D7/HP1-∆CD cell line at 40-48 hpi, generation 
2. The white arrows indicate PfEMP1 staining pattern in schizonts. The green boxes 
indicate Pfs16 staining pattern of stage I gametocytes. The proportion of each 
labelled subpopulation was not determined. Scale bar 10 µm. 
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Chapter 5. Studying PfHP1 function using a genetic 
complementation approach 
 
This chapter presents some initial analyses on the functional contribution of PfHP1 
domains to overall PfHP1 function and the functional conservation of PfHP1 domains 
among different species, using a genetic complementation approach. In this study, I 
employed the previously published PfHP1 knockdown cell line, 3D7/HP1-GFP-DD 
(Brancucci et al., 2014), to ectopically express a series of PfHP1 mutants and evaluate 
their ability to complement  three PfHP1-dependent processes: (1) maintenance of 
mutually exclusive expression of var genes, (2) mitotic progression of asexual blood 
stage parasites and (3) sexual differentiation switch (Brancucci et al., 2014). 
 
5.1 Methods 
Parasite culture and transfection 
3D7/HP1-GFP-DD parasites (Brancucci et al., 2014) were cultured at 5% hematocrit in 
RPMI-1640 medium supplemented with 25 mM HEPES, 100 mM hypoxanthine, 24 mM 
sodium bicarbonate and 0.5% Albumax II, 4 nM WR99210 (WR) and 625 nM Shield-1. 
(Brancucci et al., 2014; Lambros and Vanderberg, 1979; Trager and Jensen, 1976; Voss 
et al., 2006). Transfection was performed as described (Brancucci et al., 2014; Voss et 
al., 2006). 
Transfection cell lines and transfection constructs 
I employed the pBcam-3xHA-Cherry vector (Witmer et al., 2012) to generate a series 
of complementation constructs expressing mutant PfHP1 proteins C-terminally tagged 
with a sequence encoding the 3xHA-CherryFP epitope-fluorophore tag. These 
complementation constructs were expressed under the control of the constitutive P. 
falciparum calmodulin (cam) promoter. The pBcam-3xHA-Cherry vector can be 
selected on blasticidin for stable episomal maintenance. I have successfully 
generated seven such complementation cell lines by transfecting pBcam-3xHA-
Cherry-derived PfHP1 complementation plasmids into 3D7/HP1-GFP-DD parasites. 
They are listed below. 
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(1) 3D7/HP1-Control-HAC that ectopically expresses full-length wild type PfHP1 (aas 1-
266). 
(2) 3D7/HP1-∆CD-HAC that ectopically expresses a PfHP1 mutant consisting only of 
the Hinge and CSD regions (aas 55-266). 
(3) 3D7/HP1-∆Hinge-HAC that ectopically expresses a PfHP1 mutant in which the hinge 
region (aas 75-177) is replaced by a linker polypeptide derived from the ApiAP2 factor 
PfSIP2 (aas 232-254 of PfSIP2 that connect two AP2 domains) (Flueck et al., 2009).  
(4) 3D7/HP1-∆CSD-HAC that ectopically expresses a PfHP1 mutant consisting only of 
the CD and Hinge regions (aas 1-190). 
(5) 3D7/hsHP1-N-HAC that ectopically expresses a chimeric PfHP1 containing, in the 
following order, the human HP1α CD (aas 1-75) followed by the PfHP1 Hinge and CSD 
regions (aas 55-266, encoded by a recodonized pfhp1 sequence, GenscriptTM, see 
Chapter 2 for more details). 
(6) 3D7/Swi6-N-HAC that ectopically expresses a chimeric PfHP1 containing, in the 
following order, the S.pombe Swi6 CD (aas 1-139) followed by the PfHP1 Hinge and 
CSD regions (aas 55-266, encoded by a recodonized pfhp1 sequence, GenscriptTM). 
(7) 3D7/Swi6-C-HAC that ectopically expresses a chimeric PfHP1 containing, in the 
following order, the PfHP1 CD and Hinge regions (aas 1-190, encoded by a 
recodonized pfhp1 sequence, GenscriptTM) followed by the Swi6 CSD region (aas 260-
328). 
 
The corresponding transfection constructs are listed below. 
The pBcam-PfHP1 full-3xHA-Cherry carrying full-length wild type PfHP1 (aas 1-266) was 
obtained from N.Brancucci [N.Brancucci PhD dissertation, 2014] 
To generate the pBcam-∆CD-3xHA-Cherry, a fragment named PfHP1.HingeCSD 
encoding aas 55-266 of the endogenous PfHP1 was amplified from 3D7 gDNA using 
primers 5fwd and 5rev and cloned into the pBcam-3xHA-Cherry plasmid using BamHI 
and NotI and T4 ligase. 
The pBcam-∆Hinge-3xHA-Cherry was constructed as described in Chapter 3 
(Supplementary Information).  
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To generate the pBcam-∆CSD-3xHA-Cherry plasmid, a fragment named 
PfHP1.CDHinge encoding aas 1-190 of the endogenous PfHP1 was amplified from 3D7 
gDNA using primers 2fwd and 2rev and cloned into the pBcam-3xHA-Cherry plasmid 
using BamHI and NotI and T4 ligase.  
The pBcam-HsHP1-N-3xHA-Cherry was constructed as follows. A fragment named 
HsHP1.CD encoding aas 1-75 of the human HP1α was amplified from cDNA of human 
Jurkat cells using primers F6 and R7. A fragment named PfHP1.HingeCSD encoding 
aas 55-266 of recodonized PfHP1 (rePfHP1) was amplified from pUC57-rePfHP1 
(Genscript™) using primers F10 and R3. The resulting hybrid fragment 
HsCD/PfHP1.HingeCSD was amplified by fusion PCR from a mixture of HsHP1.CD and 
PfHP1.HingeCSD PCR products (at 1:100 dilution) using primers F6 and R3 and cloned 
into pBCam-3xHA–Cherry using BamHI and NheI and T4 ligase.  
The pBcam-Swi6-N-3xHA-Cherry was constructed as follows. A fragment named 
Swi6.CD encoding aas 1-139 of the S. pombe Swi6 was amplified from plasmid 
pMB117-Swi6 (kind gift of M. Bühler, Friedrich-Miescher Institute, Basel, Switzerland) 
using primers F8 and R9. The resulting hybrid fragment Swi6CD/PfHP1.HingeCSD was 
amplified from a mixture of Swi6.CD and PfHP1.HingeCSD PCR products (at 1:100 
dilution) by fusion PCR using primers F8 and R3 and cloned into pBcam-3xHA–Cherry 
using BamHI and NheI and T4 ligase.  
The pBcam-Swi6-C-3xHA-Cherry was constructed as follows. A fragment named 
Swi6.CSD encoding aas 260-328 of the S.pombe Swi6 was amplified from plasmid 
pMB117-Swi6 using primers F15 and R16.  The resulting hybrid fragment 
PfHP1.CDHinge/Swi6.CSD was amplified from a mixture of PfHP1.CDHinge and 
Swi6.CSD PCR products (at 1:100 dilution) by fusion PCR using primers F11 and R16 and 
cloned into pBcam-3xHA –Cherry using BamHI and NheI and T4 ligase. 
All primer sequences are listed in Table 1. 
For each of the seven transfections, 100 µg of the corresponding pBcam-3xHA-Cherry-
derived complementation vector described above was electroporated into the 
3D7/HP1-GFP-DD parasite line. Transfectants were selected in the presence of the 
indicated combinations of 625 nM Shield-1 and 4 nM WR99210 (to maintain 3D7/HP1-
GFP-DD parasites stably expressing PfHP1-GFP-DD from the endogenous locus) and 5 
µg/ml BSD (to maintain the pBcam-3xHA-Cherry-derived complementation vector). 
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Once obtained, transfectants were continuously cultured in the presence of 625 nM 
Shield-1, 4 nM WR99210 and 10 µg/ml BSD. 
Western Blot analysis 
Transfectants cultured under ON Shield-1 conditions (625 nM Shield-1, 4nM WR and 10 
µg/ml BSD) were synchronized twice 16 hrs apart to obtain an 8 hrs growth window. 
The parasites were then synchronized at 0-8 hpi generation 1 and split into two 
populations, one cultured with Shield-1 and one without Shield-1. Nuclei were isolated 
at 40-48 hpi generation 1 as described in Chapters 2 and 3. Proteins were detected 
using mouse mAb α-GFP (Roche Diagnostics #11814460001), 1:1’000; rat mAb α-HA 
(3F10, Roche Diagnostics #11867423001), 1:1’000; rabbit α-PfHP1 (Brancucci et al., 
2014), 1:5’000; rabbit α-Histone 4 (Abcam ab10158), 1:10’000.  
Fluorescence microscopy 
IFAs were performed on methanol-fixed cells using the following antibodies: rat mAb 
α-HA (3F10, Roche Diagnostics #11867423001), 1:100; mouse mAb α-GFP (Roche 
Diagnostics #11814460001), 1:100; mouse IgG1 mAb α-ATS (Duffy et al., 2002), 1:150, 
Secondary antibodies: Alexa Fluor 568-conjugated α-rat IgG (Molecular Probes 
#A11077), 1:250; Alexa Fluor 488-conjugated α-mouse IgG (Molecular Probes), 1:250. 
Nuclei were stained with DAPI. Images were taken at 63-fold magnification on a Leica 
DM 5000B microscope with a Leica DFC 300 FX camera, acquired via the Leica IM 
1000 software, processed using ImageJ software [https://imagej.nih.gov/ij/]. For each 
experiment, images were acquired and processed with identical settings.   
Parasite multiplication assay  
Parasites were tightly synchronized (0-8 hpi, generation 1), split into two equal 
populations, of which one half was maintained with 625 nM Shield-1, 4 nM WR99210 
and 10 µg/ml BSD (negative control) and the other half was induced for the depletion 
of endogenous PfHP1-GFP-DD by Shield-1 removal (4 nM WR99210 and 10 µg/ml BSD). 
Giemsa smears were prepared to determine the parasitaemia at 16-24 hpi 
(generation 1). Giemsa-stained smears were prepared every second day onwards for 
three generations. Parasitaemia was counted by visual inspection of Giemsa-stained 
blood smears (≥ 1’000 RBCs counted per experiment). Multiplication rates were 
determined as the parasitaemia observed in the following generation divided by the 
parasitaemia observed in the previous generation. The extrapolative growth cure was 
generated using a starting parasiteamia at 0.1%. 
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Gametocyte conversion assay 
Parasites were tightly synchronized (0-8 hpi, generation 1), split into two equal 
populations, of which one half was maintained with 625 nM Shield-1, 4 nM WR99210 
and 10 µg/ml BSD (negative control) and the other half was induced for the depletion 
of endogenous PfHP1-GFP-DD by Shield-1 removal as described above. 
Gametocytaemia and arrested parasitaemia was determined on day seven after 
Shield-1 removal by visual inspection of Giemsa-stained blood smears. Sexual 
conversion rates were determined as the gametocytaemia observed on day seven 
as a proportion of the total parasitaemia observed at 16-24 hpi in generation 2. 
Arrested parasitaemia was determined as the arrested trophozoites observed on day 
seven as a proportion of the total parasitaemia observed at 16-24 hpi in generation 2. 
5.2 Results and discussion 
Validation of complementation PfHP1 cell lines 
To begin studying the in vivo functional contribution and conservation of structural 
domains of PfHP1, I employed the conditional PfHP1 knockdown cell line, 3D7/HP1-
GFP-DD (Brancucci et al., 2014) and expressed a series of episomal complementation 
PfHP1 constructs cloned into the pBcam-3xHA-Cherry vector (Witmer et al., 2012). 
There were seven complementation cell lines generated successfully. The control cell 
line is 3D7/HP1-Control-HAC. Three truncated PfHP1 mutant cell lines are 3D7/HP1-
∆CD-HAC, 3D7/HP1-∆Hinge-HAC and 3D7/HP1-∆CSD-HAC. Three chimeric PfHP1 
mutant cell lines are 3D7/hsHP1-N-HAC, 3D7/Swi6-N-HAC and 3D7/Swi6-C-HAC. The 
generation of complementation cell lines and transfection constructs are explained 
in detail in the Methods section above and in Figure 5.1.  
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Figure 5.1. The generation of PfHP1 complementation cell lines. (A) Structure of PfHP1, 
Swi6 and hsHP1a (Flueck et al., 2009; Hayakawa et al., 2003; Wang et al., 2000). (B) 
Names of the complementation cell lines (left) and schematics of the ectopically 
expressed PfHP1 protein products (right) used in this study. The red oval represents 
3xHA-CherryFP. The dashed lines represent deletions. The numbers indicate positions 
of amino acid residues. The blue, green, orange and brown colors represent domains 
from PfHP1, HsHP1, Swi6 and PfSIP2, respectively. 
 
When transfectants were obtained, expression of ectopic proteins was analyzed by 
immunoblot using whole parasite protein lysates harvested at 40-48 hpi in generation 
1. In the immunoblot analysis, the α-HA antibodies recognize ectopic proteins which 
were C-terminally tagged with 3xHA-CherryFP (or shortly HAC-tag), the α-GFP 
antibodies recognize endogenous the PfHP1-GFP-DD protein at ~70 KDa. Note that 
the rabbit polyclonal α-PfHP1 antibodies recognize mostly the CD and the Hinge 
region of PfHP1 (I. Niederwieser, personal communication). The immunoblot analysis 
with α-HA antibodies revealed the correct expression of all seven ectopic PfHP1 
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mutants: (1) HP1-Control-HAC at ~63KDa; (2) HP1-∆CD-HAC at ~58KDa; (3) HP1-
∆Hinge-HAC at ~54.9KDa; (4) HP1-∆CSD-HAC at ~55.1KDa; (5) hsHP1-N-HAC at 
~66KDa; (6) Swi6-N-HAC at ~73.5KDa; (7) Swi6-C-HAC at ~72KDa. Protein molecular 
weight was predicted using Protein Calculator free software 
(http://protcalc.sourceforge.net/). As shown in Figure 5.2A, under ON Shield-1 
conditions (1) all cell lines expressed similar levels of the endogenous PfHP1-GFP-DD 
shown by analysis with α-GFP; (2) similar amounts of protein lysates were loaded as 
shown by analysis with α-H4 (histone H4); (3) the endogenous and ectopic PfHP1s in 
the 3D7/HP1-Control-HAC were expressed at similar levels shown by the analysis with 
α-PfHP1 antibodies, giving an indirect standard to compare the expression level of 
other ectopic PfPH1 mutants to that of endogenous PfHP1. However, ectopic PfHP1s 
from the other six complementation cell lines were expressed at different levels (Figure 
5.2A). To be specific, the expression level of ectopic PfHP1s from 3D7/HP1-∆CSD-HAC, 
3D7/hsHP1-N-HAC; 3D7/Swi6-N-HAC and 3D7/Swi6-C-HAC were similar to that of 
endogenous PfHP1-GFP-DD. In contrast, the expression levels of ectopic PfHP1s from 
3D7/HP1-∆CD-HAC and 3D7/HP1-∆Hinge-HAC were much lower than that of 
endogenous PfHP1-GFP-DD. In order to possibly increase the expression level of 
ectopic PfHP1s, PfHP1 mutant cell lines were challenged with a higher amount of BSD 
up to 20 µg/ml. However, under this condition, parasites revealed low multiplication 
rates, prolonged cell cycle and cell death (data not shown). Therefore, the culture 
condition with 10 µg/ml of BSD was selected as the standard condition for the optimal 
expression of ectopic PfHP1 mutants. In brief, the immunoblot assay showed that with 
the low level expression of ectopic PfHP1 mutants in 3D7/HP1-∆CD-HAC and 3D7/HP1-
∆Hinge-HAC parasites, these cell lines were not suitable for further studies, while the 
3D7/HP1-Control-HAC, 3D7/HP1-∆CSD-HAC, 3D7/hsHP1-N-HAC, 3D7/Swi6-N-HAC and 
3D7/Swi6-C-HAC were suitable for further analysis.  
In parallel to the Western blot analysis, localization IFA studies were also performed at 
trophozoite stage (around 24-32 hpi, generation 1) to analyze the localization of 
ectopic PfHP1 mutants. In the presence of endogenous PfHP1-GFP-DD (ON Shield-1 
condition), ectopic PfHP1s from 3D7/HP1-Control-HAC, 3D7/hsHP1-N-HAC, 3D7/Swi6-
N-HAC, 3D7/HP1-∆CD-HAC and 3D7/HP1-∆Hinge-HAC were concentrated into foci at 
nuclear periphery indistinguishable to endogenous PfHP1. In contrast, when the PfHP1 
CSD domain is deleted (3D7/HP1-∆CSD-HAC) or replaced by the CSD from Swi6 
(3D7/Swi6-C-HAC), the heterochromatin localization was hampered at different 
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levels. First, in the 3D7/Swi6-C-HAC line a subpopulation (percentage not determined) 
showed cytosolic localization and punctate nuclear localization, i.e. not 
heterochromatin-restricted localization. Second, in the 3D7/HP1-∆CSD-HAC line the 
CSD-truncated PfHP1 localised to the cytosol (Figure 5.2B). Together, these results 
indicate an important role of the PfHP1 CSD domain in targeting the protein to 
nucleus. In addition, the results also suggest that the replacement of the PfHP1 CD 
domain with that from other HP1 proteins (Swi6 and hsHP1a) could retain the correct 
localization of PfHP1, which is possibly obtained by dimerization of chimeric PfHP1s 
with endogenous PfHP1 via the CSD. On the contrary, it seems that replacement of 
the PfHP1 CSD domain with that from Swi6 only partly fulfilled this function. Thus, the 
IFA results corroborated the central role of the CSD domain in HP1 homodimerisation 
(Cowieson et al., 2000), specific for each species.  
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Figure 5.2. Validation of PfHP1 complementation cell lines. (A) Expression of ectopic 
PfHP1s in transgenic cell lines. α-HA antibodies recognized ectopic PfHP1 proteins, α-
GFP antibodies recognized endogenous PfHP1-GFP-DD protein at ~70 KDa. α-H4 
antibodies recognized histone H4 and used for loading control. α-HP1 antibodies 
recognized both endogenous PfHP1-GFP-DD and ectopic PfHP1 proteins. The asterisks 
represent ectopic PfHP1s recognized by α-PfHP1 antibodies (note that the α-HP1 
antibodies do not efficiently bind to the PfHP1 CSD domain). The hyphens represent 
endogenous PfHP1-GFP-DD protein at ~70 KDa. (B) Localization of ectopic PfHP1s in 
the presence of endogenous PfHP1 in trophozoites (ON Shield-1). Scale bar 10 µm. 
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In the absence of endogenous PfHP1-GFP-DD (OFF Shield-1 cultures, 24-32 hpi, 
generation 2), in 3D7/HP1-Control-HAC and 3D7/hsHP1-N-HAC parasites ectopic 
PfHP1s localized to heterochromatin foci. In contrast, the hybrid PfHP1 protein in the 
3D7/Swi6-C-HAC line mislocalized to cytoplasm and no heterochromatin foci were 
observed (Figure 5.3 left panel). Unfortunately, in 3D7/Swi6-N-HAC, 3D7/HP1-∆CD-
HAC, 3D7/HP1-∆Hinge-HAC and 3D7/HP1-∆CSD-HAC parasites the signal intensity for 
CherryFP-tagged PfHP1 mutants was not above the background so that the 
localization of these ectopic PfHP1 mutants could not be determined in parasites 
depleted of wild type PfHP1 (Figure 5.3 left panel). This was expected for 3D7/HP1-
∆CD-HAC and 3D7/HP1-∆Hinge-HAC parasites that expressed the ectopic PfHP1 
mutants at very low levels (see Figure 5.2 above). However, the ectopic PfHP1 mutants 
in 3D7/Swi6-N-HAC and 3D7/HP1-∆CSD-HAC were expressed at levels similar to that of 
endogenous PfHP1-GFP-DD so it was unexpected that these two HP1 mutants could 
not be detected by IFA. Hence, I asked if there were some problems during the IFA 
performance that did not allow the visualization of these ectopic PfHP1 mutants under 
OFF Shield-1 conditions. To this end, I conducted an immunoblot analysis using whole 
parasite protein lysates from the 3D7/HP1-Control-HAC, 3D7/Swi6-N-HAC and 
3D7/HP1-∆CSD-HAC lines to examine protein expression levels in both ON and OFF 
Shield-1 conditions. As shown in Figure 5.4, the immunoblot analysis revealed that in 
OFF Shield-1 condition, when endogenous PfHP1-GFP-DD was depleted, the ectopic 
PfHP1s in 3D7/Swi6-N-HAC and 3D7/HP1-∆CSD-HAC lines were expressed at extremely 
low levels compared to that of the 3D7/HP1-Control-HAC line. In ON Shield-1 
condition, the ectopic PfHP1s in 3D7/Swi6-N-HAC and 3D7/HP1-∆CSD-HAC lines were 
expressed at lower levels compared to that of the 3D7/HP1-Control-HAC line (Figure 
5.4), which was different to previous observation (Figure 5.2). Thus, the 3D7/Swi6-N-
HAC and 3D7/HP1-∆CSD-HAC expressed ectopic PfHP1 mutants at uneven levels. 
Therefore, alternative transgenic lines with higher and unfluctuating expression level 
of ectopic PfHP1 variants would be needed for the localization study and further 
studies of PfHP1 mutants. The other cell lines, 3D7/hsHP1-N-HAC and 3D7/Swi6-C-HAC 
should also be re-examined in term of ectopic PfHP1 expression. Nevertheless, the 
immunofluorescence study once again emphasized that (1) CD replacement does 
not severely alter the capacity of PfHP1 to localize to heterochromatin; and (2) CSD 
replacement cannot fulfil this function, probably because of the differences in CSD-
specific binding properties present in each species. 
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Figure 5.3. Localization of ectopic PfHP1 mutants and PfEMP1 expression in PfHP1 
complementation cell lines. (A) Localization study of ectopic PfHP1 mutants. (B) 
PfEMP1 expression of complementation cell lines in the presence (ON Shield-1) and 
absence (OFF Shield-1) of endogenous PfHP1-GFP-DD at 24-32 hpi, generation 2.  
 
 
Figure 5.4. Ectopic PfHP1 expression in some PfHP1complementation cell lines. 
Immunoblot analysis revealed low expression of ectopic PfHP1 mutants in 3D7/HP1-
∆CSD-HAC and 3D7/Swi6-N-HAC compared to that of the 3D7/HP1-Control-HAC line.  
 
In a recent study, it has been observed in PfHP1-depleted 3D7/HP1-GFP-DD parasites 
that (1) PfEMP1 expression is upregulated because of the derepression of var gene 
family; (2) sexual conversion rate is increased because of the derepression of the 
pfap2-g gene, which encodes for PfAP2-G, a master regulator of sexual differentiation 
(Kafsack et al., 2014) and (3) a subpopulation of parasites arrested at the trophozoite 
stage as a result of a failure in DNA replication preventing progression through 
schizogony (Brancucci et al., 2014). In parallel with the localization study, I investigated 
the functional contribution and conservation of the CD, hinge and CSD domains of 
PfHP1 in these three main PfHP1-dependent processes (var gene silencing, mitotic 
proliferation, sexual commitment). 
First, to probe the ability of PfHP1 mutants in maintaining singular choice of var gene, 
IFAs were performed to compare the expression levels of PfEMP1 in the progeny of ON 
and OFF Shield-1 parasites at 24-32 hpi in generation 2. As shown in Figure 5.3 (right 
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panel), in both the ON and OFF Shield-1 conditions, the 3D7/HP1-Control-HAC cell line 
expressed PfEMP1 at low level, represented by comparable fluorescence intensity. As 
expected, in the ON Shield-1 condition, the other complementation cell lines 
expressed comparably low levels of PfEMP1 similarly to that seen for the control cell 
line. In contrast, in the OFF Shield-1 condition strong upregulation of PfEMP1 expression 
was observed for all six other complementation lines 3D7/HP1-∆CD-HAC, 3D7/HP1-
∆Hinge-HAC, 3D7/HP1-∆CSD-HAC, 3D7/hsHP1-N-HAC, 3D7/Swi6-N-HAC and 3D7/Swi6-
C-HAC. This result is similar to the result previously presented for the PfHP1-depleted 
cell line (Brancucci et al., 2014).  
 
Figure 5.5. Phenotypes of PfHP1 complementation cell lines. (A) Growth curves of three 
PfHP1 complementation cell lines and the control cell line over three generations 
under ON/OFF Shield-1 condition. Values were obtained from one experiment (>1000 
RBCs counted for each sample). (B) Sexual conversion rates and proportion of 
arrested trophozoites determined on day seven after Shield-1 removal in the OFF 
Shield-1 population of three complementation cell lines. Values represent mean of 
two independent experiments (>2000 cells counted for each sample).   Error bars 
represent SD. n.d means not determined.  
 
A
B
ON
OFF
ON
OFF
ON
OFF
3D7/HP1-Control-HAC 3D7/hsHP1-N-HAC 3D7/Swi6-N-HAC 3D7/Swi6-C-HAC
Gen. post treatment
1 2 3
0.5
1
1.5
2
0
Pa
ra
si
ta
em
ia
 % ON
OFF
Gen. post treatment
1 2 3
Gen. post treatment
1 2 3
Gen. post treatment
1 2 3
100
n.d
Arrested trophozoites
Gametocytes
3D
7/h
sH
P1
-N
-H
AC
3D
7/S
wi6
-N
-H
AC
3D
7/S
wi6
-C
-H
AC
0
20
40
60
80
Pa
ra
si
ta
em
ia
 ra
tio
 (%
) 100
Chapter 5|            Studying PfHP1 function using genetic complementation approach 
 144 
Second, I evaluated the growth phenotype of the PfHP1 complementation cell lines 
by determining replication rates over three consecutive generations. In the 3D7/HP1-
Control-HAC line, parasites in the ON and OFF Shield-1 condition showed a highly 
comparable rate of multiplication as expected (Figure 5.5A). Meanwhile, in the 
3D7/hsHP1-N-HAC, 3D7/Swi6-N-HAC and 3D7/Swi6-C-HAC lines, parasites in the OFF 
Shield-1 condition consistently showed a proliferation defect in the cycle after Shield-
1 removal (generation 2) (Figure 5.5A). From those OFF Shield-1 populations, I 
obtained approximately 31% of arrested trophozoites at day seven after Shield-1 
removal (Figure 5.5B). These phenotypes are again similar to the growth defect of the 
3D7/HP1-GFP-DD line under OFF Shield-1 condition as described previously (Brancucci 
et al., 2014). 
Third, I examined a possible role of chimeric PfHP1s in controlling pfap2-g silencing by 
examining the sexual commitment rates in three PfHP1 complementation cell lines, 
3D7/hsHP1-N-HAC, 3D7/Swi6-N-HAC and 3D7/Swi6-C-HAC. As shown in Figure 5.5B, 
the gametocyte populations comprised of approximately 41-51% of all infected RBCs 
in the OFF Shield-1 populations. These high rates of sexual commitment are 
comparable to that of the PfHP1-depeleted parasites (Brancucci et al., 2014). 
On the one hand, these preliminary results seemingly suggest that (1) full-length PfHP1, 
or in other words, every single domain of PfHP1 is required for normal growth of asexual 
parasites as well as for controlling singular choice of var gene; (2) the replacement of 
either CD or CSD domain with that of human HP1α or S. pombe Swi6 fails to restore 
PfHP1’s roles in controlling cell cycle progression, var- and ap2-g gene silencing, or in 
other words, the CD and CSD functions are not conserved among P. falciparum, 
fission yeast and human. On the other hand, it is worth noting that HP1 operates 
position-effect variegation in a dose-dependent manner (Eissenberg et al., 1990; 
Eissenberg et al., 1992). Since the two independent immunoblots showed fluctuating 
and/or low expression levels of ectopic PfHP1 mutants in the major of transgenic cell 
lines (3D7/HP1-∆CD-HAC and 3D7/HP1-∆Hinge-HAC, 3D7/HP1-∆CSD-HAC and 
3D7/Swi6-N-HAC), the dosage effect of PfHP1 possibly explained the failure of ectopic 
PfHP1 mutants in fulfilling wild type PfHP1 functions. As mentioned above, there needs 
alternative transgenic cell lines with higher and unfluctuating expression level of PfHP1 
mutants for further studies in order to obtain firm conclusions on the functional 
contribution and conservation of PfHP1 domains among species. Nevertheless, the 
preliminary localization study indicated an important role of the PfHP1 CSD domain in 
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targeting the protein to nucleus and this function is underlined by the 
homodimerization and/or interaction that is specific for each species. This result is 
consistent with investigated role of CSD presented in Chapter 3 of this thesis. 
 
Table 1. List of primers 
Application Primer Sequence 5’-3’ 
PCR cloning  
  
  
  
  
  
  
  
  
2wd CAGT GGATCCAAAAAATGACAGGGTCAGATGAAGA 
2rev CAGTGCGGCCGCATTTAAATGTCCAGTTCTTCTAA 
5fwd CAGT GGATCCAAAAA ATGACAGGGTCAGATGAAGA 
5rev CAGTGCGGCCGCATTTAAATGTCCAGTTCTTCTAA 
R3 CAGTGCTAGCTGCTGTTCTATATCTTAATCT TG 
F6 CAGTGGATCCAAAAAATGGGAAAGAAAACCAAGCGGAC 
R7 GAAATTTGTTTTTAATGATTCCATCTCCTTCATCTTCTTATAC 
F8 CAGTGGATCCAAAAAATGAAGAAAGGAGGTGTTC 
R9 GAAATTTGTTTTTAATGATTCCATTGGTCTTCCTCCATGTTC 
F10 ATGGAATCATTAAAAACAAATTTC 
F15 GAAGAACAGGTCATTTGAATGTTAAACAAGTAGAAAACTATG 
R16 CAGT GCTAGCTTCATTTTCACGGAACGTTAAG 
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Chapter 6. General discussion and Outlook   
6.1 PfHP1 phosphorylation and speculation 
It has been well observed in other model eukaryotes that HP1 is subject to 
phosphorylation to regulate its various functions including progression through mitosis 
(Chakraborty and Prasanth, 2014; Hiragami-Hamada et al., 2011) and 
heterochromatic gene silencing (Hiragami-Hamada et al., 2011; Shimada et al., 2009; 
Zhao and Eissenberg, 1999; Zhao et al., 2001). The hinge domain of HP1 has been 
known for DNA/RNA binding activity in the human, mouse and Xenopus laevis HP1 
family proteins (Meehan et al., 2003; Muchardt et al., 2002; Sugimoto et al., 1996). In 
P. falciarpum, most of the phosphosites in PfHP1 identified by MS/MS intriguingly 
clusters in the hinge region, proposing a possible link between hinge domain 
phosphorylation and PfHP1 function at first impression.  
Focusing on investigating the role of the PfHP1 hinge phosphorylation in parasite 
biology in vivo, I have successfully applied the CRISPR/Cas9-mediated genome 
editing technique to generate a number of conditional PfHP1 phospho-mutants 
based on the DiCre/LoxP system. One of the advantages of this method is the 
conditional expression of the PfHP1 mutants in absence of wild type PfHP1, ensuring 
that dimerization between wild type and mutated PfHP1 does not occur. Thus, the 
system allows precise interpretation on the localization of PfHP1 mutants. Although 
western blot results showed high expression of PfHP1 phosphomutants and absence 
of endogenous PfHP1 (Chapter 2 of this thesis), I did not observe any clear differences 
in the localization of phosphomutated PfHP1s compared to wild type PfHP1 in my IFAs 
as well as in the three major PfHP1-dependent processes of var gene silencing, sexual 
commitment and S-phase entry (Brancucci et al., 2014). 
Considering the methodology for studying in vivo function of PfHP1 phosphorylation in 
particular, and protein phosphorylation in general, alanine is largely used as a non-
phosphoryltable residue to substitute serine, and is a powerful approach to mimic the 
effect of non-phosphorylation (Chen and Cole, 2015). Although serine and alanine 
are both small amino acids, serine is polar amino acid, meaning it is hydrophilic, while 
alanine is non-polar and hydrophobic. Furthermore, the side chain from serine can 
form hydrogen bonds with a variety of polar substrates in contrast to the non-active 
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side chain from alanine (Chen and Cole, 2015). The serine-to-alanine substitution 
might, therefore, alter the hydrophobicity or secondary structure of the PfHP1 hinge 
region. However, since the hinge region is unstructured (Lomberk et al., 2006), it is 
possible that the serine-to-alanine substitution does not largely affect PfHP1 global 
structure, hence, PfHP1 functions. In my study, all phosphomutants (3D7/HP1-3M and 
3D7/HP1-HIM) retain PfHP1 functions, suggesting that the serine-to-alanine 
substitutions did not negatively impact on PfHP1 function. 
So, the question is: what role do these phosphosites in the hinge region play? I raise a 
hypothesis that the phosphorylation of PfHP1 hinge domain might contribute to 
regulate PfHP1 interaction with (1) DNA/RNA and/or (2) a so far unknown interactor. 
The first hypothesis could be tested in vitro by mobility shift electrophoresis assay - 
EMSA using purified recombinant wtPfHP1 and hinge-phosphomutated PfHP1s. The 
second hypothesis could be tested by PfHP1 pull-down experiments between the 
DMSO- and RAP-treated conditions using the 3D7/HP1-HIM cell line. However, such 
factors could appear in only a certain stage among many stages during the P. 
falciparum life cycle, so nuclear protein extraction should be conducted in time 
course. Together with the fact that no major effects were observed by the non-
phosphorylatable PfHP1 hinge domain during blood stages, such pull-down 
experiments should also be performed in mosquito stage of the parasites.  Beside the 
localization, interaction and the three major PfHP1-dependent cellular processes, the 
function of PfHP1 hinge phosphorylation could be tested on the fitness of parasites 
during cellular stress such as heat shock or anti-malaria drug susceptibility. 
Of course, with the experimental design system and “knock-in” technique I 
established by the CRISPR/Cas9 and DiCre/loxP systems, my study provides an elegant 
approach to allow studying the functional contribution of other phosphosites within 
the PfHP1 CD and CSD domains. One of the most interesting phosphosite to me is S206, 
whose position is next to a predicted NLS motif (aas 201-204) residing in the CSD region 
(Chapter 3 of this thesis). It is worth noting that the S206 residue was detected only 
once in our four MS/MS experiments mapping phosphorylated residues in native 
PfHP1-GFP purified by immunoprecipitation (IP) from protein extracts of blood stage 
parasites (Bui et al., manuscript submitted). The apparent low frequency of the S206 
phosphorylation is possibly due to its phosphorylation state occurring in a narrow time 
window or in a very small subpopulation of the parasites. From this point of view, the 
phosphorylation state of S206 itself in the CSD domain possibly regulates the 
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interaction of PfHP1 with other effectors to modulate a special process occurring only 
in such a short time period or small subpopulation. To enlighten this hypothesis, a cell 
line carrying a serine-to-alanine substitution at S206 could be easily generated. It is 
certainly worth to generate a phosphomimetic control cell line of by serine-to-
glutamate substitution (Chen and Cole, 2015; Hiragami-Hamada et al., 2011; Shimada 
et al., 2009; Zhao and Eissenberg, 1999)  at S206 in order to compare the effects of 
phosphorylation (DMSO control condition) versus constitutive phosphorylation (serine-
to-glutamate) and non-phosphorylation (serine-to-alanine). 
In summary, successful identification of PfHP1-associated processes with PfHP1 
phosphorylation will undoubtedly contribute to our understanding about PfHP1 and 
its function in malaria pathology. 
6.2 Functional contribution of PfHP1 individual domains and speculation 
While the hinge phosphorylation is likely not involved in PfHP1 function during the 
parasitic IDC (Bui et al., manuscript submitted), it can be predicted that hinge domain 
replacement should not influence PfHP1 functions. In fact, the replacement of PfHP1 
hinge domain by PbHP1 hinge domain retained PfHP1 function (Chapter 3 of this 
thesis). It is probably because of the high similarity in length (the PbHP1 hinge domain 
is 15 residues longer than the PfHP1 hinge domain) and in the sequences (Chapter 3 
of this thesis). However, the replacement of PfHP1 hinge domain by a shorter linker 
prevented PfHP1 heterochromatin localization and induced gametocytogenesis 
(Chapter 3 of this thesis). Furthermore, when the hinge domain was preserved and the 
CD was partly shortened (deletion of residues 30-58, 3D7/HP1-∆CD line), 
heterochromatin targeting was also hampered, probably because of the 
abolishment in H3K9me3 binding ability. Together, these results emphasized the CD 
and hinge regions as targeting module of PfHP1 to heterochromatin. In addition, this 
function also likely depends on the length of the hinge domain as implied in an in vivo 
study in S. pombe (Wang et al., 2000). In S. pombe, when the hinge domain was 72-
residues shortened to the length of mouse HP1α (M31), the truncated protein still fully 
functioned as opposed to a longer removal of 95 residues in the hinge that resulted in 
a major reduction of Swi6 functions in normal zygote asci formation and mitotic 
stability (Wang et al., 2000).  
In my study, I tackled the functional contribution of the hinge domain by the 
substitution of the hinge domain with a short linker from another protein (PfSIP2). At first 
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glance, this replacement was a good solution since the small linker between two AP2 
domains of PfSIP2 has fulfilled the purpose of mimicking a spacer between CD and 
CSD domain from PfHP1. However, going beyond this aim and in order to incorporate 
other scientific questions, for example which residues of the hinge domain are 
essential for PfHP1 function or to what extent the hinge domain reduction in length is 
tolerable for PfHP1 functions, my approach employed here cannot answer. In 
general, the insertion of another gene fragment into pfhp1 could interfere with 
downstream analysis, for example the interpretation of localization results since PfSIP2 
also localizes to nucleus at heterochromatin loci and co-localizes with PfHP1 (Flueck 
et al., 2009). Fortunately, PSORTII prediction did not reveal any NLS in the PfSIP2 linker. 
In any case, to fulfil the research aims more comprehensively, the methodology would 
be more optimal to preserve PfHP1 hinge sequences and study its functional 
contribution by a series of hinge deletion. 
In summary, although there have been some disadvantages in the method applied, 
my study still implies the essence of the CD-hinge region in targeting PfHP1 to 
heterochromatin, in which the contribution of the hinge domain as a spacer is still an 
open question that can be investigated in future.  
6.3 PfHP1 and var gene regulation during gametocytogenesis 
Chronic malaria is caused by the persistence of the parasites during blood stage 
infection (Buffet et al., 2011; Cowman et al., 2016; Kyes et al., 2001). The underlying 
reason for this persistence is the antigenic variation of the variant surface adhesion 
antigens, especially PfEMP1 expressing on iRBCs that allows immune evasion (Buffet et 
al., 2011; Cowman et al., 2016; Kyes et al., 2001). Further, PfEMP1 also mediates 
parasite rosetting (attachment of iRBCs to uninfected RBCs and the cytoadhesion to 
the microvasculature (Cowman et al., 2016; Newbold et al., 1997; Reeder and Brown, 
1996; Rowe et al., 2009). Once sequestered, the parasites escape from splenic 
clearance, causing severe symptoms (Buffet et al., 2011; Cowman et al., 2016; Kyes 
et al., 2001). Thus, PfEMP1 is considered the major virulence factor of P. falciparum 
and the study on controlling mechanisms of var gene expression would contribute to 
understanding on pathology and assist malaria prevention. PfEMP1 is encoded by the 
var gene family that contains 60 members but only one var gene is transcribed by a 
single parasite (Dzikowski and Deitsch, 2009; Scherf et al., 1998; Voss et al., 2006). This 
is known as mutually exclusive expression. The expression switch of PfEMP1/var gene 
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in mutually exclusive expression is a key component of antigenic variation (Reeder 
and Brown, 1996; Scherf et al., 2008). The mutually exclusive expression of var genes 
has been shown to be regulated by different epigenetic mechanisms including 
lncRNAs (Amit-Avraham et al., 2015; Jiang et al., 2013; Ralph et al., 2005), chromatin 
structure changes involving histone variants (Petter et al., 2011; 2013) and histone post-
translational modifications (Lopez-Rubio et al., 2007; Westenberger et al., 2009), 
subnuclear compartmentalisation/genome organization (Brolin et al., 2009; Marty et 
al., 2006; Ralph et al., 2005; Voss et al., 2006), histone-modifying enzymes like HDACs 
(Duraisingh et al., 2005; Tonkin et al., 2009), HKMTs (Jiang et al., 2013; Volz et al., 2012)  
and PfHP1 (Brancucci et al., 2014). Among the epigenetic factors that maintain 
singular choice of var gene expression, PfHP1 has been shown to be a key regulator 
of antigenic variation as conditional depletion of PfHP1 (3D7/HP1-GFP-DD in OFF 
Shield-1 condition) disrupted transcriptional silencing of almost all of var genes as well 
as the ap2-g gene encoding for PfAP2-G (Brancucci et al., 2014). In repressive state, 
internal and subtelomeric var genes were tethered at nuclear periphery while in 
permissive state, an actively transcribed var gene was disassociated with telomeric 
clusters and repositioned to another site of the nuclear periphery (Ralph et al., 2005; 
Voss et al., 2006). Interestingly, using the same PfHP1-depleted cell line (3D7/HP1-GFP-
DD in OFF Shield-1 condition) and applying the Hi-C (chromosome conformation 
capture coupled with next-generation sequencing) technique, recently Bunnik and 
colleagues showed a complete loss of tethering between internal and subtelomeric 
var genes, suggesting a role for PfHP1 in maintaining the structure of repressive var 
clusters (Bunnik et al., 2018). While these studies clearly demonstrated the important 
role of PfHP1 in derepression of var genes, I still propose some aspects need to be 
revisited. First, is there any correlation between the induction in var gene transcription 
and PfEMP1 protein translation? Brancucci and colleagues revealed the hyper-
expression of PfEMP1 in the PfHP1-depleted cell line both by IFA and by immunoblot 
analysis. However, since there are two subpopulations in the investigated progeny of 
PfHP1-depleted parasites (approximately 50% each of arrested trophozoites and early 
gametocytes), it is unclear whether both of the two subpopulations hyper-expressed 
PfEMP1. In my preliminary results about the expression of PfEMP1, I consistently 
observed lack of PfEMP1 expression in the progeny of all RAP-treated PfHP1-GFP 
mutant cell lines (3D7/HP1-KO, 3D7/HP1-∆CD, 3D7/HP1-∆Hinge and 3D7/HP1-∆CSD). 
Hence, my preliminary results are seemingly in contrast to the results previously 
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presented (Brancucci et al., 2014). The major difference between the PfHP1 depleted 
cell line (3D7/HP1-GFP-DD in OFF Shield-1 condition) and the PfHP1 knockout cell line 
(3D7/HP1-KO in RAP treated condition) resides in the sexual conversion rate that the 
former one produced ~50% (Brancucci et al., 2014) while later one produced up to 
nearly 100% gametocytes (Chapter 3-4 of this thesis). Therefore, I speculate that in 
PfHP1 depleted cell line, the subpopulation hyper-expressing PfEMP1 likely derives 
from the arrested trophozoites. To confirm the observation of my study, microarray or 
qRT-PCR would be practical methods to examine the var transcription profile in 
gametocytes produced by PfHP1 knockout cell line. Nevertheless, my preliminary 
results suggest an unknown mechanism employed by early gametocytes to suppress 
the expression of var/PfEMP1 even in a PfHP1-depleted background. In other words, 
during onset of gametocytogenesis the repression of var gene transcription possibly 
follows another regulatory mechanism that is PfHP1-independent. The downregulation 
of var gene at the onset of gametocytogenesis could be due to the low abundance 
(or absence) of the transcription factor(s) activating var gene, which is previously 
abundant in asexual stage parasites. Further, this result is highly consistent with 
previously reported result (Tibúrcio et al., 2013). Gametocytes with wild type PfHP1 
background have been shown to minimally express PfEMP1 on the membrane of 
knob-less gametocyte-iRBCs (Tibúrcio et al., 2013). It has also been shown that stage 
I/II gametocyte-iRBCs were unable to bind to the host ligands used by PfEMP1 
expressed by the asexual parasites to bind endothelial cells such as ICAM1 and CD36 
by cytoadhesion assays (Tibúrcio et al., 2013). Although a defined subset of 
nonsubtelomeric type C var genes were selectively transcribed during gametocyte 
development (early stage II and III) independent to the phenotype of asexual 
progenitors (Sharp et al., 2006; Tibúrcio et al., 2013), global transcription of var genes 
was dramatically reduced at early gametocytogenesis in 3D7 (Tibúrcio et al., 2013). 
Additionally, the PfEMP1 reduction phenotype is not surprising because of the need 
of low antigenicity of immature gametocytes during their long residence in the bone 
marrow in order to avoid destruction by the reticulo-endothelial system (Alano, 2007; 
Rogers et al., 2000).  
In a PfHP1-depleted cell line with almost all of var gene transcription upregulated 
(Brancucci et al., 2014), the proportion of parasites hyper-expressing PfEMP1 was not 
specified (Brancucci et al., 2014). As there is limitation for the physical purification of 
gametocytes stage I and arrested trophozoites as well as changes in experimental 
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conditions as mentioned before (chapter 4 of this PhD thesis), I was not able to repeat 
the PfEMP1 expression experiments of the 3D7/HP1-GFP-DD cell line (Brancucci et al., 
2014). I therefore suggest experimental methods that would allow to resolve these 
obstacles. The first and easier method is to repeat a double-labelling IFA using α-ATS 
antibodies recognizing the conserved ATS domain of PfEMP1 and antibodies 
recognizing the early gametocyte marker; Pfs16 (Bruce et al., 1994) and PfGEXP5 
(Tibúrcio et al., 2015) are such early gametocyte markers. However, antibodies 
available for those are all mouse-derived (Tibúrcio et al., 2015), causing problems for 
co-labelling with the mouse-derived α-ATS antibodies. We later determined by ELISA 
that α-ATS is mouse IgG1-κ antibodies while α-Pfs16 is mouse IgG1-λ antibodies (with 
help from Julia Hauser, Swiss TPH). Thus, Pfs16 and PfEMP1 double-labelling IFA using 
different antibody subtypes could be feasible. Alternatively, a second method is to 
regenerate a PfHP1 loss-of-function mutant as Brancucci and colleagues described 
previously, however in a conditional PfAP2-G overexpression cell line. Such a cell line 
could be obtained by the insertion of a pfap-2g gene targeted with a sequence 
encoding the glmS ribozyme (Prommana et al., 2013) and a fluorescent tag like 
CherryFP or the tandem dimer Tomato (tdTomato) (Morris et al., 2010) into the non-
essential cg6 locus (Nkrumah et al., 2006). I expect a homogenous sexually committed 
population when Shield-1 is removed to deplete PfHP1 while PfAP2-G is simultaneously 
overexpressed by glucosamine removal (Prommana et al., 2013) at early ring stage 
(Bancells et al., 2019; Brancucci et al., 2014) to drive sexual commitment. In this case, 
the non-overexpression of PfAP2-G by the continuous presence of glucosamine is 
considered as control condition, in which I expect two subpopulations of 
gametocytes and arrested trophozoites as described previously in the PfHP1-depleted 
cell line (Brancucci et al., 2014). Moreover, another external control cell line could be 
added to the study by generating a PfHP1 loss-of-function mutant in a null PfAP2-G 
background cell line, where the sexual conversion is blocked. In the latter control cell 
line, I expect that the PHP1 depletion results in a pure arrested trophozoite population. 
α-PfEMP1 IFAs among three conditions (pure gametocytes, pure arrested trophozoites 
and mixed of the two populations) would hopefully allow concluding on the actual 
overexpression of PfEMP1 whether in gametocytes and/or only in arrested 
trophozoites with a PfHP1-depleted background.   
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6.4 Significance of the research 
Although there is tremendous amount of research in the field of malaria, this tropical 
disease is still a burden to developing countries and claims over 400.000 deaths in 2017 
(World malaria report 2018, WHO). This is mainly because of the impressive biology of 
the parasite as it lives a very complex life cycle, changing between different hosts 
and various environments as well as combining both asexual proliferation and sexual 
differentiation within the human blood stream. Another striking feature is that this 
human malaria parasite can express highly stage-specific and variable antigens, 
allowing the parasite to escape the human immune response. Together, this causes a 
lot of difficulties in malaria eradication unless there is deep understanding in the 
underlying mechanisms that take part in regulating its transmission and antigenic 
variation. In this theme, epigenetics in general and PfHP1 in particular has emerged 
as a central part that needs to be studied in much more detail.  
For the first time, I have conducted a detailed study on the function of PfHP1 as well 
as its central contribution to the three main PfHP1-dependent processes (var gene 
silencing, mitotic proliferation, sexual commitment) through the conditional expression 
of truncated and chimeric PfHP1s in a DiCre recombinase-expressing 3D7 cell line 
(1G5DC) (Collins et al., 2013). Following up on this aspect, PfCK2 was revealed to 
phosphorylate PfHP1 in vitro at a cluster of serines in the hinge region. In addition, 
PfHP1 phosphorylation was also analyzed for the first time although the 
phosphorylation of the hinge region showed unimportant to control PfHP1 function in 
blood stage parasites. In this study, the success in generating an inducible PfHP1-
knockout parasite line that produces gametocytes at high levels is indeed an 
important tool to perform further research on gametocyte biology and development 
or applied research to prevent malaria transmission such as identifying anti-malarial 
gametocyte drug screen. Beside relevant research prospection, the method for the 
generation of conditional knockout cell lines presented in this study by combining 
CRISPR/Cas9-based gene editing and conditional gene replacements using the 
DiCre/loxP system presents an elegant and versatile approach to analyze function 
and phosphorylation also of other important proteins. Furthermore, this study may also 
be relevant to study pathogenesis and transmission in general and the underlying 
epigenetic mechanisms in particular, in some other unicellular pathogenic eukaryotes 
since they also share common features such as changing living environments and 
mutually exclusive expression of surface antigens. 
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